Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,retinoid binding (GO:0005501),-0.8272255889571947,-2.6268732789327034,0.0,0.0,0.0,8/22,7.45%,NR2F2;ALDH1A2;PTGDS;RBP4;CYP26B1;RBP1;CRABP2;ABCA4
prerank,retinoic acid binding (GO:0001972),-0.7529570543053538,-1.997302464195624,0.0,0.05774617539323421,0.094,2/12,3.86%,NR2F2;CYP26B1
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.6922356834491983,-1.993741102856674,0.0,0.02967511791041203,0.096,9/16,11.03%,PTPRK;PTPRG;PTPRB;PTPRD;PTPRM;PTPRN2;PTPRZ1;PTPRO;PTPRT
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.6922356834491983,-1.993741102856674,0.0,0.02967511791041203,0.096,9/16,11.03%,PTPRK;PTPRG;PTPRB;PTPRD;PTPRM;PTPRN2;PTPRZ1;PTPRO;PTPRT
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.771978707116635,-1.9619707437278502,0.0,0.03293670744651137,0.128,4/11,11.15%,ITPR1;RASA3;ITPR3;RYR2
prerank,monocarboxylic acid binding (GO:0033293),-0.6369769139297048,-1.947365587029896,0.0,0.03315058217019001,0.155,3/18,6.32%,NR2F2;CYP26B1;NAPEPLD
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.872363245680994,1.8973279868652453,0.0,0.04135458632155604,0.032,3/14,0.87%,NOX4;DUOX1;NCF4
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.5844848963720342,-1.86418498701408,0.0,0.06691223497946187,0.333,9/26,7.80%,SLC6A13;SLC16A12;SLC16A2;ABCG2;SLC16A6;SLC6A12;SLC6A1;SLC16A11;SLC16A4
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.9199464065433457,1.8553009330805652,0.0,0.05513944842874138,0.089,3/10,0.87%,NOX4;DUOX1;NCF4
prerank,semaphorin receptor activity (GO:0017154),-0.7225017671937859,-1.8429554232051026,0.010416666666666666,0.07097967392085039,0.394,6/11,8.63%,PLXNA2;NRP2;PLXNA4;PLXND1;NRP1;PLXNB1
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.7234135769685888,-1.8261980846167376,0.0030303030303030303,0.07331150250540229,0.433,7/11,14.12%,ITPR1;TRPC5;ITPR3;TRPC6;TRPC4;TRPC7;TRPC3
prerank,CoA-ligase activity (GO:0016405),-0.6679121231568433,-1.8212322076696374,0.011583011583011582,0.0689745983863631,0.441,5/14,12.68%,ACSL1;ACSS3;AACS;ACSS1;ACSS2
prerank,amino acid:sodium symporter activity (GO:0005283),-0.6997385221669024,-1.7890592927995028,0.0037174721189591076,0.08486937898702605,0.545,4/11,3.01%,SLC6A13;SLC1A3;SLC6A12;SLC6A1
prerank,acid-thiol ligase activity (GO:0016878),-0.6753920721986248,-1.7775972396232256,0.003676470588235294,0.08572811840785698,0.578,5/13,12.68%,ACSL1;ACSS3;AACS;ACSS1;ACSS2
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),-0.4614774534810623,-1.77703856335012,0.0,0.07929816677931308,0.58,12/55,4.70%,SLC7A2;SLC6A13;SLC16A12;SLC13A3;SLC16A2;SLC16A6;SLC6A12;PDPN;SLC38A11;SLC7A5;SLC16A11;SLC22A4
prerank,fibroblast growth factor receptor binding (GO:0005104),0.740224677243572,1.7557430216514194,0.0024937655860349127,0.2622405910390736,0.484,4/21,2.88%,FGF18;FGF7;NPTN;FGF2
prerank,store-operated calcium channel activity (GO:0015279),-0.718284087596746,-1.7453628305159485,0.005934718100890208,0.09738938310366882,0.675,6/10,14.12%,TRPC5;TRPC6;TRPC4;ORAI2;TRPC7;TRPC3
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.6954319666412325,-1.7440762542906603,0.007874015748031496,0.09196613118181746,0.681,8/12,19.35%,CNOT2;PAN3;CNOT7;NOCT;CNOT6L;TOE1;PNLDC1;CNOT1
prerank,serine-type peptidase activity (GO:0008236),0.6203257158279865,1.738102244319058,0.0,0.25920463926546733,0.582,23/96,16.64%,HTRA3;PCSK6;KLK9;PRSS48;DPP4;HPN;FAP;PCSK5;MMP2;GZMK;PRSS12;PCSK4;RHBDF1;TPP1;MASP2;GZMM;PIK3IP1;KLK1;KLK6;CLPP;PRSS8;HGF;HTRA2
prerank,sulfuric ester hydrolase activity (GO:0008484),0.8213324904210407,1.7240411840207754,0.0013422818791946308,0.2573830682013035,0.667,5/12,7.26%,ARSA;SULF2;ARSJ;ARSI;SULF1
prerank,protease binding (GO:0002020),0.6086467591983065,1.6770397353804376,0.0,0.43471547288016643,0.892,24/99,10.48%,COMP;COL3A1;COL1A2;TIMP2;COL1A1;CCBE1;DPP4;FAP;CD177;ITGB3;ANXA2;ECM1;SRI;BIN1;SPATA2;SYVN1;ADAMTSL4;ATP9A;CARD16;TRIP4;CLTC;ADRM1;ITGAV;CSTB
prerank,platelet-derived growth factor binding (GO:0048407),0.8163568067703869,1.6741775132613554,0.004178272980501393,0.38864871430768483,0.9,6/11,10.13%,COL3A1;COL1A2;COL1A1;COL5A1;COL6A1;COL2A1
prerank,serine-type endopeptidase activity (GO:0004252),0.6061846801360707,1.6650153921410304,0.0010471204188481676,0.38142221134078025,0.919,19/80,16.64%,PCSK6;KLK9;PRSS48;DPP4;HPN;FAP;PCSK5;MMP2;PRSS12;PCSK4;RHBDF1;MASP2;GZMM;PIK3IP1;KLK1;KLK6;CLPP;HGF;HTRA2
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.6518504838689422,-1.6486101651613732,0.03484320557491289,0.17678082629063022,0.894,6/10,15.93%,CASP4;CASP3;CASP7;CFLAR;CASP9;CASP6
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.6100029417673467,-1.6476964638600644,0.027888446215139442,0.16757713643526792,0.896,4/13,1.98%,BMP6;CDH5;BMP5;BMP7
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.6669179495948199,-1.647073054507534,0.03460207612456748,0.15898021126779296,0.898,4/11,14.89%,PPP1R1A;PPP1R8;PPP1R14A;PABIR1
prerank,microtubule plus-end binding (GO:0051010),0.7006476997583493,1.6024285009722548,0.010282776349614395,0.7234864532921961,0.996,13/20,22.51%,DCTN1;CLIP1;DST;MAPRE3;CLIP2;MAPRE1;CLIP4;PAFAH1B1;STIM1;CLIP3;CLASP2;NUMA1;FBXW11
prerank,protein tyrosine kinase activator activity (GO:0030296),0.6864133017970693,1.5874272944161243,0.022443890274314215,0.7710661082954888,0.999,7/19,12.37%,EFNA5;ANGPT4;DGKQ;GAS6;ABI1;NRG3;EGF
prerank,filamin binding (GO:0031005),-0.6147282649902309,-1.5846730118289634,0.038314176245210725,0.22800171200584,0.966,6/11,15.73%,NEBL;SYNPO2;TMEM67;CEACAM1;FBLIM1;MICALL2
prerank,BMP receptor binding (GO:0070700),-0.6100041636005827,-1.5841066351715445,0.03802281368821293,0.2170293758529053,0.966,4/12,1.98%,BMP6;CDH5;BMP5;BMP7
prerank,low-density lipoprotein particle binding (GO:0030169),-0.5611925828209562,-1.5763716432180983,0.03404255319148936,0.21687915432079763,0.97,6/16,10.51%,PLTP;SCARB1;THBS1;STAB1;CDH13;SORL1
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",-0.55506235761771,-1.5669261974542579,0.06329113924050633,0.21815221815221816,0.975,10/16,33.13%,ETHE1;CDO1;ALOX12;ADI1;PIR;BCO2;HGD;ALOXE3;HAAO;ALOX5
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.7274833941158472,1.5635838896440089,0.02425876010781671,0.8976272546159393,1.0,2/13,3.53%,EHHADH;MIF
prerank,calcium-release channel activity (GO:0015278),-0.5290158167540752,-1.5343252640238996,0.029661016949152543,0.25334855854889954,0.989,3/17,5.14%,ITPR1;RASA3;ITPR3
prerank,phospholipase binding (GO:0043274),0.7117541031888578,1.528970165843388,0.037889039242219216,1.0,1.0,4/13,6.81%,SYK;FYN;DGKQ;SRC
prerank,protein kinase C binding (GO:0005080),0.5911362086170933,1.5230845255090573,0.010112359550561797,1.0,1.0,15/43,10.44%,AVPR1A;NELL2;IRS1;DACT3;ADAM9;HDAC9;HDAC7;DACT1;DACT2;YWHAG;PRKD2;PARD6A;TIRAP;ITGAV;SQSTM1
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.7146669409275731,1.5092346695565266,0.02861035422343324,1.0,1.0,4/14,10.95%,CAPN5;CAPN2;CAPN1;CAPN11
prerank,clathrin adaptor activity (GO:0035615),0.6927448926141975,1.5023173289003808,0.04516129032258064,1.0,1.0,4/15,6.08%,STON2;AP1G2;AP1M1;AP2A2
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.5387627976779119,-1.494320778619676,0.06639004149377593,0.30062765847079576,0.997,5/15,9.79%,ALDH1A1;ALDH1A2;ALDH7A1;ALDH4A1;ALDH1L1
prerank,dipeptidyl-peptidase activity (GO:0008239),0.7167485938404964,1.4926797016916766,0.06111111111111111,1.0,1.0,3/10,6.10%,DPP4;FAP;PRCP
prerank,C-C chemokine binding (GO:0019957),0.6252472449909972,1.4905311033393376,0.03975155279503106,1.0,1.0,6/22,17.61%,ACKR3;ACKR4;ACKR1;ZFP36;CXCR4;CXCR2
prerank,frizzled binding (GO:0005109),0.5994152141458877,1.489893996424388,0.041237113402061855,1.0,1.0,6/34,2.82%,MYOC;LRP6;WNT10B;WNT2;CCDC88C;WNT9A
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.5502889290490338,-1.4787095904554832,0.06640625,0.3151657928128516,0.999,5/13,9.79%,ALDH1A1;ALDH1A2;ALDH7A1;ALDH4A1;ALDH1L1
prerank,growth factor receptor binding (GO:0070851),0.5178083038710214,1.452893430053812,0.008316008316008316,1.0,1.0,27/95,16.67%,AREG;FGF18;FGF7;TIMM50;GLMN;BTC;FYN;ITGB3;VEGFA;FGF2;ITGA5;PTPRJ;ARF4;SRC;TLR5;SNX1;ESM1;ATXN2;PSEN1;ERN1;PIBF1;EGF;PDGFRA;FER;IL4;IL6;EFEMP1
prerank,3'-5' DNA helicase activity (GO:0043138),0.6547082962525506,1.4513211867021065,0.07840616966580977,1.0,1.0,6/16,18.32%,NAV2;HELQ;ASCC3;ERCC3;RECQL;BLM
prerank,ferrous iron binding (GO:0008198),-0.46603830816096364,-1.4482437269891046,0.043010752688172046,0.357129658788784,1.0,17/21,35.26%,SNCA;FTH1;PHYH;EGLN3;FECH;EGLN1;ISCU;CDO1;FTL;FTO;ALKBH2;TET2;ACP5;ALKBH3;HAAO;HIF1AN;HEPH
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.6601045769781062,1.4427827918272966,0.08115183246073299,1.0,1.0,3/15,4.54%,SLC1A5;SLC1A7;SLC1A6
prerank,amino acid transmembrane transporter activity (GO:0015171),-0.37907726818326554,-1.4406688275919797,0.05319148936170213,0.3574480335555136,1.0,15/47,13.34%,SLC7A11;SLC7A2;SLC6A13;SLC16A2;PDPN;SLC6A1;SLC38A11;SLC7A5;SLC22A4;SLC3A2;SLC38A5;SLC25A44;SLC6A6;SLC43A1;SLC7A14
prerank,ligand-gated calcium channel activity (GO:0099604),-0.4771708065228567,-1.4399506661593788,0.06451612903225806,0.34552225448583995,1.0,3/19,5.14%,ITPR1;RASA3;ITPR3
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.5554992653087135,-1.4381153024422262,0.09558823529411764,0.3375164389363173,1.0,6/11,15.93%,CASP4;CASP3;CASP7;CFLAR;CASP9;CASP6
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.5895104333592908,-1.4348498357004449,0.07911392405063292,0.3317909880001383,1.0,3/10,3.01%,SLC6A13;SLC6A12;SLC6A1
prerank,bHLH transcription factor binding (GO:0043425),-0.4884925367854886,-1.4279354037118654,0.0821256038647343,0.33226473201172757,1.0,8/19,12.63%,FHL2;SMAD3;CREBBP;SP1;TCF12;SIRT1;LMO2;USF1
prerank,phospholipase inhibitor activity (GO:0004859),0.7186381235868619,1.4240999685039784,0.06403269754768393,1.0,1.0,3/10,2.53%,SNCB;ANXA1;ANXA2
prerank,water transmembrane transporter activity (GO:0005372),-0.5465393779918657,-1.4210655075717082,0.10163934426229508,0.3332435538317891,1.0,2/11,8.86%,PDPN;AQP11
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.6856823113887494,1.4187630604643622,0.08096590909090909,1.0,1.0,3/11,14.44%,AKR1B1;RDH14;RDH13
prerank,acylglycerol lipase activity (GO:0047372),0.697847151383169,1.4156006413352065,0.08310991957104558,1.0,1.0,1/11,0.62%,MGLL
prerank,chemokine binding (GO:0019956),0.5695384043723549,1.414291881391193,0.060141509433962265,1.0,1.0,9/30,17.61%,ACKR3;ITGB3;FGF2;ACKR4;ITGAV;ACKR1;ZFP36;CXCR4;CXCR2
prerank,tropomyosin binding (GO:0005523),-0.4881356701721477,-1.413348530404178,0.08296943231441048,0.33613977404827083,1.0,3/16,6.57%,NEBL;CALD1;TMOD3
prerank,phospholipase activator activity (GO:0016004),0.6908314809222984,1.4090839991465292,0.10714285714285714,1.0,1.0,4/10,9.18%,CCL8;FYN;SRC;STX4
prerank,carbohydrate:cation symporter activity (GO:0005402),0.6836175271162733,1.4065002843931254,0.08748317631224764,1.0,1.0,5/11,13.02%,SLC5A9;SLC17A5;SLC2A10;SLC23A1;SLC23A2
prerank,ubiquitin-specific protease binding (GO:1990381),0.6105473714260969,1.4030727356283659,0.09440993788819876,1.0,1.0,9/19,24.40%,SPATA2;SYVN1;CLTC;AMFR;SELENOS;PTEN;DERL1;RHBDD2;LCOR
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.6545144894030501,1.3998786960281686,0.08921438082556592,1.0,1.0,1/14,0.74%,DHRS9
prerank,receptor antagonist activity (GO:0048019),0.6248229009975266,1.3991106559201048,0.0851063829787234,1.0,1.0,4/17,17.99%,DKK2;IGSF1;DKK3;PXDN
prerank,UDP-glycosyltransferase activity (GO:0008194),0.5196691338037561,1.391030355129963,0.04569606801275239,1.0,1.0,13/70,10.58%,HAS2;HAS1;B4GALT1;B3GALNT1;CSGALNACT2;EXT1;B4GALNT4;POMGNT2;CHSY3;B3GAT3;RFNG;LARGE1;B3GNT8
prerank,growth factor activity (GO:0008083),0.5063111690760314,1.3886980205732886,0.04021164021164021,1.0,1.0,17/74,16.31%,LIF;AREG;FGF18;FGF7;BTC;VEGFA;FGF2;CLCF1;INHA;JAG1;NRG3;EGF;GDNF;ARTN;IL4;IL6;HGF
prerank,solute:sodium symporter activity (GO:0015370),0.5719312443721656,1.3822527498419688,0.0847457627118644,1.0,1.0,3/27,2.11%,SLC5A9;SLC4A10;SLC4A8
prerank,galactosyltransferase activity (GO:0008378),0.6562856311131777,1.3763569139757428,0.11917808219178082,1.0,1.0,2/11,2.22%,B4GALT3;B4GALT1
prerank,lipoprotein particle binding (GO:0071813),-0.45668716567027245,-1.3740838889714189,0.10222222222222223,0.3953537171530251,1.0,6/20,10.51%,PLTP;SCARB1;THBS1;STAB1;CDH13;SORL1
prerank,cardiolipin binding (GO:1901612),0.6830363633790463,1.3739842059818572,0.11554921540656206,1.0,1.0,1/10,0.56%,UCP1
prerank,C-C chemokine receptor activity (GO:0016493),0.5802756328606639,1.370412069362582,0.09,1.0,1.0,4/21,17.61%,ACKR3;ACKR4;CXCR4;CXCR2
prerank,glucuronosyltransferase activity (GO:0015020),0.6102801055952205,1.3700629060307314,0.1032258064516129,1.0,1.0,5/19,21.54%,EXT1;B3GAT3;LARGE1;CHPF;B3GAT2
prerank,lipase activity (GO:0016298),0.5341413621768923,1.3697433723844146,0.06989853438556934,1.0,1.0,10/43,19.37%,MGLL;SMPD3;CEL;LCAT;SEC23IP;PNPLA8;DAGLB;LIPC;LIPH;DDHD1
prerank,metalloendopeptidase activity (GO:0004222),0.5019583907078903,1.36842566231327,0.04488517745302714,1.0,1.0,23/76,18.46%,ADAMTS5;ADAMTS2;MMP2;ADAM9;ADAMTS3;ADAMTSL1;ADAM19;ADAM33;ADAMTSL4;MMP11;ADAMTSL5;ECE1;ADAMTSL3;ADAMTS18;EEF1AKMT4-ECE2;ECE2;PAPLN;THOP1;RCE1;IDE;SPG7;MMP16;ADAMTS6
prerank,lipase activator activity (GO:0060229),0.6776559928732124,1.367308260124816,0.12273361227336123,1.0,1.0,3/10,6.81%,CCL8;FYN;SRC
prerank,LRR domain binding (GO:0030275),-0.4859436611140471,-1.367138978206755,0.14347826086956522,0.3969820406795197,1.0,2/14,0.31%,PAWR;ROBO1
prerank,cytokine activity (GO:0005125),0.4795817804460774,1.3660138586136534,0.02727272727272727,1.0,1.0,18/131,6.74%,LIF;CCL8;WNT10B;WNT2;TGFB3;IL16;CTF1;VEGFA;WNT9A;FGF2;TGFB2;MIF;BMP15;CLCF1;IL33;CXCL10;TNFRSF11B;INHA
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.5496386573787495,1.3658179944687214,0.08669833729216152,1.0,1.0,8/35,7.45%,SYK;SRMS;TNK1;FYN;CLK1;CSK;SRC;ABL2
prerank,ATPase binding (GO:0051117),0.5064973837745133,1.3611816595528425,0.05296610169491525,1.0,1.0,22/71,17.23%,AR;ESR1;EGFR;ANK2;ATP6V0A2;TOR1AIP2;SYVN1;ZNHIT6;SRC;ABCA1;PKD2;PSEN1;ATP6V1E1;PDE4D;BBC3;SNU13;PPP3CA;CLPP;ATP6V0A1;SELENOS;ANK1;NUFIP1
prerank,cytokine receptor binding (GO:0005126),0.49120043616877723,1.360732588246029,0.04421052631578947,1.0,1.0,10/83,6.96%,TNFSF9;SYK;LIF;TIMM50;VEGFA;TGFB2;MIF;CLCF1;SOCS2;TLR5
prerank,peptidoglycan binding (GO:0042834),-0.5360253016273929,-1.3593439566703822,0.125,0.40021307668366496,1.0,7/10,35.83%,RNASE7;NOD1;NOD2;PGLYRP1;JCHAIN;NLRP3;TLR2
prerank,thiol-dependent deubiquitinase (GO:0004843),0.4972126875453775,1.3587004172039405,0.04963041182682154,1.0,1.0,25/83,16.13%,UCHL1;DESI2;JOSD2;USP36;COPS5;OTUD3;ZRANB1;USP32;USP10;USP29;USP4;OTUD1;UCHL5;USP39;USP26;USP33;OTUD7B;USP48;USP50;USP5;ZC3H12A;STAMBPL1;USP7;MINDY3;USP22
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.6338985582031109,1.3581099933183711,0.12795549374130738,1.0,1.0,3/13,10.24%,GPSM2;GPSM1;GDI1
prerank,metallocarboxypeptidase activity (GO:0004181),-0.41013773838915724,-1.3551503234413285,0.10625,0.39751796614541707,1.0,4/26,5.64%,AEBP1;CPE;CPM;AGBL3
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.669063718530873,1.3535955660212196,0.13001383125864455,1.0,1.0,2/10,7.87%,AMDHD1;DPEP1
prerank,hormone activity (GO:0005179),0.5024440812931028,1.3496770034597638,0.08432432432432432,1.0,1.0,9/54,13.44%,AMH;METRNL;INHA;GRP;ADCYAP1;SPX;CCL25;HCRT;TRH
prerank,chemoattractant activity (GO:0042056),0.5642948240062506,1.3438581231225708,0.09336609336609336,1.0,1.0,8/26,16.31%,FGF7;VEGFA;FGF2;MIF;CXCL10;GPNMB;GDNF;HGF
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.5425776855333792,1.3377189137497616,0.1242603550295858,1.0,1.0,4/29,4.54%,SLC1A5;SLC25A21;SLC26A5;SLC1A6
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.5614623011768576,1.3328695163901123,0.11853720050441362,1.0,1.0,7/25,11.05%,PARP3;ART4;PARP11;PARP6;SIRT2;ZC3HAV1;PARP14
prerank,pre-mRNA binding (GO:0036002),0.5433369563915434,1.3289683273806812,0.10256410256410256,1.0,1.0,11/28,19.99%,TARBP2;HNRNPA1;SRSF6;RBM4;U2AF1;RBM22;CELF2;DDX5;SLBP;U2AF2;PTBP1
prerank,anion transmembrane transporter activity (GO:0008509),-0.5142877309753843,-1.328816595098408,0.14186851211072665,0.43678284029161224,1.0,4/12,4.48%,ABCG2;SLCO2B1;SLC39A8;SLC22A6
prerank,metallopeptidase activity (GO:0008237),0.47608203368493224,1.3285683988173131,0.038657171922685654,1.0,1.0,32/113,18.46%,ADAMTS5;BMP1;ADAMTS2;ANPEP;MMP2;ADAM9;ADAMTS3;COPS5;ADAMTSL1;ADAM19;ADAM33;ADAMTSL4;LNPEP;DPEP1;MMP11;ADAMTSL5;ECE1;ADAMTSL3;ADAMTS18;EEF1AKMT4-ECE2;ECE2;NUDT16;PAPLN;THOP1;ADAM15;RCE1;IDE;SPG7;LAP3;MMP16;METAP2;ADAMTS6
prerank,O-acyltransferase activity (GO:0008374),0.541903660209138,1.325921421476665,0.11305361305361306,1.0,1.0,11/30,21.00%,GPAT4;MOGAT1;PLAAT1;LCAT;LPCAT1;MBOAT7;MOGAT2;PIGW;GPAT3;GPAM;SOAT1
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.5442295689652799,1.3106895665813059,0.15147783251231528,1.0,1.0,6/25,11.98%,FMO4;FMO2;FMO1;CYP27B1;MICAL2;POR
prerank,adrenergic receptor binding (GO:0031690),0.5873713292245708,1.3092596766674904,0.16993464052287582,1.0,1.0,6/16,11.84%,GNAS;UCHL1;DLG4;C1QBP;MAGI2;PDE4D
prerank,omega peptidase activity (GO:0008242),0.4752102551674882,1.3080447091424887,0.07820646506777894,1.0,1.0,26/89,16.13%,UCHL1;DESI2;JOSD2;USP36;COPS5;OTUD3;ZRANB1;USP32;USP10;USP29;USP4;OTUD1;UCHL5;USP39;USP26;USP33;OTUD7B;USP48;USP50;USP5;ZC3H12A;GGT7;STAMBPL1;USP7;MINDY3;USP22
prerank,deubiquitinase activity (GO:0101005),0.4767330713861045,1.3070642959790568,0.08622502628811778,1.0,1.0,25/88,16.13%,UCHL1;DESI2;JOSD2;USP36;COPS5;OTUD3;ZRANB1;USP32;USP10;USP29;USP4;OTUD1;UCHL5;USP39;USP26;USP33;OTUD7B;USP48;USP50;USP5;ZC3H12A;STAMBPL1;USP7;MINDY3;USP22
prerank,calcium-activated potassium channel activity (GO:0015269),0.6302719857403484,1.3063888881185277,0.1574585635359116,1.0,1.0,2/11,5.97%,KCNMA1;KCNU1
prerank,hexosyltransferase activity (GO:0016758),0.47173053374142043,1.3043571255632012,0.07135470527404343,1.0,1.0,20/101,11.50%,HAS2;HAS1;B4GALT3;B4GALT1;B3GALNT1;CSGALNACT2;FUT2;DPY19L2;EXT1;B4GALNT4;POMGNT2;PIGZ;CHSY3;B3GAT3;RFNG;ALG1;LARGE1;FUT9;B3GNT8;GBA2
prerank,microtubule binding (GO:0008017),0.45308099179093453,1.3003734323975724,0.021042084168336674,1.0,1.0,75/222,22.87%,MID1;NME8;MAP1B;SAXO1;DNM1;DCTN1;CCDC88C;CEP295NL;FGF13;S100A8;S100A9;HOOK2;CLIP1;MID2;CEP44;NDEL1;REEP3;FHDC1;DST;PSRC1;KIFC2;KIF21B;MAPRE3;FSD1;STARD9;HDAC6;GAS2L1;TOGARAM1;CLIP2;SYBU;DYNC1I1;KIF2A;POLB;ALMS1;MAPRE1;CLIP4;CAMSAP1;MAPT;KIF20B;CCSAP;SBDS;KIF3A;KIF21A;CFAP157;MAP6;ABRAXAS1;CRIPT;TERF1;KIF3B;CHP1;MAP4;CDK5RAP2;MAP7D3;SNPH;RCC2;CKAP5;CENPE;EML1;UXT;NAV3;PAFAH1B1;STIM1;CLIP3;MDM1;RMDN2;KIF26B;CLASP2;NUMA1;TUBGCP5;MAP1A;DCX;FBXW11;MAP1S;CCDC88A;RMDN1
prerank,protein tyrosine phosphatase activity (GO:0004725),-0.3111579335392541,-1.299789179515233,0.016666666666666666,0.48275363911361896,1.0,22/71,13.45%,PTPRK;PTPN14;EYA1;PTPRG;PTPRB;PTPRD;PTPN9;PTPRM;PTPRN2;PALD1;PTPRZ1;PTPRO;PTPN1;CDC25A;PTPRT;PTPN2;HACD2;PTPN4;PTPN21;PTP4A2;PTPRN;UBASH3B
prerank,carboxypeptidase activity (GO:0004180),-0.35592464686139524,-1.2991795989233146,0.1015625,0.4719413121373906,1.0,5/35,5.64%,AEBP1;CPE;CPM;MINDY2;AGBL3
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.3445871502287332,-1.2988695113087334,0.060240963855421686,0.4610565232277332,1.0,9/48,8.81%,TRPM3;TRPM6;SLC12A7;NALCN;SLC41A1;SLC12A2;ABCC9;TRPC6;CALHM5
prerank,single-stranded telomeric DNA binding (GO:0043047),0.6252510940966316,1.2976629380081857,0.17216642754662842,1.0,1.0,5/11,22.09%,HNRNPA1;CTC1;TERF1;RAD50;TERF2IP
prerank,transcription coactivator binding (GO:0001223),0.564216290010046,1.297140491398264,0.15586034912718205,1.0,1.0,4/20,8.96%,AR;ESR1;SMAD4;CDK9
prerank,protein phosphatase inhibitor activity (GO:0004864),-0.3943000975110062,-1.2927487958432695,0.147239263803681,0.4626313963382124,1.0,8/26,14.89%,PTN;PPP1R1A;LMTK2;BOD1L1;PPP1R8;PPME1;PPP1R14A;PABIR1
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.5238770704293899,-1.2895075490314623,0.18214285714285713,0.4582390300584555,1.0,3/10,5.55%,PRKAG2;PKIG;PRKAR1B
prerank,endopeptidase activity (GO:0004175),0.4459081161582141,1.2876383736887544,0.02902902902902903,1.0,1.0,54/257,16.91%,ADAMTS5;HTRA3;PCSK6;KLK9;PRSS48;DPP4;HPN;UCHL1;FAP;PCSK5;ADAMTS2;MMP2;ADAM9;PRSS12;USP36;ADAMTS3;ADAMTSL1;ADAM19;ADAM33;PCSK4;ADAMTSL4;RHBDF1;USP10;USP29;TPP1;MMP11;ADAMTSL5;PSEN1;ECE1;MASP2;ADAMTSL3;ADAMTS18;USP26;USP33;GZMM;EEF1AKMT4-ECE2;ECE2;USP48;NAPSA;PAPLN;PIK3IP1;USP5;THOP1;KLK1;KLK6;RCE1;TASP1;USP7;CLPP;PDIA3;HGF;HTRA2;IDE;SPG7
prerank,ionotropic glutamate receptor binding (GO:0035255),0.6300039053169447,1.2873104242679367,0.18811881188118812,1.0,1.0,5/10,21.47%,GNAS;DLG4;SQSTM1;NSF;SHISA6
prerank,ribosome binding (GO:0043022),0.48912747809095125,1.286502322130583,0.13048368953880765,1.0,1.0,14/46,18.02%,RPSA;IGHMBP2;C1QBP;SRP19;GTPBP6;MRPS27;EIF6;SBDS;EIF2S1;ZC3H12A;SEC61A1;CPEB1;YTHDF1;NAA15
prerank,kinase inhibitor activity (GO:0019210),0.513263316300955,1.278317990537089,0.151270207852194,1.0,1.0,14/33,25.02%,LRP6;TAOK3;PPP1R1B;GSKIP;NPM1;SMCR8;CDKN1A;NCK1;QARS1;GMFB;DUS2;YWHAB;HEXIM1;DNAJC3
prerank,pentosyltransferase activity (GO:0016763),0.49879772948238627,1.2771927434373713,0.16345062429057888,1.0,1.0,9/36,11.05%,PARP3;UMPS;ART4;PARP11;PARP6;SIRT2;LARGE1;ZC3HAV1;PARP14
prerank,calcium:sodium antiporter activity (GO:0005432),-0.5129892986395246,-1.2769746359870042,0.19047619047619047,0.47319782613900263,1.0,4/10,12.84%,SLC24A3;SLC8A3;SLC3A2;SLC24A5
prerank,gap junction channel activity (GO:0005243),-0.41205768327214526,-1.2765736730953237,0.12727272727272726,0.4634902900698107,1.0,10/22,30.55%,GJB6;GJB2;GJA1;GJC1;GJD3;GJA4;PANX2;GJA5;GJD2;GJA3
prerank,chemokine receptor activity (GO:0004950),0.5275667441589837,1.2759130252112714,0.16930572472594396,1.0,1.0,4/24,17.61%,ACKR3;ACKR4;CXCR4;CXCR2
prerank,myosin II binding (GO:0045159),0.6322068249921173,1.2755346536655983,0.20346320346320346,1.0,1.0,2/10,3.65%,GSN;LLGL1
prerank,1-phosphatidylinositol binding (GO:0005545),0.5813226265016546,1.2744992919338824,0.1752021563342318,1.0,1.0,4/15,11.34%,SESTD1;SCIN;FRMPD2;WDFY1
prerank,wide pore channel activity (GO:0022829),-0.40448630737720903,-1.2736987271038278,0.1493212669683258,0.4591332383318743,1.0,10/23,30.55%,GJB6;GJB2;GJA1;GJC1;GJD3;GJA4;PANX2;GJA5;GJD2;GJA3
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.5356739477112054,1.273599546483792,0.17747858017135862,1.0,1.0,4/24,5.66%,CAMKK1;EEF2K;CAMK2D;PHKA2
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.5532378513210091,1.2696679181926662,0.18041237113402062,1.0,1.0,3/18,15.11%,DHRS9;HSD3B7;HSD17B8
prerank,calcium ion binding (GO:0005509),0.4356326419616722,1.2670272478534945,0.021042084168336674,1.0,1.0,40/323,8.22%,ASPN;COMP;FBN1;GSN;CDH26;THBS3;LOXL2;CDHR5;SNCB;SCIN;ANXA1;LRP1;SYT2;CLEC3B;ARSA;SPARC;ANXA2;EFHD1;SLIT3;SLIT2;S100A10;PLSCR4;SRI;S100A8;S100A9;SMOC2;SLIT1;SYT12;SYT11;CALU;DSC3;DSC2;COLEC11;SYT13;RCN3;THBS4;RET;PKD2;S100A6;CAPN1
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.5636940585119363,1.2657411362330315,0.18318695106649938,1.0,1.0,3/18,2.53%,ANXA1;PKP3;ANXA2
prerank,ligand-gated channel activity (GO:0022834),0.5065871008457642,1.2644464854502457,0.16646848989298454,1.0,1.0,13/29,27.38%,GRIN3A;GRIN2D;GRIA2;CNGB1;GRID1;GRIN2A;CHRNA5;GRIA3;GRIK5;GRIK2;GRIK4;ANXA6;GRID2
prerank,nuclear import signal receptor activity (GO:0061608),0.572102222421898,1.2613606031448574,0.20026178010471204,1.0,1.0,9/15,26.59%,KPNA2;IPO9;TNPO2;IPO5;KPNA1;RANBP6;TNPO1;KPNA6;KPNB1
prerank,ribonuclease P activity (GO:0004526),0.604731850272032,1.2610576228488537,0.20476858345021037,1.0,1.0,3/11,5.83%,RPP25;RPP21;PRORP
prerank,receptor ligand activity (GO:0048018),0.435406269937987,1.2582907483136159,0.034,1.0,1.0,32/245,9.59%,LIF;SEMA3C;AREG;AMH;FGF18;WNT10B;FGF7;DPP4;WNT2;TGFB3;IL16;CTF1;BTC;VEGFA;WNT9A;FGF2;TGFB2;MIF;BMP15;METRNL;CLCF1;IL33;CXCL10;TNFRSF11B;INHA;GAS6;SEMA3A;JAG1;TNFSF13B;CCL25;NRG3;BMP8A
prerank,ligand-gated ion channel activity (GO:0015276),0.5027554373837705,1.2575165662813088,0.17261904761904762,1.0,1.0,13/30,27.38%,GRIN3A;GRIN2D;GRIA2;CNGB1;GRID1;GRIN2A;CHRNA5;GRIA3;GRIK5;GRIK2;GRIK4;ANXA6;GRID2
prerank,O-methyltransferase activity (GO:0008171),0.610703581759595,1.2557780452618388,0.20028818443804033,1.0,1.0,7/10,29.90%,MEPCE;COQ3;COMT;CMTR2;FTSJ3;ASMT;LRTOMT
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.6167810500821352,1.2549998355483232,0.21961932650073207,1.0,1.0,4/10,25.79%,DESI2;STAMBPL1;CYLD;OTUD4
prerank,myosin V binding (GO:0031489),0.5765490486720353,1.2534986714295397,0.2049934296977661,1.0,1.0,7/15,26.10%,RAB6A;RAB6B;RAB3D;RAB27B;RAB10;RAB39B;RAB3C
prerank,neuropeptide hormone activity (GO:0005184),0.5360411908372769,1.2528472659813659,0.20049813200498132,1.0,1.0,4/22,12.23%,GRP;ADCYAP1;SPX;HCRT
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.5402131348020225,1.2497915383635885,0.21987577639751552,1.0,1.0,9/21,28.08%,REV3L;POLB;POLE3;POLI;POLD1;REV1;POLH;POLE2;CHRAC1
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.45624335543577027,1.248229351707654,0.13113006396588486,1.0,1.0,17/72,12.04%,GSN;SESTD1;SCIN;ANXA2;AMER3;SVIL;KCNJ2;CGAS;OSBPL2;PFN2;FZD7;TIRAP;TWF1;PLEKHA4;SNX21;AVIL;SLC9A1
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.5064642861357417,1.2482198655027563,0.18771726535341832,1.0,1.0,10/33,17.52%,AR;SCAF8;RTRAF;NCOA3;AGO2;ELP4;URI1;LLPH;UVSSA;ERCC5
prerank,G protein-coupled receptor binding (GO:0001664),0.4414040009044071,1.2472150440041099,0.09257375381485249,1.0,1.0,18/132,10.16%,MYOC;LRP6;WNT10B;GNAS;WNT2;GNAI3;CCDC88C;WNT9A;USP4;C1QBP;BICD1;S1PR2;STUB1;FZD7;CCL25;GNAZ;USP33;CALCA
prerank,dynactin binding (GO:0034452),0.5953760685521936,1.2399657641372357,0.21954484605087016,1.0,1.0,5/12,18.96%,BICD1;MAPT;BBS4;SNX6;PAFAH1B1
prerank,heme binding (GO:0020037),0.4594635861813785,1.2387087400426857,0.16381156316916487,1.0,1.0,5/65,6.81%,NOX4;CYP2S1;NR1D1;DGCR8;SRC
prerank,general transcription initiation factor binding (GO:0140296),0.5260205302947988,1.2346320865774325,0.22073170731707317,1.0,1.0,6/25,15.51%,AR;ESR1;BRF2;DR1;GTF2A2;YEATS2
prerank,ionotropic glutamate receptor activity (GO:0004970),0.5425056296567159,1.2299983661549074,0.22503328894806923,1.0,1.0,8/17,24.46%,GRIN3A;GRIN2D;GRIA2;GRIN2A;GRIA3;GRIK5;GRIK2;GRIK4
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.45141981759982597,-1.2291805776408284,0.2066420664206642,0.5417856298123298,1.0,5/12,19.64%,H3-3A;POU2F1;STAT1;GTF2B;TAF1
prerank,cell-cell adhesion mediator activity (GO:0098632),0.47839307585410085,1.2287056308478905,0.20247469066366705,1.0,1.0,11/42,13.54%,ANXA1;PKP3;NPTN;ANXA2;JAM3;CD47;SIRPA;DSCAM;PDLIM1;IGSF9;PALLD
prerank,protein heterodimerization activity (GO:0046982),-0.2400722809899326,-1.2285474824239724,0.125,0.5320133751506301,1.0,29/178,9.11%,TCF4;ATP1A2;BMP6;TPM1;TENM4;BCL2L1;MEF2C;EPAS1;BCL2;ARNT2;YWHAH;ADRA1B;RALGAPA1;ZHX3;ITGA3;KCNB1;KCNB2;AHR;ABCG1;IRAK2;AGTR1;PSMF1;MICU2;IKBKG;MIGA2;ZHX1;ADRA2A;ERBB2;SMC3
prerank,gated channel activity (GO:0022836),0.5667106818943444,1.228381793990158,0.2348993288590604,1.0,1.0,3/14,7.21%,PIEZO2;TMEM63A;TMEM266
prerank,glucose transmembrane transporter activity (GO:0005355),0.5460033135303444,1.2262356080761336,0.21604139715394566,1.0,1.0,4/17,14.47%,SLC5A9;MFSD4A;SLC2A10;SLC2A3
prerank,exopeptidase activity (GO:0008238),0.4584456999516776,1.222937452790584,0.18659217877094972,1.0,1.0,22/50,26.90%,DPP4;FAP;ANPEP;PRCP;LNPEP;DPEP1;CNDP2;XPNPEP3;NUDT16;NPEPPS;RCE1;LAP3;METAP2;DPP9;METAP1;METAP1D;JMJD7;ZMPSTE24;DPEP2;DPP10;CTSA;DPP7
prerank,phospholipase activity (GO:0004620),0.4503109581259815,1.2151197839862478,0.18036286019210246,1.0,1.0,15/67,20.38%,MGLL;SMPD3;PLCE1;PLCB4;PLAAT1;SEC23IP;PNPLA8;PLA2G4E;PDIA3;SMPD1;LIPC;LIPH;DDHD1;GPLD1;GDPD3
prerank,cAMP binding (GO:0030552),-0.4752078354472317,-1.214254175486525,0.22142857142857142,0.5530844002232558,1.0,2/11,0.58%,RAPGEF4;RAPGEF2
prerank,enoyl-CoA hydratase activity (GO:0004300),0.6154500719298908,1.214237920505009,0.23782234957020057,1.0,1.0,2/10,7.64%,EHHADH;AUH
prerank,alanine transmembrane transporter activity (GO:0022858),-0.4566121567276745,-1.2132451243202844,0.24603174603174602,0.544161459455577,1.0,3/12,12.50%,SLC3A2;SLC38A5;SLC6A6
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.48258229529566893,1.212138315602146,0.2414605418138987,1.0,1.0,12/31,22.48%,UBE2B;UBE2J2;UBE2N;UBE2W;UBE2G2;UBE2A;CDC34;UBE2G1;UBE2R2;UBE2D3;UBE2Q2;UBE2Z
prerank,tubulin binding (GO:0015631),0.42205172980515127,1.2120820238886245,0.043,1.0,1.0,103/296,25.85%,MID1;NME8;RAB11FIP5;MAP1B;SAXO1;DNM1;DCTN1;CCDC88C;FYN;CEP295NL;FGF13;S100A8;S100A9;HOOK2;ATF5;CLIP1;MID2;GPAA1;DLEC1;CEP44;NDEL1;REEP3;FHDC1;DST;PSRC1;KIFC2;KIF21B;MAPRE3;FSD1;STARD9;HDAC6;GAS2L1;TOGARAM1;CLIP2;SYBU;DYNC1I1;KIF2A;NCALD;POLB;ALMS1;CAMSAP1;MAPT;TBCEL;KIF20B;SETD2;TPPP3;CCSAP;SBDS;KIF3A;KIF21A;CFAP157;MAP6;ABRAXAS1;CRIPT;TERF1;KIF3B;BBS4;INO80;BCAS3;BLOC1S2;CHP1;MAP4;CDK5RAP2;MAP7D3;SNPH;RCC2;CKAP5;CENPE;EML1;ALDOA;UXT;NAV3;PAFAH1B1;CLIP3;MDM1;RMDN2;STMN4;KIF26B;TTLL11;CLASP2;NUMA1;TUBGCP5;MAP1A;DCX;MAP1S;DNAL1;CCDC88A;TPR;RMDN1;TRIM36;NLRP5;KATNA1;EMD;RMDN3;ARL8A;MTCL1;VBP1;AGBL1;PHF6;KIF13B;EML6;CCDC88B;TPGS1
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.5701890990852262,1.2102921798954942,0.24021592442645073,1.0,1.0,6/13,14.13%,ITGB3;VEGFA;ITGA5;PTPRJ;ERN1;PDGFRA
prerank,protein tyrosine kinase activity (GO:0004713),0.4355456086994242,1.209996510930482,0.15273477812177502,1.0,1.0,28/108,14.52%,SYK;DDR2;EPHB2;AXL;SRMS;EGFR;TNK1;FGFR1;EPHA3;FYN;MST1R;CLK1;CSK;RET;SRC;ABL2;TWF1;EPHB3;DYRK2;MUSK;CAMKK2;EPHA10;SCYL1;FLT3;HIPK4;PDGFRA;FER;DDR1
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.43938717752633366,-1.2064710846093556,0.19838056680161945,0.5482531764730919,1.0,2/14,0.45%,SLC7A11;SLC1A3
prerank,translation initiation factor activity (GO:0003743),0.48621193104290567,1.2057449196042964,0.2323699421965318,1.0,1.0,19/36,27.14%,EIF3B;COPS5;EIF4A1;EIF3K;AGO2;EIF1;EIF3A;EIF2S1;EIF3E;EIF3D;EIF2S2;EIF2B1;EIF2A;EIF4G3;EIF3L;EIF2B2;EIF4G1;EIF4E2;EIF3M
prerank,anion:anion antiporter activity (GO:0015301),0.5358861008114043,1.2056149906941087,0.2493368700265252,1.0,1.0,5/17,11.33%,SLC26A5;SLC26A11;SLC4A3;SLC25A4;SLC26A6
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.4354516911149957,1.205056128689488,0.18039624608967675,1.0,1.0,21/91,12.04%,GSN;SESTD1;SCIN;ANXA2;AMER3;SVIL;KCNJ2;CGAS;OSBPL2;PFN2;FZD7;CLVS2;TIRAP;WIPI2;TWF1;PLEKHA4;WDR45B;SNX21;AVIL;MAPT;SLC9A1
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.47126613761743263,1.2022851928013607,0.24210526315789474,1.0,1.0,13/34,22.48%,UBE2B;UBE2J2;UBE2N;UBE2W;UBE2G2;UBE2A;CDC34;UFC1;UBE2G1;UBE2R2;UBE2D3;UBE2Q2;UBE2Z
prerank,chemokine receptor binding (GO:0042379),0.48349153450397286,1.1996456983330064,0.22429906542056074,1.0,1.0,5/35,12.90%,CCL8;ITCH;CXCL10;CCL25;CCL13
prerank,ribosomal large subunit binding (GO:0043023),0.5751881392665468,1.198611871903342,0.2725988700564972,1.0,1.0,6/11,14.08%,DHX33;CPSF6;NPM1;EIF6;LTN1;RBM3
prerank,chloride transmembrane transporter activity (GO:0015108),0.5473407793584557,1.1964342788716615,0.2529335071707953,1.0,1.0,5/16,17.09%,SLC26A5;SLC4A8;SLC26A6;SLC12A5;SLC26A1
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),-0.3853411379750778,-1.195900919453998,0.21787709497206703,0.5616679281837652,1.0,11/22,29.41%,DUSP10;PPM1F;DUSP7;MTMR3;DUSP6;DUSP19;DUSP15;MTMR2;DUSP4;CDKN3;DUSP18
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.5150938547749201,1.195035500650519,0.2675544794188862,1.0,1.0,7/20,15.12%,GPAT4;MOGAT1;AGPAT3;LPCAT1;MOGAT2;AGPAT5;GPAT3
prerank,peptidase inhibitor activity (GO:0030414),0.473781621600029,1.1948238059582783,0.24401368301026224,1.0,1.0,7/33,12.41%,TIMP2;GPC3;UCHL5;CAST;CSTB;SLPI;RECK
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.4743789410950869,1.1940908092077858,0.23596792668957617,1.0,1.0,11/38,15.33%,NCF4;SESTD1;PLEKHF1;ATG2B;WIPI2;PLEKHA4;WDR45B;SNX21;ATG2A;DENND1A;PLA2G4E
prerank,glutamate receptor binding (GO:0035254),0.5327702061198251,1.1908612899384916,0.26496815286624203,1.0,1.0,5/17,15.86%,GNAS;DLG4;SQSTM1;SYNDIG1;NSF
prerank,cAMP response element binding (GO:0035497),0.5957505603225982,1.1905640847784074,0.2791666666666667,1.0,1.0,5/10,21.89%,CREB5;CREB3L1;ATF7;E4F1;JUN
prerank,cytokine receptor activity (GO:0004896),0.430113411589265,1.1894975746552454,0.18607068607068608,1.0,1.0,11/83,15.34%,IL4R;GHR;IL1RL1;CD44;IL17RA;IL10RA;ACKR4;CSF2RA;FLT3;CNTFR;FZD4
prerank,androgen receptor binding (GO:0050681),0.4998703048474606,1.1893958702022762,0.2457627118644068,1.0,1.0,15/25,30.27%,FOXP1;PRMT2;SMARCA4;RNF14;TRIM68;DDX5;NSD1;TMF1;RNF6;KDM4C;CALR;KDM3A;PRPF6;ZBTB7A;WIPI1
prerank,syntaxin-1 binding (GO:0017075),-0.3773868879893599,-1.1859345921457487,0.20673076923076922,0.5736079735339817,1.0,5/22,8.74%,UNC13B;UNC13C;SYNPR;STXBP5;DAPK1
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.46315908244681925,-1.1849546899730055,0.24573378839590443,0.5653025798269081,1.0,3/11,4.37%,SGMS1;PIGN;SAMD8
prerank,calcium-dependent phospholipid binding (GO:0005544),0.45627976005387183,1.184457130641794,0.23767798466593648,1.0,1.0,7/49,5.23%,ANXA1;SYT2;ANXA2;CPNE8;SYT12;SYT11;SYT13
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.5421287531746246,1.1844032576838421,0.26897470039946736,1.0,1.0,5/15,17.09%,SLC26A5;SLC4A8;SLC4A3;SLC26A6;SLC26A1
prerank,peptidase activator activity (GO:0016504),0.4977273639066144,1.1843863523824172,0.26256281407035176,1.0,1.0,4/22,8.52%,PCOLCE2;PCOLCE;ADRM1;CLPX
prerank,mechanosensitive ion channel activity (GO:0008381),0.561986741996736,1.1842298643244822,0.27977839335180055,1.0,1.0,2/12,5.18%,PIEZO2;TMEM63A
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.4399298693477144,1.1823307401734737,0.2225705329153605,1.0,1.0,14/73,18.00%,AVPR1A;VIPR2;F2R;GLP2R;S1PR2;CRHR1;LTB4R2;INPP5K;GPR37L1;TSHR;GPR37;LHCGR;SORCS1;RXFP1
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.5567415851886238,1.1807942201110333,0.3023255813953488,1.0,1.0,2/12,6.28%,IRS1;SH2B1
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.5514894754125015,1.1803391801190812,0.273224043715847,1.0,1.0,5/12,18.36%,TENT5B;TENT4A;PAPOLB;TENT2;TENT4B
prerank,protein tyrosine kinase binding (GO:1990782),0.4301819775592917,1.1746608230515159,0.2346723044397463,1.0,1.0,10/71,10.44%,NOX4;ANGPT4;PIK3R2;ACVR1;BANK1;GAS6;FLT3LG;NRG3;SIRPA;SQSTM1
prerank,DNA polymerase activity (GO:0034061),0.5029585996575509,1.1746583344685475,0.27633209417596033,1.0,1.0,9/22,28.08%,REV3L;POLB;POLE3;POLI;POLD1;REV1;POLH;POLE2;CHRAC1
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.5422578954043209,1.1735664530917858,0.29088471849865954,1.0,1.0,3/14,5.83%,RPP25;RPP21;PRORP
prerank,CoA hydrolase activity (GO:0016289),0.5363234991143082,1.173227460008631,0.28608582574772434,1.0,1.0,4/16,14.25%,ACOT6;NUDT7;ACOT9;ACOT1
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.554642774951726,1.1715464710885761,0.2774869109947644,1.0,1.0,5/13,15.12%,GPAT4;AGPAT3;LPCAT1;AGPAT5;GPAT3
prerank,nucleotide diphosphatase activity (GO:0004551),-0.42614871341460137,-1.1712702520541782,0.2748091603053435,0.5859000839392996,1.0,6/14,15.83%,ENPP1;NUDT4;ENPP4;NUDT3;NUDT12;NUDT13
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.5737183636322034,1.170242914726924,0.2926470588235294,1.0,1.0,4/10,12.08%,DSC2;CD47;SIRPA;JUP
prerank,poly-purine tract binding (GO:0070717),-0.35461455643907835,-1.1691900675985343,0.2215568862275449,0.5797150769139565,1.0,11/27,19.34%,RBPMS;ATXN1;RBMS2;ZC3H14;PPIE;KHDRBS1;TIA1;HNRNPDL;PABPC4L;EIF4A3;PNPT1
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.5682596435912802,1.1669852807674694,0.2958152958152958,1.0,1.0,4/10,24.78%,KAT2B;CDKN1A;CDKN2C;HEXIM1
prerank,insulin-like growth factor I binding (GO:0031994),0.5544341407122507,1.1648518972440316,0.29545454545454547,1.0,1.0,4/13,4.58%,IGFBP5;ITGB3;IGFBP6;IGFBP4
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.49637818756933205,1.1646877655399184,0.27965043695380776,1.0,1.0,10/21,21.50%,ACBD3;WASF1;GSKIP;AKAP14;AKAP8;AKAP9;AKAP1;ARFGEF1;PRRC1;AKAP8L
prerank,myosin binding (GO:0017022),0.4412281539655476,1.1642295680751762,0.24160346695557963,1.0,1.0,17/55,20.96%,MYOC;GSN;RAB6A;LLGL1;RAB6B;TRAK2;RAB3D;MOBP;RHOA;TRIOBP;RAB27B;GIPC1;CXCR4;ARFGEF1;RALA;RAB10;PYCARD
prerank,RNA polymerase binding (GO:0070063),0.5101884527270085,1.163565941312801,0.2848258706467662,1.0,1.0,5/18,12.63%,BIN1;SCAF8;TCERG1;ANP32B;ZFP36
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.4734910275495865,1.163077203323766,0.27611044417767105,1.0,1.0,10/28,23.63%,RPP25;RPP21;PRORP;AGO2;NUDT16L1;NUDT16;POP4;AGO3;RPP30;EDC3
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.5266447962872144,1.1604419578040475,0.28998699609882966,1.0,1.0,2/16,4.54%,SLC1A5;SLC1A6
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.511141635966909,1.1595169450870628,0.28188775510204084,1.0,1.0,4/18,6.87%,AKR1B1;ALDH18A1;ALDH3A2;FAR1
prerank,telomeric DNA binding (GO:0042162),0.45649251256762885,1.1573988445517678,0.28587962962962965,1.0,1.0,15/32,28.52%,CTC1;ACD;HNRNPD;XRCC5;TERF1;SMG7;SMG6;RAD50;BLM;TINF2;TERF2IP;UPF1;SMG5;STN1;XRCC6
prerank,death domain binding (GO:0070513),-0.4439275663035428,-1.1573893541682507,0.2679245283018868,0.5950219944027993,1.0,4/11,11.68%,BCL2L1;BCL2;DAPL1;RIPK1
prerank,ion gated channel activity (GO:0022839),0.48432770647595524,1.1561596382545645,0.28044280442804426,1.0,1.0,3/24,5.18%,KCNT2;ANO3;TMEM63A
prerank,BMP binding (GO:0036122),-0.44691641531089354,-1.1548792475056273,0.28125,0.5906261119242865,1.0,3/11,7.95%,ENG;GREM2;BMPR2
prerank,epidermal growth factor receptor binding (GO:0005154),0.47780313415000364,1.1548551097375084,0.28042959427207637,1.0,1.0,8/25,16.67%,AREG;BTC;ARF4;SNX1;ATXN2;EGF;FER;EFEMP1
prerank,snoRNA binding (GO:0030515),0.4752860399261054,1.1534500509084888,0.3022700119474313,1.0,1.0,16/30,29.13%,NUDT1;NUDT7;NUDT16L1;GAR1;DDX21;NUDT16;XRCC5;SNU13;NUDT5;NUFIP1;TBL3;PRKDC;NOP56;TSR1;NHP2;NOP58
prerank,chemorepellent activity (GO:0045499),0.48698843935159875,1.152024211984888,0.2865707434052758,1.0,1.0,5/25,12.28%,SEMA3C;DPP4;SEMA3A;NRG3;SEMA3D
prerank,ribonuclease P RNA binding (GO:0033204),0.5609759122190187,1.1516377259989334,0.3195435092724679,1.0,1.0,5/10,26.60%,RPP25;RPP21;POP4;RPP30;RPP14
prerank,R-SMAD binding (GO:0070412),0.5141277333209286,1.151481939495197,0.31241997439180536,1.0,1.0,8/18,22.02%,LDLRAD4;PMEPA1;SMAD4;SMAD6;DDX5;PPM1A;JUN;SMURF1
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.46290274486988947,-1.1511346299249634,0.29595015576323985,0.5889892390390895,1.0,2/10,2.52%,KDM7A;KDM4A
prerank,triglyceride lipase activity (GO:0004806),0.4953268216944965,1.1510893080011915,0.3051702395964691,1.0,1.0,5/20,18.64%,CEL;LCAT;DAGLB;LIPC;LIPH
prerank,regulatory RNA binding (GO:0061980),0.45161179241925736,1.149719678734965,0.2806818181818182,1.0,1.0,11/38,19.45%,TARBP2;HNRNPA1;RBM4;TRIM71;RC3H1;AGO2;DDX21;PUM1;ZC3H12A;AGO4;AGO3
prerank,insulin-like growth factor receptor binding (GO:0005159),0.5465988289703474,1.1488682408844313,0.33067729083665337,1.0,1.0,4/12,6.99%,GNAS;IRS1;SOCS2;YWHAG
prerank,alkali metal ion binding (GO:0031420),-0.4451168026552279,-1.1475271357668757,0.2605633802816901,0.5872643454342801,1.0,2/13,3.29%,ATP1A2;PDXK
prerank,insulin-like growth factor binding (GO:0005520),0.5281084852307779,1.1464170517824375,0.31209362808842656,1.0,1.0,4/15,4.58%,IGFBP5;ITGB3;IGFBP6;IGFBP4
prerank,manganese ion binding (GO:0030145),0.44135752327329214,1.1456327849808647,0.27510917030567683,1.0,1.0,18/48,26.91%,B4GALT1;MGAT1;ABL2;XPNPEP3;DYRK2;LARGE1;GALNT1;NUDT16;MPPE1;MGAT5;MGAT2;NEK4;XYLT2;MGAT5B;ADCY2;GALNT4;XXYLT1;ADPRM
prerank,ribonuclease activity (GO:0004540),0.43366913401820256,1.1433697184691616,0.28210757409440174,1.0,1.0,13/56,15.16%,DIS3L2;ANG;RNASE4;NYNRIN;AGO2;EXOSC7;SAMHD1;ERN1;RNASE6;RCL1;ZC3H12A;EXOSC1;SMG6
prerank,RNA polymerase core enzyme binding (GO:0043175),0.4625548974567215,1.1422066040248908,0.3137254901960784,1.0,1.0,12/33,21.44%,MAF1;SCAF8;RTRAF;NCOA3;SPTY2D1;AGO2;ELP4;URI1;UVSSA;ERCC5;RRN3;PAF1
prerank,flavin adenine dinucleotide binding (GO:0050660),0.42898849771915226,1.141731793703558,0.28774617067833697,1.0,1.0,11/53,15.89%,NOX4;ETFA;AIFM2;ACADVL;MICAL2;NQO2;POR;PPOX;AOX1;ACOX1;ETFDH
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.4934916411967354,1.1399219242185414,0.31757575757575757,1.0,1.0,5/21,9.15%,CDKL2;CDK14;CDK4;CDK9;CDK20
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.4934916411967354,1.1399219242185414,0.31757575757575757,1.0,1.0,5/21,9.15%,CDKL2;CDK14;CDK4;CDK9;CDK20
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.4974483274722228,1.1389690811722617,0.31863979848866497,1.0,1.0,8/20,18.84%,MAGI3;DLG2;AK2;MPP1;CMPK2;AK8;AK9;CARD11
prerank,leucine zipper domain binding (GO:0043522),-0.4564160303789175,-1.1377083955150633,0.3382899628252788,0.5996731699078212,1.0,1/10,0.28%,PAWR
prerank,protein phosphorylated amino acid binding (GO:0045309),0.446530048406857,1.1372055644916794,0.2982062780269058,1.0,1.0,14/42,24.09%,SYK;IRS1;PIK3R2;ABL2;YWHAE;PIN1;PTPN5;RASA1;PTPN3;YES1;YWHAB;VAV2;SH3BP2;NCK2
prerank,sodium channel regulator activity (GO:0017080),0.4489426008410107,1.1336706354190136,0.29445727482678985,1.0,1.0,11/37,20.22%,FGF13;SGK3;SGK2;ATP2B4;CAMK2D;FXYD5;SCN4B;PRSS8;FGF14;GPLD1;PTPN3
prerank,metal ion binding (GO:0046872),0.38813646856422085,1.1332765440241903,0.11,1.0,1.0,93/477,19.25%,ASPN;COMP;FBN1;GSN;CDH26;THBS3;GCLC;LOXL2;CDHR5;SNCB;SCIN;ANXA1;LRP1;MAPK12;DIS3L2;SYT2;POSTN;CLEC3B;ARSA;SPARC;ANXA2;EFHD1;IRAK3;SLIT3;SLIT2;S100A10;PLSCR4;SRI;S100A8;S100A9;SMOC2;SLIT1;SYT12;SYT11;CALU;FOXK2;DSC3;DSC2;COLEC11;SYT13;MVK;RCN3;THBS4;RET;IDH1;EYA2;ABL2;UBA2;PKD2;S100A6;CAPN1;IQGAP1;NDUFAB1;CDH22;ERN1;DYRK2;CAMKK2;CALML4;MAP3K6;NUDT16;CERK;FAN1;GLCE;CALM2;ATP2A2;S100G;CASQ1;STK3;PPP3CA;TUBB4A;GEM;DNASE1L2;CHP1;PLA2G4E;NUDT5;ANXA4;NME1;CANT1;PADI2;SYT1;ANXA8;ANXA8L1;TPM4;ADPRH;NCS1;STK38;EFCAB9;RP2;EML1;IDH3G;PPP3CB;STIM1;TNNC2
prerank,CXCR chemokine receptor binding (GO:0045236),0.5437483117426192,1.1325065112698682,0.340365682137834,1.0,1.0,2/11,6.20%,ITCH;CXCL10
prerank,FAD binding (GO:0071949),-0.34398512122352,-1.1309807075420286,0.25862068965517243,0.6047997730477174,1.0,5/24,7.85%,MICAL3;DDO;PRODH;CRY1;AGPS
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.42274318080203127,1.1306167852345594,0.29653679653679654,1.0,1.0,16/60,14.52%,DDR2;EPHB2;AXL;EGFR;FGFR1;EPHA3;MST1R;TGFBR2;ACVR1;RET;EPHB3;MUSK;EPHA10;FLT3;PDGFRA;DDR1
prerank,nucleotidyltransferase activity (GO:0016779),0.49391754410883204,1.1300324881861776,0.3312577833125778,1.0,1.0,9/19,23.90%,PAPSS2;TENT4A;CGAS;YRDC;NUDT5;TENT2;TENT4B;CRPPA;REV1
prerank,phosphatidate phosphatase activity (GO:0008195),0.5303304236734268,1.1295083823834138,0.34574468085106386,1.0,1.0,6/13,20.27%,PLPP3;PLPP5;PLPP1;PLPPR3;PLPP2;LPIN3
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),-0.3221864955747165,-1.1291418586024964,0.272108843537415,0.5994942453081264,1.0,8/32,10.95%,KDM7A;KDM4A;TET1;PHYH;EGLN3;BBOX1;TMLHE;EGLN1
prerank,transcription coregulator binding (GO:0001221),0.43269096673225327,1.1287656935806314,0.30913091309130913,1.0,1.0,20/50,25.29%,AR;ESR1;SMAD4;NR1D1;HDAC6;PHF1;CDK9;HDAC3;EHMT2;PER1;CTCF;CIT;RPL23;CTBP1;EZH2;RORA;PER3;RELA;LCOR;CHD6
prerank,hormone receptor binding (GO:0051427),0.523386313019546,1.1287606982769183,0.32608695652173914,1.0,1.0,5/14,28.27%,SOCS2;ADCYAP1;NCOA6;NPPC;JAK2
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.4399560912485152,1.1272788781274938,0.3176206509539843,1.0,1.0,7/38,12.89%,SERPINB8;ANXA2;SERPINE3;SERPINF1;SERPINH1;SLPI;SERPING1
prerank,histone deacetylase activity (GO:0004407),0.4831851314455633,1.127176504950025,0.3341804320203304,1.0,1.0,7/19,20.07%,HDAC9;HDAC6;SIRT2;HDAC3;HDAC4;SUDS3;MIER1
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),-0.4520827101359316,-1.1255089140349877,0.3345070422535211,0.5979970691980496,1.0,2/11,8.69%,SLC22A4;SLC25A20
prerank,GDP binding (GO:0019003),0.42249672084312795,1.1254752771495764,0.29329004329004327,1.0,1.0,26/63,27.93%,GNAI3;RAP1B;RIT2;DYNC1LI1;RAB2A;NRAS;KRAS;RRAGD;NME2;ARF6;GEM;RAB27B;RAB35;RAB5B;RAB5C;RRAS2;RALA;RAB10;RAB18;RAB12;RAB29;RAP1A;DIRAS2;RHEBL1;RAB8B;RAP2B
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.544281067591833,1.1233287221169823,0.3259361997226075,1.0,1.0,5/11,16.05%,NUDT1;NUDT7;NUDT16L1;NUDT16;NUDT5
prerank,transcription corepressor binding (GO:0001222),0.462288641026474,1.1228282642839527,0.32113341204250295,1.0,1.0,12/27,24.40%,ESR1;NR1D1;HDAC6;PHF1;HDAC3;EHMT2;PER1;CTBP1;EZH2;RORA;PER3;LCOR
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.5340775045908959,1.1188303920443774,0.33519553072625696,1.0,1.0,3/11,19.05%,CNGB1;HCN4;HCN1
prerank,MHC class II protein complex binding (GO:0023026),0.543807227599969,1.1184906266618235,0.34825174825174826,1.0,1.0,4/11,15.67%,CD81;YWHAE;HSP90AA1;PKM
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.4695368221415276,1.1181093513634452,0.3301088270858525,1.0,1.0,8/26,22.43%,B3GALNT1;CSGALNACT2;B4GALNT4;CHSY3;B3GNT8;B3GALNT2;CHPF;CHPF2
prerank,AMP binding (GO:0016208),-0.4332909140032688,-1.1161708564062733,0.3519163763066202,0.6111387969608181,1.0,5/11,13.11%,PRKAG2;PFKM;PRKAG3;ACSS2;PFKL
prerank,lipid phosphatase activity (GO:0042577),0.519009970839958,1.1161191222099127,0.352,1.0,1.0,6/14,17.79%,PLPP3;PLPP1;PLPP7;INPP5K;PLPPR3;PLPP2
prerank,vinculin binding (GO:0017166),0.5357504086846672,1.1154432508663423,0.3649932157394844,1.0,1.0,2/11,3.91%,CORO2B;SORBS3
prerank,ligand-gated cation channel activity (GO:0099094),0.4042238163083304,1.112429299061922,0.3077731092436975,1.0,1.0,18/75,24.46%,SCNN1B;P2RX3;GRIN3A;KCNJ2;GRIN2D;GRIA2;KCNJ3;ASIC2;GRIN2A;CHRNA7;CHRNA5;KCNH2;GRIA3;ASIC1;GRIK5;GRIK2;KCNJ11;GRIK4
prerank,double-stranded RNA binding (GO:0003725),0.40468058944809426,1.1121882126618583,0.31684210526315787,1.0,1.0,11/70,9.74%,MBNL1;TARBP2;ADARB1;RFTN1;EIF4A1;DGCR8;RC3H1;CLTC;DHX33;AGO2;SIDT2
prerank,RNA binding (GO:0003723),0.3761228143546713,1.10841337090646,0.049,1.0,1.0,496/1321,29.16%,COL14A1;DCN;RPSA;AHNAK;DDX18;SRSF2;LRP1;C1D;AFF2;ZC3H8;MBNL1;DNM1;PKP3;RPP25;EIF3B;FNDC3B;TARBP2;ADARB1;MTHFSD;HNRNPA1;MRPS11;ANG;ANXA2;ALDH18A1;SRSF6;DIMT1;NXF1;HDLBP;NYNRIN;RFTN1;RRBP1;DDX19B;ABT1;RBMS3;USP36;URB1;DDX49;DHX16;ZFP36L1;TNS1;DAZL;TRMT6;NUDT1;RBM4;CLUH;GTPBP4;KRI1;EIF4A1;RPP21;GNL3L;ZCRB1;ERI3;SUGP2;DDX42;SCAF8;USP10;SAMD4B;NUDT7;KCTD12;KPNA2;DDX51;CFAP65;RBBP6;RTRAF;RCAN3;TRMT2A;UBAP2L;TARDBP;DGCR8;IGHMBP2;C1QBP;MEPCE;SYNE1;FSCN1;YWHAG;DNAJC2;RC3H1;UCHL5;SRP19;LSM4;FNDC3A;CLTC;TDRD3;MYO5A;FCF1;NOC2L;DHX33;U2AF1;SPATS2;POLR1G;CAST;SRSF3;UBE2N;ZFP36L2;ATXN2;NSRP1;USO1;YWHAE;DYNC1LI1;LARP4;CHCHD1;PRPF3;GPATCH1;MRPL13;NUP98;CPSF6;AGO2;DUSP11;DALRD3;ESF1;HNRNPD;RBM22;NOP9;TDRD7;NUDT16L1;GAR1;KHDC4;EXOSC7;SAMHD1;LGALS1;SIDT2;EIF1;SRP9;ARF1;SELENOH;MEX3A;MRPS27;HELZ2;MBNL2;SON;CSTB;CPSF4;CHD2;SMC1A;GSPT2;HNRNPH1;YRDC;RRP36;NPM1;MAPRE1;RPL10A;WDR46;TCERG1;ZC3HAV1;SERPINH1;DDX56;DDX21;DHX8;ASCC3;SEC23IP;MRPL10;HNRNPUL2;GFM1;CELF2;DAP3;PEG10;UBTF;MAPT;SARS2;RBFOX2;GTPBP10;NUDT16;SLPI;PUM1;PRPF40A;IGF2BP1;UNK;PSTK;SRSF11;EIF3A;FLNB;XRCC5;LARP1;SBDS;ZFP36;RPP25L;POLR2D;RPS27L;POLR2G;MPHOSPH10;DDX17;RPS5;RPGR;ZCCHC24;SNU13;DNA2;AKAP8;EIF2S1;ATXN2L;NOLC1;ELP1;DDX11;HNRNPA3;DCAF13;DDX4;LLPH;TRMT10B;AQR;POLDIP3;ZC3H12A;RBM3;RRP7A;NUFIP2;EXOSC1;PNISR;MRM3;SMG7;CISD2;THOC2;PTCD2;HSP90AA1;MRPL3;SEC63;DDX50;EIF3E;SF3B4;GSPT1;ZC3H11A;DIAPH1;TRMT1;GTF2F1;BTF3;SMG6;FYTTD1;MRPL21;DYNC1H1;DDX20;ZCCHC8;MDH2;MANF;RSL1D1;RPL6;NOP53;BAG4;DDX52;MAP4;PKM;PRPF38B;PPIL4;HMGB3;SNTB2;PDIA3;CCDC124;GRWD1;POP4;SF3A1;NUDT5;PSIP1;SPTBN1;RBM33;CPSF2;RTCA;PHF5A;EIF3D;PPP1CC;DDX5;SNRPA;CHD3;SNRPG;FXR2;SNRPD3;SAP18;AGO4;NME1;PNN;ABCF1;PPIA;NUFIP1;ILF2;RCC2;PWP2;YTHDF1;SNIP1;YTHDF2;LUC7L3;DDX31;RCC1L;DDX39A;IPO5;SRRM1;EPRS1;FKBP4;RPF2;RBM6;NAA15;ARCN1;AKAP1;EIF2S2;EBNA1BP2;RBM39;PUF60;ZBED4;TENT4B;METAP2;NCBP3;SUPV3L1;SLBP;SRFBP1;STRAP;TCF20;ALDOA;TYW5;AIMP1;NOC3L;DDX24;ARL6IP4;HNRNPUL1;SRRM3;UBFD1;U2AF2;DUS2;PTCD1;MEX3C;MCAT;AGO3;TBL3;LUC7L2;RPL22L1;RPL23;RPL17;NOL10;KMT2C;ELAVL2;PDCD11;NOVA1;LSM7;XPOT;PTBP1;GTF2E2;FLNA;ANXA7;KRR1;REPIN1;RBM28;GANAB;SF3B2;SF3B1;RPS25;ZCCHC17;RBM45;MTIF2;SRPK1;TEP1;MAK16;PRR3;NEMF;AKAP8L;THRAP3;RC3H2;KIN;IMMT;EIF2A;JUN;RPP30;LARP7;PTBP2;PRPF38A;GPKOW;DUSP14;PLEC;NOP2;RSL24D1;YTHDF3;RBM5;RNMT;TPR;NOC4L;BAZ2A;SNRPA1;ZC3H4;PURG;MRPL54;EDC3;CSTF2T;RRP1B;TRAP1;CCT4;TNRC6A;EIF4G3;DAZAP1;EIF3L;RTF1;BRIX1;DIDO1;EIF4H;RALY;AGFG1;CPSF7;SCAF4;NOA1;MKRN2;G3BP1;WDR33;RTN4;PSMD4;API5;PABPN1;SEC61B;KHNYN;MARK2;PPIG;HEXIM1;CALR;MTCL1;LARP6;RPL22;CELF3;EWSR1;PARP12;RAMAC;EXOSC10;S100A16;PHF6;HSP90B1;TNPO1;APEH;ERAL1;UBAP2;DHX32;FBRSL1;ALYREF;UPF3B;CEBPZ;H1-0;OTUD4;CSNK1E;ZNF638;R3HDM1;DCP1A;LRRC59;MRPL14;DCP1B;RBMX;EIF4G1;NOP16;CRNKL1;FTSJ3;PRPF6;TASOR;KPNB1;RPP14;SAFB;EIF4E2;DHX29;GDI2;CCDC9;BZW1;CMSS1;RSRC2;UPF1;DDX1;MRPL12;LSM5;SMG5;PRKDC;CDC40;RPL34;HTATSF1;THOC5;ZFR;AGO1;NOP56;AATF;TSR1;DUT;CCT6A;NHP2;CELF1;YARS1;TBL2;CPSF3;ZRANB2;SARS1;RPS26;GOT2;CCDC86;LSM1;MRPS23;RBM15;MYH10;MSI1;XRCC6;HNRNPC;SNRPC;CNBP;WBP11;ATP5F1A;SRSF5;WDR43;PDIA4;PEBP1;UTP18;IGF2BP3;DHFR;NOP58;SUMO1
prerank,transforming growth factor beta binding (GO:0050431),0.4577505174013646,1.1074718748589307,0.3504273504273504,1.0,1.0,6/23,11.85%,TGFB3;TGFBR2;ACVR1;ITGAV;TSKU;VASN
prerank,snRNA binding (GO:0017069),0.4300787372722415,1.1069769785706867,0.32531500572737687,1.0,1.0,15/42,24.78%,MEPCE;LSM4;PRPF4;CDK9;RBM22;SNRPB2;DDX21;SNU13;SNRPA;SNRPD3;LSM7;LARP7;SNRPA1;COIL;HEXIM1
prerank,endopeptidase inhibitor activity (GO:0004866),0.40072504674153536,1.106405907545325,0.32676348547717843,1.0,1.0,14/82,12.89%,TIMP2;SERPINB8;ANXA2;BIN1;SERPINE3;CARD16;UCHL5;CAST;SERPINF1;CSTB;SERPINH1;SLPI;RECK;SERPING1
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.43708996418549906,1.1044449850547078,0.3325766174801362,1.0,1.0,17/37,31.04%,MARS2;TARS1;SARS2;VARS1;HARS1;GARS1;VARS2;EPRS1;QARS1;EARS2;NARS1;YARS1;SARS1;DARS1;WARS2;AARS1;LARS2
prerank,double-stranded DNA binding (GO:0003690),0.3801101261063628,1.1041384574573618,0.138,1.0,1.0,80/531,14.75%,LMX1A;LHX8;ESR1;PAX9;SP9;NFIX;IRF4;EGFR;CREB5;WT1;MEOX2;TBX15;SCRT2;HSF2;SIX4;HOXA2;ELF4;NEUROD2;KLF3;PBX1;KLF12;FOXP1;BHLHE40;TLX3;GLIS2;TEF;LMX1B;MEF2D;PAX1;SOX10;IRX5;RFX1;KLF2;RAD51B;JUND;ZBTB12;NFATC4;MAFF;NR1D2;NFATC1;HOXA5;CREB3L1;MEIS2;NR1D1;NFIB;MND1;TARDBP;DPF1;CGAS;SMAD5;MTF1;HOXA4;GLI2;TBX6;ETV3;SOX8;NR6A1;MYBL2;FOXC2;ONECUT1;POLG2;MBNL2;CPSF4;ATF7;BCL6;CEBPB;MAPT;GLI3;XRCC5;BACH2;KDM5B;TERF1;SIX1;DDX11;RFX5;KLF4;HOXA7;HOXC4;HOXA9;POU3F2
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.4458270247333646,-1.1020752334557922,0.33587786259541985,0.6335066531144963,1.0,2/11,3.59%,SASH1;DAB2IP
prerank,beta-tubulin binding (GO:0048487),-0.31638857440461415,-1.101450280713101,0.29411764705882354,0.6253441547559194,1.0,12/31,16.84%,EML4;GJB6;IFT74;PDCD5;GABARAPL1;GABARAP;SMC3;HTT;TRPV4;PEX14;TAOK1;VAPB
prerank,chloride channel regulator activity (GO:0017081),0.5058303883693165,1.1009051432213952,0.3669849931787176,1.0,1.0,7/14,28.25%,SGK3;STX1A;CHRNA7;WNK2;STX7;CFTR;STX8
prerank,sequence-specific DNA binding (GO:0043565),0.3772884670022234,1.10036300856543,0.147,1.0,1.0,90/590,14.75%,LMX1A;LHX8;ESR1;PAX9;SP9;FOXP2;NFIX;IRF4;CREB5;WT1;MEOX2;TBX15;SCRT2;HSF2;SIX4;HOXA2;ELF4;NEUROD2;KLF3;CTC1;PBX1;KLF12;FOXP1;BHLHE40;TLX3;GLIS2;TEF;SMAD4;NFE2L2;ATF5;LMX1B;MEF2D;PAX1;CXXC1;SOX10;IRX5;RFX1;FOXK2;KLF2;JUND;ZBTB12;NFATC4;MAFF;TCF7L2;NR1D2;NFATC1;HOXA5;CREB3L1;MEIS2;FOXO1;NR1D1;NFIB;DPF1;SMAD5;MTF1;HOXA4;GLI2;TBX6;FOXL1;ACD;ETV3;SOX8;WDR77;NR6A1;MYBL2;FOXC2;HNRNPD;ONECUT1;MBNL2;CPSF4;ATF7;CSRNP3;BCL6;CEBPB;MAPT;GLI3;XRCC5;BACH2;KDM5B;TERF1;SIX1;HDAC4;RFX5;SMG7;PLAGL2;KLF4;HOXA7;HOXC4;HOXA9;POU3F2
prerank,phosphotyrosine residue binding (GO:0001784),0.4368276064484663,1.0991535303674125,0.3583617747440273,1.0,1.0,4/37,7.45%,SYK;IRS1;PIK3R2;ABL2
prerank,transferrin receptor binding (GO:1990459),0.5456920991103418,1.0989336748405598,0.3632286995515695,1.0,1.0,3/10,8.18%,SNX1;CD81;CHUK
prerank,potassium ion leak channel activity (GO:0022841),0.5068576311678967,1.098833394050824,0.36530880420499345,1.0,1.0,3/15,9.44%,KCNK5;KCNK13;KCNK9
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.44081889876293295,1.0982224903238178,0.3494809688581315,1.0,1.0,14/34,28.59%,CKS1B;ETAA1;STRADA;IQGAP1;CALM2;DBF4;STK3;MAP2K2;CAB39;ALS2;PARP16;CKS2;FAM20A;INCENP
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.5166225053284945,1.0972693590581035,0.3968668407310705,1.0,1.0,4/12,14.86%,AIFM2;DHRS4;NQO2;CRYZ
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.5341700939637859,1.0951202283515766,0.3542538354253835,1.0,1.0,5/11,31.65%,PRMT2;FBXO11;CARM1;PRMT8;PRMT7
prerank,palmitoyltransferase activity (GO:0016409),0.451073391756737,1.0938121800687568,0.3524590163934426,1.0,1.0,11/28,23.21%,ZDHHC16;ZDHHC7;HHAT;ZDHHC2;ZDHHC4;ZDHHC24;ZDHHC21;ZDHHC20;ZDHHC18;ZDHHC8;ZDHHC5
prerank,protein kinase inhibitor activity (GO:0004860),0.4270297995870508,1.0934549723559857,0.3585972850678733,1.0,1.0,16/42,25.02%,CAMK2N1;TAOK3;PPP1R1B;GSKIP;NPM1;SMCR8;CDKN1A;NCK1;QARS1;GMFB;IBTK;DUS2;CIT;YWHAB;HEXIM1;DNAJC3
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.33642145207716595,-1.0928546183163192,0.3522012578616352,0.6352551075734466,1.0,7/27,5.74%,SLC22A8;SLC26A7;ANO1;ANKH;SLC39A8;SLC22A6;SLC5A5
prerank,cysteine-type endopeptidase activity (GO:0004197),0.3973075553133355,1.0917212152894527,0.35578947368421054,1.0,1.0,16/78,15.82%,CAPN5;UCHL1;CAPN2;GPAA1;USP36;USP10;USP29;CAPN1;USP26;USP33;CAPN11;USP48;USP5;PIGK;USP7;PDIA3
prerank,chemokine activity (GO:0008009),0.4468643996816888,1.0910182913272777,0.3588235294117647,1.0,1.0,4/31,12.90%,CCL8;CXCL10;CCL25;CCL13
prerank,carboxy-lyase activity (GO:0016831),0.4742149443932219,1.0908335880918674,0.341645885286783,1.0,1.0,9/23,25.37%,UMPS;GGCX;ODC1;BCKDHA;UXS1;AZIN2;AMD1;UROD;MVD
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.448851708861675,1.0890493077952688,0.36053593179049936,1.0,1.0,2/28,3.23%,TNFSF9;TMBIM1
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.37267887142756423,1.0863627396469124,0.173,1.0,1.0,101/597,16.80%,LMX1A;AR;LHX8;ESR1;PAX9;SP9;NFIX;BNC2;IRF4;CREB5;WT1;MEOX2;TBX15;SCRT2;HSF2;SIX4;HOXA2;ELF4;NEUROD2;KLF3;PBX1;KLF12;FOXP1;BHLHE40;TLX3;GLIS2;RUNX1;TEF;SMAD4;NFE2L2;ATF5;LMX1B;MEF2D;PAX1;SOX10;IRX5;RFX1;FOXK2;KLF2;JUND;ZW10;ZBTB12;NFATC4;MAFF;TCF7L2;NR1D2;NFATC1;HOXA5;CREB3L1;MEIS2;NR1D1;NFIB;CREBZF;DPF1;SMAD5;MTF1;HOXA4;GLI2;TBX6;DHX33;ETV3;SOX8;NR6A1;MYBL2;FOXC2;SOX5;ONECUT1;SMAD6;RNF10;BRD7;MCM3;MBNL2;CPSF4;MZF1;ATF7;BCL6;CEBPB;GLI3;XRCC5;BACH2;KDM5B;NCOR1;SIX1;DDX11;HDAC4;RFX5;KLF4;HOXA7;HOXC4;HOXA9;POU3F2;NR2C2;E2F3;CDK5RAP2;GRWD1;CENPC;UBP1;PER1;SNAI2;CHD3;TFAP4
prerank,lysophospholipase activity (GO:0004622),0.4651194682928781,1.0842813509358453,0.3842239185750636,1.0,1.0,1/20,0.62%,MGLL
prerank,actinin binding (GO:0042805),-0.3450114217816447,-1.0835373532390329,0.325,0.6469555409595193,1.0,4/21,4.69%,PDLIM5;SYNPO2;PROM1;CACNA1D
prerank,SUMO transferase activity (GO:0019789),0.48609240789407687,1.083493097422461,0.37715803452855245,1.0,1.0,8/16,28.12%,RNF212B;CBX4;PIAS3;HDAC4;NSMCE2;MDM2;MUL1;TOPORS
prerank,DNA polymerase binding (GO:0070182),0.4795328803697828,1.0834462955204207,0.37531172069825436,1.0,1.0,6/18,15.16%,FANCD2;ACD;POLG2;HSP90AA1;SMARCA4;SMG6
prerank,MAP kinase activity (GO:0004707),0.49789852217750197,1.0822287476305483,0.35856573705179284,1.0,1.0,4/14,9.77%,MAPK12;MAPK7;MAPK14;MAPK11
prerank,WW domain binding (GO:0050699),0.4529316445791347,1.08102782458307,0.3894230769230769,1.0,1.0,8/26,21.96%,SCNN1B;PMEPA1;TCEAL6;KIF20B;NDFIP1;WBP1;TCEAL9;TRAF4
prerank,signal sequence binding (GO:0005048),0.430725023573992,1.0796629916411848,0.38073394495412843,1.0,1.0,18/35,26.59%,KDELR3;KPNA2;KDELR1;CABP1;KDELR2;TNPO2;TIMM22;SEC61A1;PEX5L;IPO5;PEX5;KPNA1;BRAP;RANBP6;AP2M1;TNPO1;KPNA6;KPNB1
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.4708153353292165,1.0783984416038688,0.37218543046357616,1.0,1.0,6/16,24.98%,MTMR11;INPP5F;MTMR6;MTMR1;PTEN;MTM1
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.43971419267565887,1.0780777132748978,0.36992840095465396,1.0,1.0,11/31,22.78%,KCNK5;SLC12A8;SLC12A4;PKD2;KCNK9;KCNA2;SLC12A5;HCN1;SLC12A6;KCNF1;ABCC8
prerank,sulfate transmembrane transporter activity (GO:0015116),0.49741169493213644,1.0775813812276411,0.3932885906040268,1.0,1.0,4/14,17.09%,SLC26A5;SLC26A11;SLC26A6;SLC26A1
prerank,miRNA binding (GO:0035198),0.4382225547934605,1.0739341623998666,0.3919239904988123,1.0,1.0,10/30,19.45%,HNRNPA1;RBM4;TRIM71;RC3H1;AGO2;DDX21;PUM1;ZC3H12A;AGO4;AGO3
prerank,cGMP binding (GO:0030553),0.5196741040735426,1.0719235845973492,0.401673640167364,1.0,1.0,4/11,11.90%,PDE11A;PDE10A;CNGB1;PDE5A
prerank,damaged DNA binding (GO:0003684),0.4101493662884104,1.0704871121271393,0.4,1.0,1.0,14/44,22.85%,MPG;ERCC3;RAD1;ERCC4;DDB1;SMC6;FANCG;NBN;ERCC5;POLD1;DCLRE1A;OGG1;SDE2;ERCC1
prerank,N-acetyltransferase activity (GO:0008080),0.4690717429414837,1.0704733298435125,0.4040920716112532,1.0,1.0,6/19,18.79%,GNPNAT1;ATAT1;KAT2B;NAT8;SAT1;NAA50
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.5281952120643417,1.0701510266271317,0.4256480218281037,1.0,1.0,5/10,21.16%,DNAJB2;FAN1;PML;IDE;FAAP20
prerank,"DNA binding, bending (GO:0008301)",-0.3994776156917688,-1.06992976825481,0.35361216730038025,0.670497258732553,1.0,3/14,3.59%,LEF1;HMGB1;FOXC1
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.4954407214480112,1.0691240541876388,0.4019073569482289,1.0,1.0,5/14,21.67%,DESI2;OTUD7B;USP7;MINDY3;USP13
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.3663842277407882,1.0684108097397385,0.21,1.0,1.0,125/730,16.81%,EBF2;PRRX1;AR;ESR1;HOXA3;PAX9;EBF1;SP9;FOXP2;NFIX;IRF4;CREB5;WT1;ZFHX4;MEOX2;TBX15;SCRT2;ZNF367;HSF2;SIX4;HOXA2;ELF4;HIVEP2;NEUROD2;SKIL;KLF3;PBX1;KLF12;FOXP1;BHLHE40;TLX3;GLIS2;RUNX1;TEF;SMAD4;NFE2L2;MEF2D;SKI;PAX1;SOX10;IRX5;RFX1;FOXK2;KLF2;JUND;ZBTB12;NFATC4;MAFF;TCF7L2;NR1D2;NFATC1;HOXA5;CREB3L1;MEIS2;FOXO1;NR1D1;NFIB;EBF3;ZBTB7C;MUC1;NFIA;ZFHX3;MLXIPL;SMAD5;HDAC6;MYT1;MTF1;HOXA4;GLI2;TBX6;FOXL1;STAT5A;SOX8;ZBTB1;VDR;NR6A1;MYBL2;ZNF260;FOXC2;SOX5;ONECUT1;SATB2;MYPOP;CHD2;MZF1;MITF;PRDM15;ATF7;BCL6;CEBPB;GLI3;BACH2;ZNF691;ZNF112;ATF1;IKZF5;PROX2;TWIST1;SIX1;NACC2;HDAC4;RFX5;PLAGL1;ZNF569;KLF4;HOXA7;HOXC4;HOXA9;POU3F2;ZNF692;MLXIP;NFE2L3;NR2C2;E2F3;ZFP28;ZBTB25;ZBTB5;UBP1;PER1;HIVEP3;STAT5B;SNAI2;E4F1;TFAP4;ZEB1
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.3428047127532453,-1.067864224009486,0.3772455089820359,0.665993840255094,1.0,3/23,1.51%,PDE1A;PDE7B;PDE3A
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.3523871524861819,-1.0675701592089075,0.3709677419354839,0.6575756608436347,1.0,3/21,1.51%,PDE1A;PDE7B;PDE3A
prerank,aminopeptidase activity (GO:0004177),0.4326666018863071,1.0675280136685061,0.40145985401459855,1.0,1.0,11/26,24.69%,ANPEP;LNPEP;XPNPEP3;NPEPPS;LAP3;MMP16;METAP2;METAP1;METAP1D;JMJD7;MMP15
prerank,sulfotransferase activity (GO:0008146),0.42321056614212904,1.066128889105695,0.3833718244803695,1.0,1.0,6/33,9.57%,CHST1;CHST10;GAL3ST3;CHST12;CHST14;HS2ST1
prerank,antiporter activity (GO:0015297),0.4696862507785533,1.0656648970643268,0.3957286432160804,1.0,1.0,5/20,16.60%,SLC35E3;ATP1A3;SLC25A16;SLC35D1;SLC35E1
prerank,Toll-like receptor binding (GO:0035325),0.5165211673549942,1.0626931529173997,0.4174496644295302,1.0,1.0,3/11,8.91%,S100A8;S100A9;TIRAP
prerank,mRNA 3'-UTR binding (GO:0003730),0.3892459584622902,1.0625017463014819,0.37763713080168776,1.0,1.0,21/79,16.96%,RBMS3;ZFP36L1;DAZL;RBM4;TARDBP;RC3H1;CARHSP1;AUH;ZFP36L2;LARP4;CELF2;PUM1;IGF2BP1;LARP1;ZFP36;ZC3H12A;CRYZ;RSL1D1;DDX5;FXR2;CPEB1
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.36340193509262375,1.0591572409428076,0.252,1.0,1.0,123/731,16.81%,EBF2;PRRX1;AR;ESR1;HOXA3;PAX9;EBF1;SP9;FOXP2;NFIX;IRF4;CREB5;WT1;ZFHX4;MEOX2;TBX15;SCRT2;ZNF367;HSF2;SIX4;HOXA2;ELF4;HIVEP2;NEUROD2;SKIL;KLF3;PBX1;KLF12;FOXP1;BHLHE40;TLX3;GLIS2;RUNX1;TEF;SMAD4;NFE2L2;MEF2D;SKI;PAX1;SOX10;IRX5;RFX1;FOXK2;KLF2;JUND;ZBTB12;NFATC4;MAFF;TCF7L2;NR1D2;NFATC1;HOXA5;MEIS2;FOXO1;NR1D1;NFIB;EBF3;ZBTB7C;MUC1;NFIA;ZFHX3;MLXIPL;SMAD5;HDAC6;MYT1;MTF1;HOXA4;GLI2;TBX6;FOXL1;STAT5A;SOX8;ZBTB1;VDR;NR6A1;MYBL2;ZNF260;FOXC2;SOX5;ONECUT1;SATB2;MYPOP;CHD2;MZF1;MITF;PRDM15;ATF7;BCL6;CEBPB;GLI3;BACH2;ZNF691;ZNF112;ATF1;IKZF5;PROX2;SIX1;NACC2;HDAC4;RFX5;PLAGL1;ZNF569;KLF4;HOXA7;HOXC4;HOXA9;POU3F2;ZNF692;MLXIP;NFE2L3;NR2C2;E2F3;ZFP28;ZBTB25;ZBTB5;UBP1;PER1;HIVEP3;STAT5B;SNAI2;E4F1;TFAP4;ZEB1
prerank,calcium activated cation channel activity (GO:0005227),0.47486772653414755,1.0588280028728139,0.41613316261203587,1.0,1.0,2/17,5.18%,KCNMA1;TMEM63A
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.5240366046391829,1.0581139160749586,0.4231843575418994,1.0,1.0,1/10,0.43%,SLCO2A1
prerank,TBP-class protein binding (GO:0017025),0.46286063594928806,1.0571601090561524,0.39949748743718594,1.0,1.0,5/21,15.51%,ESR1;BRF2;DR1;GTF2A2;YEATS2
prerank,nuclear localization sequence binding (GO:0008139),0.4617512671899215,1.0561941270677604,0.4067584480600751,1.0,1.0,10/18,26.59%,KPNA2;CABP1;TNPO2;IPO5;KPNA1;BRAP;RANBP6;TNPO1;KPNA6;KPNB1
prerank,E-box binding (GO:0070888),0.41524995578454116,1.0543326716021506,0.3888888888888889,1.0,1.0,9/34,16.81%,SCRT2;NEUROD2;BHLHE40;MITF;TWIST1;PER1;SNAI2;TFAP4;ZEB1
prerank,Hsp70 protein binding (GO:0030544),0.4229260306040155,1.0540993221272603,0.40328253223915594,1.0,1.0,12/31,27.95%,DNAJC2;STUB1;DNAJC8;ERN1;PPEF2;DNAJB2;GPR37;DNAJB1;MVD;TSC1;DNAJA1;HDAC8
prerank,RNA polymerase II complex binding (GO:0000993),0.4293493943368486,1.0539789581158907,0.42907385697538103,1.0,1.0,16/32,31.70%,SCAF8;RTRAF;NCOA3;AGO2;ELP4;URI1;UVSSA;ERCC5;PCIF1;PAF1;ELOF1;AGO1;WDR43;SCAF1;RPRD1A;WAC
prerank,glycerophospholipid flippase activity (GO:0140333),0.4994073166809928,1.053445925194987,0.4192200557103064,1.0,1.0,2/11,7.63%,ATP8B1;ATP11A
prerank,transition metal ion binding (GO:0046914),0.36107411330832,1.052848655583738,0.329,1.0,1.0,100/397,21.58%,TIMP2;LOXL2;SNCB;WT1;SEC24D;B4GALT1;ANG;ANPEP;S100A8;S100A9;CRIP1;CLIP1;SKI;ADAMTS3;ADAM33;MSRB1;MGAT1;TK1;RBAK;SEC24A;RASSF1;ABCE1;MDM4;RC3H1;MYT1;MELTF;SLC11A2;LNPEP;ABL2;GLI2;ZFPM2;RNF2;MYCBP2;TIMM9;DPEP1;SEC23A;SIAH1;ECE1;SIRT2;KDM5C;SAMHD1;GDA;XPNPEP3;USP33;DYRK2;LARGE1;ZNF3;GALNT1;TARS1;WDFY1;RNF7;NUDT16;NQO2;MPPE1;NPEPPS;CZIB;ACO2;KDM5B;MGAT5;MGAT2;IKZF5;ZCCHC4;HDAC4;PEX12;KLF4;CHORDC1;AOX1;SOD3;PHF5A;SLC30A5;CHD3;GRIN2A;ZEB1;IDE;SEC24B;FBXL5;NEK4;TIMM8B;ZDHHC20;TYR;EPRS1;ARIH2;BLM;MMP16;FDX1;SMPD1;CTCF;TYW5;SCD5;KDM1B;KMT2A;FBXL19;XYLT2;ARIH1;MGAT5B;CCS;TAB2;MBD1;KDM2B;NSD1
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.4714034170869651,1.0527422830445796,0.4178343949044586,0.9983318756141413,1.0,4/18,16.12%,PIK3R2;SOCS2;WDR91;SOCS6
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.35985185800054426,1.052292586085609,0.265,0.9954853758056971,1.0,133/830,16.81%,LMX1A;EBF2;PRRX1;AR;LHX8;ESR1;HOXA3;PAX9;EBF1;TRPS1;SP9;FOXP2;NFIX;IRF4;CREB5;WT1;ZFHX4;MEOX2;TBX15;SCRT2;ZNF367;HSF2;SIX4;HOXA2;ELF4;HIVEP2;NEUROD2;SKIL;KLF3;PBX1;KLF12;FOXP1;BHLHE40;TLX3;GLIS2;RUNX1;TEF;SMAD4;NFE2L2;ZNF25;ATF5;LMX1B;MEF2D;SKI;PAX1;SOX10;IRX5;RFX1;FOXK2;KLF2;JUND;ZBTB12;NFATC4;MAFF;TCF7L2;NR1D2;NFATC1;RBAK;HOXA5;MEIS2;FOXO1;NR1D1;NFIB;EBF3;ZBTB7C;MUC1;NFIA;ZFHX3;MLXIPL;SMAD5;HDAC6;MYT1;MTF1;HOXA4;GLI2;TBX6;FOXL1;STAT5A;SOX8;ZBTB1;VDR;NR6A1;MYBL2;ZNF260;FOXC2;SOX5;ONECUT1;SATB2;MYPOP;ZNF3;CHD2;MZF1;MITF;PRDM15;ATF7;BCL6;CEBPB;GLI3;BACH2;ZNF691;ZNF112;ATF1;PEG3;IKZF5;PROX2;TWIST1;SIX1;NACC2;HDAC4;RFX5;PLAGL1;ZNF569;KLF4;HOXA7;HOXC4;HOXA9;POU3F2;ZNF692;MLXIP;NFE2L3;NR2C2;E2F3;ZFP28;ZBTB25;ZBTB5;UBP1;PER1;HIVEP3;STAT5B;SNAI2;E4F1;TFAP4;ZEB1
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.41871990416223376,-1.052262337937219,0.41216216216216217,0.6850876165944658,1.0,5/10,25.75%,CACNB2;CACNA1D;CACNB3;CACNA1B;CACNB4
prerank,I-SMAD binding (GO:0070411),0.4974788871985161,1.0515888161871536,0.43826322930800543,0.9935330670499747,1.0,4/13,10.09%,SMAD4;AXIN1;SMAD5;SMAD6
prerank,RNA stem-loop binding (GO:0035613),0.5023200153515506,1.0512274992782393,0.42436974789915966,0.9903625531747846,1.0,8/12,34.87%,RC3H1;ZC3H12A;EPRS1;RC3H2;LARP6;MYH10;CPEB3;DDX3X
prerank,deoxyribonuclease activity (GO:0004536),0.4845885467031316,1.0510415571387268,0.4218533886583679,0.9867079209898264,1.0,7/14,24.95%,ERCC4;DNASE1L2;NME1;ERCC5;MAP1S;DFFB;DNASE1L1
prerank,ubiquitin-dependent protein binding (GO:0140036),0.5230439113958029,1.0492112518358938,0.4323943661971831,0.9887777235216569,1.0,5/10,21.16%,DNAJC2;DNAJB2;FAN1;IDE;FAAP20
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.4089569444734751,1.0483785828894012,0.42152466367713004,0.9875617671129114,1.0,8/42,15.13%,CCNL2;CKS1B;KAT2B;CCNC;CDKN1A;CCND1;CCNH;CCNQ
prerank,iron ion binding (GO:0005506),-0.2678091594021171,-1.0434996240672703,0.32954545454545453,0.697000383274893,1.0,13/48,13.05%,KDM7A;SNCA;FTH1;TET1;PHYH;EGLN3;FECH;PHF2;NFU1;EGLN1;ETHE1;SCD;ISCU
prerank,GTPase activity (GO:0003924),0.3631252972464123,1.042198409378777,0.4030150753768844,1.0,1.0,65/192,28.13%,GNG8;GNAS;DNM1;GNAI3;RAB32;RAB6A;RAB23;GTPBP4;RAB19;RAB6B;RAP1B;RIT2;GNAZ;RHOJ;RHOQ;GSPT2;RAB2A;GFM1;NRAS;KRAS;GTPBP10;NKIRAS1;RAB43;RHOA;RRAGD;GNB1;GEM;RAB27B;GSPT1;RND3;RAB33B;RAC3;RAB35;RAB1B;RAB5B;RAB5C;RRAS2;RAB24;RALA;GNAO1;GPN1;GNB5;SEPTIN9;RABL3;RAB18;ARL8A;AGAP3;GNA14;RAC1;RAB29;ATL1;RHOT2;RAB1A;RHOBTB2;GNA13;RAB3C;RND2;RAP1A;DIRAS2;RHEBL1;RAB8B;TSR1;RAP2B;RAP1GAP;HBS1L
prerank,sialyltransferase activity (GO:0008373),-0.34028782197085466,-1.0410565563231475,0.38974358974358975,0.6930681712381059,1.0,6/20,9.81%,ST3GAL6;ST8SIA4;ST6GALNAC3;ST6GALNAC5;ST6GAL1;ST8SIA2
prerank,nucleoside-triphosphatase activity (GO:0017111),0.3608997994800023,1.0404873470216809,0.40521564694082246,1.0,1.0,84/248,28.13%,GNG8;GNAS;DNM1;GNAI3;RAB32;RAB6A;KLC1;RAB23;GTPBP4;RAB19;RAB6B;RAP1B;VPS4B;ABCG4;RIT2;CLPX;DYNC1I1;TOR1A;KIF2A;GNAZ;RHOJ;RHOQ;GSPT2;RAB2A;GFM1;NRAS;KRAS;GTPBP10;KIF20B;NKIRAS1;RAB43;PIN1;RHOA;DNA2;RRAGD;GNB1;DDX4;HSP90AA1;GEM;RAB27B;GSPT1;RND3;RAB33B;RAC3;CHD3;RAB35;RAB1B;RAB5B;RAB5C;DYNC2H1;ATP2B1;ATAD1;RRAS2;RAB24;RALA;ABCB10;GNAO1;GPN1;GNB5;SEPTIN9;RABL3;RAB18;ARL8A;AGAP3;GNA14;RAC1;RAB29;ATL1;RHOT2;RAB1A;RHOBTB2;GNA13;RAB3C;RND2;CFTR;DHX29;RAP1A;DIRAS2;RHEBL1;RAB8B;TSR1;RAP2B;RAP1GAP;HBS1L
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.48142928848749794,1.0402516069707408,0.4381443298969072,1.0,1.0,5/15,15.12%,GPAT4;AGPAT3;LPCAT1;AGPAT5;GPAT3
prerank,mannose binding (GO:0005537),0.4924224230907063,1.0399811377891623,0.4323962516733601,0.9992088720121098,1.0,3/12,18.59%,COLEC11;LMAN1;MBL2
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.36467732530280383,1.0383646460222429,0.42168674698795183,1.0,1.0,32/173,16.81%,TRPS1;FOXP2;SCRT2;SKIL;KLF12;FOXP1;BHLHE40;ZNF25;SKI;FOXK2;ZBTB12;NFATC4;CREB3L1;NR1D1;ZFHX3;ZBTB1;MYPOP;ZNF3;MZF1;MITF;BCL6;CEBPB;PEG3;IKZF5;NACC2;PLAGL1;ZNF692;ZBTB25;ZBTB5;SNAI2;E4F1;ZEB1
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.36255085605017073,1.0383245952735707,0.3897795591182365,0.9965262304166228,1.0,48/254,16.80%,PRRX1;AR;ESR1;IRF4;WT1;MEOX2;HSF2;ELF4;GLIS2;RUNX1;SMAD4;ATF5;SOX10;FOXK2;MAFF;NFATC1;HOXA5;CREB3L1;SMARCD2;MEIS2;FOXO1;NFIB;NFIA;MDM4;MTF1;SMARCD1;MYBL2;FOXC2;ONECUT1;SATB2;MZF1;MITF;PRDM15;ZNF112;ATF1;SIX1;RFX5;PLAGL1;PLAGL2;KLF4;HOXA7;HOXC4;MLXIP;NR2C2;E2F3;UBP1;E4F1;TFAP4
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),-0.340549305031757,-1.0378130399775256,0.3686440677966102,0.6919972967444588,1.0,8/18,20.76%,TNFAIP8;SNCA;XIAP;PRDX3;RPS6KA1;MT3;SERPINB9;BIRC2
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.49537744504287734,1.0370772741299372,0.4409340659340659,0.9967293462170944,1.0,4/12,18.40%,CISD1;CISD2;AOX1;FDX1
prerank,active ion transmembrane transporter activity (GO:0022853),-0.2867179373274437,-1.036378202307407,0.37398373983739835,0.6864128712868209,1.0,7/37,6.74%,SLC22A8;SLCO2B1;SLCO1C1;SLC22A6;SLC22A4;COX4I1;ATP13A3
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.29266529369104116,-1.0353493166102952,0.40714285714285714,0.6801216212980918,1.0,8/34,9.65%,MYO1B;ADAP2;ARAP2;IQGAP2;ARAP3;FCHSD2;HIP1R;ZFYVE1
prerank,semaphorin receptor binding (GO:0030215),0.44122116561550545,1.0346533609007869,0.4430844553243574,1.0,1.0,4/23,12.28%,SEMA3C;RIT2;SEMA3A;SEMA3D
prerank,cholesterol binding (GO:0015485),0.4022716029322866,1.0335602420456589,0.4326710816777042,1.0,1.0,9/47,11.99%,OSBP2;GRAMD1A;OSBPL3;OSBPL2;ABCA1;CD81;SCP2;OSBPL6;VDAC2
prerank,transforming growth factor beta receptor binding (GO:0005160),0.4477750650566945,1.0290526947143401,0.4312169312169312,1.0,1.0,4/18,10.09%,TGFB3;TGFB2;TGFBR2;SMAD6
prerank,death receptor activity (GO:0005035),-0.4051031257606847,-1.0263157003951462,0.43795620437956206,0.6932789777168035,1.0,5/11,22.92%,TNFRSF19;TNFRSF11A;FAS;TNFRSF10B;TNFRSF25
prerank,mannosyltransferase activity (GO:0000030),-0.3218777807915133,-1.0259896141447915,0.42786069651741293,0.6854952237305179,1.0,7/21,13.39%,TMTC1;TMTC4;TMTC2;ALG12;DPY19L4;PIGB;POMT2
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.37412490979301055,1.0232635649044657,0.45665961945031713,1.0,1.0,16/75,22.82%,EHHADH;DHRS9;UGDH;DHRS4;HSD3B7;HIBADH;PTGR1;KCNAB3;HSD17B8;MDH2;BDH2;GLYR1;LDHA;HSD17B4;HSD17B11;LDHAL6B
prerank,phosphatidylglycerol binding (GO:1901611),0.48456037303623073,1.0225667899705888,0.4649243466299862,1.0,1.0,1/13,0.56%,UCP1
prerank,methyltransferase activity (GO:0008168),0.393042814706394,1.0222906735058725,0.43673012318029114,1.0,1.0,23/46,34.89%,NTMT1;MEPCE;FTSJ1;COMTD1;COQ3;GAMT;COMT;TRMT11;COQ5;N6AMT1;FTSJ3;EEF1AKMT3;ASMT;NNMT;SUV39H1;PRMT8;LRTOMT;AS3MT;PRMT7;DNMT3B;NSUN3;EEF1AKMT1;BUD23
prerank,MAP kinase phosphatase activity (GO:0033549),-0.3896253388441291,-1.0201797019542558,0.44402985074626866,0.6902476653142352,1.0,3/12,16.45%,DUSP10;DUSP7;DUSP6
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),-0.28510540796801326,-1.0176649391720325,0.39568345323741005,0.6874246606432164,1.0,9/29,18.14%,PRKAG2;PKIG;PRKAR1B;RPTOR;PRKAR2B;SPRED2;HSPB1;INKA2;CIB1
prerank,cell adhesion mediator activity (GO:0098631),0.4236845106764723,1.0170720225042647,0.4562043795620438,1.0,1.0,7/24,13.54%,NPTN;JAM3;CD47;SIRPA;DSCAM;IGSF9;PALLD
prerank,telomerase RNA binding (GO:0070034),0.43279454639808856,1.0164037575621596,0.45955882352941174,1.0,1.0,10/22,28.61%,GAR1;SMG7;SMG6;SNRPD3;TENT4B;TEP1;EXOSC10;SMG5;NHP2;HNRNPC
prerank,phosphatidylinositol binding (GO:0035091),0.3611862495497525,1.0146253400718799,0.46659707724425886,1.0,1.0,17/91,14.55%,SESTD1;SCIN;GAP43;GPAA1;FRMPD2;AIDA;PARD3B;PLEKHF1;SNX1;DPEP1;WDFY1;MAPT;PASK;MPPE1;DENND1A;PIGK;BCAS3
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.48174056609980553,1.0144892230099243,0.4830393487109905,1.0,1.0,3/12,4.65%,ITGB3;VEGFA;ITGA5
prerank,potassium:proton antiporter activity (GO:0015386),0.4949447570875446,1.0143469990387917,0.4403292181069959,1.0,1.0,4/10,15.88%,SLC9A9;SLC9A1;SLC9A7;SLC9A6
prerank,methylation-dependent protein binding (GO:0140034),0.37640974332706395,1.0135847287060715,0.45837837837837836,1.0,1.0,26/57,30.66%,MORC4;CXXC1;SPIN4;TDRD3;PHF1;MSL3;ING4;ZCWPW2;WDR5;MPHOSPH8;CDYL;CHD8;CHD1;GLYR1;SGF29;SPIN1;JMJD7;TRIM24;PYGO1;MSH6;ING1;CBX2;ATRX;MBTD1;THAP7;CBX5
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.3771643772449111,1.012411283565371,0.4700854700854701,1.0,1.0,21/69,23.21%,CERS6;ZDHHC16;MOGAT1;PLAAT1;ZDHHC7;SCP2;KAT2B;HHAT;MBOAT7;MOGAT2;ZDHHC2;PLA2G4E;ZDHHC21;ZDHHC20;NAA15;MCAT;SOAT1;ZDHHC18;KAT6B;ZDHHC8;ZDHHC5
prerank,solute:proton symporter activity (GO:0015295),0.4643279217621534,1.0119845683106183,0.48533333333333334,1.0,1.0,5/16,15.20%,SLC11A2;SLC17A5;SLC2A10;SLC15A4;SLC25A3
prerank,poly(A) binding (GO:0008143),-0.3307648086979161,-1.0085868073320177,0.43523316062176165,0.6995120706436558,1.0,9/21,19.25%,RBPMS;RBMS2;ZC3H14;PPIE;KHDRBS1;TIA1;HNRNPDL;PABPC4L;EIF4A3
prerank,MHC protein binding (GO:0042287),0.43090184518875,1.008165853820461,0.4681404421326398,1.0,1.0,7/20,28.84%,KIR3DL2;CD81;COL2A1;ABCB9;DERL1;ATP5F1B;ATP5F1A
prerank,cholesterol transfer activity (GO:0120020),0.4602538939414284,1.007199118291536,0.4801536491677337,1.0,1.0,3/16,7.00%,GRAMD1A;OSBPL2;ABCA1
prerank,histone deacetylase binding (GO:0042826),0.3639814674868528,1.0063053606661296,0.48497409326424873,1.0,1.0,40/88,30.64%,HDAC9;MEF2D;DACT1;KPNA2;HDAC6;YWHAE;SIRT2;KAT2B;SATB2;HDAC3;GLI3;NCOR2;NCOR1;CCND1;AKAP8;NACC2;HDAC4;HSP90AA1;GMNN;TFAP4;TOP2B;NIPBL;SUDS3;MIER1;KCTD21;AKAP8L;YWHAB;RELA;LCOR;PHF6;SMG5;HES1;HIC1;TP53;MEF2B;BRMS1L;BRMS1;TRAF6;THAP7;RAD9A
prerank,endonuclease activity (GO:0004519),0.385489594651664,1.006295096246373,0.4900662251655629,1.0,1.0,13/49,20.44%,ANG;NYNRIN;N4BP2;AGO2;ERN1;ERCC4;RCL1;ZC3H12A;SMG6;ERCC5;AGO3;YBEY;OGG1
prerank,fibroblast growth factor binding (GO:0017134),0.42621340906801886,1.0056404828538668,0.4726609963547995,1.0,1.0,4/21,9.97%,FGFR1;ITGB3;GLG1;ITGAV
prerank,zinc ion binding (GO:0008270),0.34639157242095686,1.0055341371457764,0.48,1.0,1.0,70/293,21.58%,TIMP2;WT1;SEC24D;ANPEP;S100A8;S100A9;CRIP1;CLIP1;SKI;ADAMTS3;ADAM33;MSRB1;TK1;RBAK;SEC24A;RASSF1;MDM4;RC3H1;MYT1;LNPEP;GLI2;ZFPM2;RNF2;MYCBP2;TIMM9;DPEP1;SEC23A;SIAH1;ECE1;SIRT2;KDM5C;SAMHD1;GDA;USP33;ZNF3;TARS1;WDFY1;NQO2;NPEPPS;CZIB;KDM5B;IKZF5;ZCCHC4;HDAC4;PEX12;KLF4;CHORDC1;PHF5A;SLC30A5;CHD3;GRIN2A;ZEB1;IDE;SEC24B;TIMM8B;ZDHHC20;EPRS1;ARIH2;BLM;MMP16;SMPD1;CTCF;KDM1B;KMT2A;FBXL19;ARIH1;TAB2;MBD1;KDM2B;NSD1
prerank,phosphate ion binding (GO:0042301),0.5006414275167522,1.0047740277984,0.47270114942528735,1.0,1.0,5/10,25.18%,CHST14;ADSS2;MTHFD2;RELA;RPH3A
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.4030087491098166,1.0034358182294747,0.47149643705463185,1.0,1.0,8/30,19.98%,SLC39A13;SLC39A14;SLC11A2;SLC39A7;SLC25A28;TMEM165;SLC30A5;SLC39A3
prerank,phosphatase binding (GO:0019902),0.36490866446114106,1.0031724198099046,0.49640287769784175,1.0,1.0,26/105,17.67%,EGFR;EIF2AK3;DLG4;PIK3R2;MAPK14;RCAN3;CARHSP1;FBXL2;IQGAP1;SIRPA;ANAPC5;MAGI2;JUP;SHOC2;STX17;KIF3A;PPP1R3C;SFI1;CDC27;GTF2F1;TRPC4AP;ANK1;CNST;TRAF3;SH2D4A;ANAPC4
prerank,disordered domain specific binding (GO:0097718),0.4327879348804971,1.0028840341912804,0.47174447174447176,1.0,1.0,9/23,24.79%,FYN;NCOA3;CLTC;CALM2;HSP90AA1;FKBP8;NUMA1;DFFB;MDM2
prerank,lysine-acetylated histone binding (GO:0070577),0.4313674752350909,1.0021692970465286,0.4752851711026616,1.0,1.0,10/20,23.83%,DPF2;BRD9;ATAD2B;BRD7;SMARCA4;KMT2A;BRD2;CARM1;BAZ2A;TRIM24
prerank,acetylation-dependent protein binding (GO:0140033),0.4313674752350909,1.0021692970465286,0.4752851711026616,1.0,1.0,10/20,23.83%,DPF2;BRD9;ATAD2B;BRD7;SMARCA4;KMT2A;BRD2;CARM1;BAZ2A;TRIM24
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.4273946374052794,1.0019157929450113,0.46124523506988563,1.0,1.0,5/21,27.35%,P2RX3;CHRNA7;CHRNA5;GRIK2;P2RX4
prerank,glycine binding (GO:0016594),0.4857861698143823,1.0018132803446824,0.4930747922437673,1.0,1.0,5/11,30.12%,GRIN3A;GLDC;SRR;GLRA3;GLRA2
prerank,U6 snRNA binding (GO:0017070),0.4593512234461331,1.0000416143469115,0.4791386271870794,1.0,1.0,5/14,21.92%,LSM4;PRPF4;RBM22;LSM7;LARP7
prerank,protein phosphatase 1 binding (GO:0008157),-0.3187057018463012,-0.9995189326792522,0.44660194174757284,0.7123555975096592,1.0,6/21,12.82%,PPP1R16B;PPP1R3B;SH3RF2;KCNQ1;PPP1R16A;PHACTR4
prerank,SH2 domain binding (GO:0042169),0.40744625032218545,0.999454676676122,0.4831981460023175,1.0,1.0,5/31,12.63%,LAX1;IRS1;SRC;SQSTM1;RUFY1
prerank,phosphatidylinositol kinase activity (GO:0052742),0.4590252475789802,0.997733223575841,0.4865211810012837,1.0,1.0,7/15,22.25%,PIK3C2B;PI4K2B;PIK3CA;PI4KB;PI4KA;PIK3CG;PI4K2A
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.46345200942547576,0.99760575507402,0.489851150202977,1.0,1.0,5/14,17.92%,NME2;CMPK2;NME1;AK8;AK9
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.4803980399836722,0.9975768342985273,0.5076495132127955,0.9938157807057585,1.0,5/11,25.45%,GRPEL2;BAG4;BAG3;BAG5;HSPH1
prerank,adenyl nucleotide binding (GO:0030554),0.4803980399836722,0.9975768342985273,0.5076495132127955,0.9938157807057585,1.0,5/11,25.45%,GRPEL2;BAG4;BAG3;BAG5;HSPH1
prerank,methylated histone binding (GO:0035064),0.3692058479355555,0.9967173550721121,0.4689880304678999,0.9928833080559871,1.0,20/62,24.23%,MORC4;DPF2;CXXC1;SPIN4;TDRD3;PHF1;MSL3;ING4;ZCWPW2;WDR5;MPHOSPH8;CDYL;CHD8;CHD1;GLYR1;SGF29;SPIN1;JMJD7;TRIM24;PYGO1
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.46791059798249945,0.9959072976054905,0.4931693989071038,0.9917131565133067,1.0,9/13,35.14%,FTSJ1;TRMT10B;TRMT1;TRMT11;METTL1;WDR4;THUMPD3;TRMT10C;THUMPD2
prerank,ribosomal small subunit binding (GO:0043024),0.44580402187496027,0.9954315019433323,0.49293966623876767,0.9894220649729037,1.0,9/17,26.66%,ABCE1;EIF1;NPM1;LARP1;NME1;MTIF2;EIF4H;ERAL1;DHX29
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.45011434367458475,0.9942191808983781,0.48517520215633425,0.9894647424865229,1.0,5/14,24.98%,MTMR11;MTMR6;MTMR1;PTEN;MTM1
prerank,methyl-CpG binding (GO:0008327),-0.31840078966699836,-0.9937962557858927,0.4473684210526316,0.7177132492011384,1.0,5/22,13.12%,CXXC4;TET1;ZBTB38;CXXC5;LRWD1
prerank,motor activity (GO:0003774),0.36987142572729426,0.9919952729813081,0.4957356076759062,0.9926852733201308,1.0,17/60,21.55%,KLC1;KIFC2;KIF21B;STARD9;DNAH8;DYNC1I1;KIF2A;KIF20B;KIF3A;KIF21A;PIN1;KIF3B;DYNC2H1;CENPE;KIFC3;KIF26B;DYNLRB1
prerank,guanyl ribonucleotide binding (GO:0032561),0.34467261381791375,0.9916616867629472,0.5145728643216081,0.990219577912301,1.0,66/196,27.93%,GNAI3;RAB32;RAB6A;GTPBP4;RAP1B;PDE11A;ARF4;SCG5;PDE10A;RIT2;DYNC1LI1;CNGB1;RHOJ;ARF1;RHOQ;TUBB6;RAB2A;NRAS;KRAS;GTPBP10;NUDT16;PDE5A;RRAD;TUBD1;RHOA;RRAGD;NME2;ARF6;TUBB4A;TUBA4A;GEM;RAB27B;GLUD1;RND3;RAC3;RAB35;NME1;RAB1B;RAB5B;RAB5C;RRAS2;PIP4K2B;RALA;RAB10;ADSS2;TUBG2;RABL3;RAB18;ARL8A;NOA1;RAB12;ANXA6;RAC1;RAB29;ATL1;RHOT2;RHOBTB2;EIF2B2;RND2;RAP1A;DIRAS2;TUBB2A;RHEBL1;RAB8B;TSR1;RAP2B
prerank,sterol binding (GO:0032934),0.37544745629684395,0.9888992577262377,0.5117021276595745,0.9948481402019558,1.0,10/56,11.99%,OSBP2;GRAMD1A;OSBPL3;OSBPL2;ABCA1;CD81;INSIG2;SCP2;OSBPL6;VDAC2
prerank,RNA methyltransferase activity (GO:0008173),0.42201374798244545,0.9877676608843192,0.5106649937264742,0.9947046938787755,1.0,4/19,12.67%,TYW3;MEPCE;FTSJ1;TGS1
prerank,protein homodimerization activity (GO:0042803),0.3369399867736377,0.9876629760788502,0.57,0.9914701610671537,1.0,139/590,21.08%,MID1;GHR;LRP6;MGLL;CADM3;FOXP2;SRM;ST3GAL2;DPP4;FGFR1;STK25;FAP;TARBP2;ANG;VEGFA;IRAK3;TGFB2;SLIT2;S100A10;SLC51A;BHLHE40;NECTIN3;SLC39A13;SMAD4;EXT1;MID2;AXIN1;ACVR1;TENM3;VPS4B;CAMK2D;ALDH3A2;PRMT2;ABCG4;DGCR8;IDH1;SYNE1;MLXIPL;TMEM266;STUB1;MYO9B;SNX1;TIMM9;PKD2;S100A6;SLK;CHUK;ZBTB1;INPP5F;NR6A1;HPS4;DPY30;ECE1;PON3;NUDT16L1;ODC1;XPNPEP3;ERN1;NPM1;MZF1;SPPL2B;ZHX2;GSTM2;CEBPB;AKT1;NUDT16;KIF20B;IRAK1;NQO2;GLA;JUP;BAK1;FLRT3;GLCE;ADCY8;ALDH1A3;MGAT2;GDNF;ZDHHC2;GTF2A2;TERF1;CRYM;CR2;NACC2;NFS1;PDGFRA;SYNDIG1;CISD2;HSP90AA1;FZD4;PANK1;MTMR1;AOX1;TRIM68;ACOX1;HARS1;NUDT5;PHETA2;PRPS1;PRPS1L1;FXR2;TFAP4;PML;IDE;CANT1;CHRNA7;PADI2;ABCB9;SRGAP2;QTRT1;ERCC5;TYR;EPRS1;SNX6;TPM4;BLM;SUPV3L1;KCNH2;PRDM9;TYW5;AIMP1;PANK3;MKLN1;MCL1;GLDC;ABCD3;GALM;STK26;ACP3;KMT2A;FLNA;PIP4K2B;NECTIN1;ABCB10;ATIC;HSD17B4;PYCARD;BMPR1A;TPST2
prerank,amyloid-beta binding (GO:0001540),0.3604723040259426,0.9865683138709493,0.5158898305084746,0.9911949325253009,1.0,19/79,20.22%,EPHB2;APBA3;LRP1;TGFB2;APBA1;ATP1A3;ITGA2;TLR4;GRIA2;TM2D1;HSPG2;FZD4;GRIN2A;CHRNA7;PFDN6;IAPP;GRIA3;ITGAM;BACE1
prerank,metalloaminopeptidase activity (GO:0070006),0.44009505615233,0.9861656594692217,0.4896640826873385,0.9889832329303399,1.0,5/16,18.34%,ANPEP;LNPEP;XPNPEP3;NPEPPS;MMP16
prerank,SH3 domain binding (GO:0017124),-0.2573729976234368,-0.9858327244770327,0.49122807017543857,0.7287035134732354,1.0,16/62,14.39%,AFAP1L1;CD2AP;AFAP1;SHANK3;DAB2IP;AFAP1L2;PLSCR1;LANCL1;ZNF106;EVL;KHDRBS1;ABL1;CASP9;ABI3;SGIP1;ABI2
prerank,titin binding (GO:0031432),0.467217592332418,0.9854787835890954,0.4945652173913043,0.9875356237099158,1.0,3/13,12.62%,ANKRD23;CAMK2D;CALM2
prerank,receptor tyrosine kinase binding (GO:0030971),0.3680072340907578,0.9844935370341837,0.4923747276688453,0.9869974896883223,1.0,16/56,23.60%,IRS1;ANGPT4;PIK3R2;SH2B1;GAS6;FLT3LG;NRG3;SQSTM1;CBL;NCK1;DOCK4;PITPNM1;RNF41;GAB2;MAP3K7;CBLB
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.3686535902118654,0.9839249988168621,0.5200868621064061,0.9852577403230226,1.0,16/60,16.67%,DDR2;EPHB2;AXL;EGFR;FGFR1;EPHA3;MST1R;RET;EPHB3;MUSK;EPHA10;FLT3;PDGFRA;DDR1;IGF2R;EFEMP1
prerank,CCR chemokine receptor binding (GO:0048020),0.4084256666218818,0.9835221756307938,0.49823321554770317,0.9830021034990849,1.0,5/28,20.70%,CCL8;CCL25;CCL13;MSMP;CNIH4
prerank,endoribonuclease activity (GO:0004521),0.39552580650341096,0.9834745206624188,0.4838709677419355,0.9797536790188415,1.0,12/32,28.07%,NYNRIN;AGO2;ERN1;RCL1;ZC3H12A;SMG6;AGO3;YBEY;RNASEK;KHNYN;AGO1;CPSF3
prerank,copper ion binding (GO:0005507),0.3814747818845775,0.9814883299780698,0.5164212910532276,0.9820118003319604,1.0,3/42,2.48%,LOXL2;SNCB;ANG
prerank,translation elongation factor activity (GO:0003746),0.4537348175153973,0.9811443651480823,0.5285118219749653,0.9796830498829135,1.0,4/14,20.39%,GTPBP2;GFM1;EEF1B2;EIF5A2
prerank,ubiquitin-protein transferase activity (GO:0004842),0.33679888993387824,0.9802050273737375,0.57,0.9789555136017808,1.0,119/346,26.47%,SH3RF3;TSPAN17;MIB2;UBE2B;UBE2J2;SMURF2;FBXW8;NEURL4;SYVN1;TRIM71;ITCH;RFWD3;RMND5B;RNF121;RBBP6;MSL2;COP1;RNF111;RC3H1;PELI3;STUB1;RNF2;MYCBP2;ANKRD39;UBE2N;UBE2W;FBXO2;FANCL;MAGEL2;SIAH1;FBXO17;MYLIP;CUL3;DTL;UBE2G2;ASB12;HECW2;RNF10;CDC23;TRIM11;IRF2BPL;RNF7;RNF141;UBE2A;CDC34;RSPRY1;LTN1;BSPRY;FBXL3;TRAF3IP2;PEX12;CBL;UBR4;AMFR;RNF128;UHRF2;RNF216;RNF14;TRIM68;RNF187;TRAF3;RBCK1;HACE1;RNF138;PML;UBE2G1;FBXL5;FBXO11;ANAPC4;VPS11;ARIH2;UBE2R2;RNF19A;RING1;UBE3C;MEX3C;LRSAM1;BRAP;UBE2D3;TRIM35;FBXW2;ARIH1;RNF41;CUL5;KCTD10;RC3H2;UBE2Q2;KLHL9;SMURF1;FBXO24;UBE3A;RNF6;SEL1L;UBE2Z;FBXW11;UBR2;DTX2;RNF114;RNF123;TRIM36;RNF13;TRAF5;CBLB;TRIM24;RNF157;MKRN2;TRIM44;MDM2;RNF166;UBA7;FBXO22;RNF20;ZNRF2;RNF126;UBE2K;RNF167;PRPF19;RNF31;MUL1
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.3965001068616522,-0.9797114295638307,0.4724137931034483,0.7267244375087513,1.0,3/10,16.45%,DUSP10;DUSP7;DUSP6
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.3965001068616522,-0.9797114295638307,0.4724137931034483,0.7267244375087513,1.0,3/10,16.45%,DUSP10;DUSP7;DUSP6
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.3699523042202783,-0.9791360113983997,0.4898785425101215,0.7200368927621627,1.0,4/12,9.63%,PDE7B;PDE3A;PDE8B;PDE2A
prerank,voltage-gated cation channel activity (GO:0022843),0.35068169853618386,0.975108761335199,0.5457380457380457,0.990068447975387,1.0,20/97,19.05%,KCNMA1;KCNV1;CACNA2D2;GRIN3A;KCND1;GRIN2D;PKD2;ITGAV;HCN4;KCNA2;KCNA6;CACNG2;CACHD1;CATSPER3;KCNC2;CACNB1;GRIN2A;NCS1;KCNH2;HCN1
prerank,potassium channel activity (GO:0005267),0.3524495634031135,0.9750712713625485,0.5516162669447341,0.9868774404715277,1.0,11/89,11.20%,KCNK5;KCNT2;KCNMA1;KCNV1;KCND1;PKD2;KCNK13;KCNK9;HCN4;KCNA2;KCNA6
prerank,sterol transfer activity (GO:0120015),0.4388620506335127,0.9747038626970115,0.5196950444726811,0.9845867497295618,1.0,3/17,7.00%,GRAMD1A;OSBPL2;ABCA1
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.39387678160715567,0.9737602070753011,0.5129716981132075,0.9838953561720997,1.0,9/29,20.79%,HEXD;PARG;GBA2;GLA;GAA;PGGHG;IDUA;OVGP1;GANAB
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.37897420132142023,0.9733553124208411,0.5284280936454849,0.9817841361539444,1.0,10/46,13.40%,B3GALNT1;EXT1;MGAT1;POMGNT2;RFNG;LARGE1;B3GNT8;MGAT5;MGAT2;MGAT4B
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.3615554441279857,0.9721259663415917,0.5426105717367853,0.9817478039592434,1.0,20/60,21.17%,TIMM50;CDC14B;ILKAP;PPP5C;CTDSP2;PPM1G;PHLPP2;PPEF2;PGAM5;PPP1R3C;CTDP1;PPP3CA;MTMR6;PPP1CC;PDP2;PPP3CB;PPP1R3D;PPM1A;PTEN;PPP6C
prerank,P-type ion transporter activity (GO:0015662),0.46198107078063966,0.9721148863955751,0.5204359673024523,0.9785295871583073,1.0,4/12,18.07%,ATP2B4;ATP6V1E1;ATP2A2;ATP2B1
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.44735142247239323,0.9717961230847355,0.5238095238095238,0.9761092704314033,1.0,1/14,0.32%,TIMP2
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.3996859600540652,0.9697219747238544,0.5194805194805194,0.9784887681313473,1.0,8/27,15.88%,SLC4A8;SLC9A9;SLC9A1;SLC23A1;SLC8A2;CNNM4;SLC9A7;SLC9A6
prerank,leak channel activity (GO:0022840),0.43394252281252155,0.9694767490736411,0.5158831003811944,0.975984378713438,1.0,3/18,9.44%,KCNK5;KCNK13;KCNK9
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.41718834810182603,0.969227121357371,0.5084541062801933,0.9734609625496192,1.0,6/23,15.33%,SESTD1;CLVS2;WIPI2;PLEKHA4;WDR45B;PLA2G4E
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.4156609029465954,0.9649614727576721,0.5358974358974359,0.9814706358464905,1.0,5/21,25.39%,GRM1;CHRNA7;CHRFAM7A;CHRNA5;GRM5
prerank,single-stranded RNA binding (GO:0003727),0.37203893562536056,0.9639366535094138,0.5410573678290214,0.9810621145731356,1.0,22/43,34.87%,HNRNPA1;AGO2;POLR2D;POLR2G;DDX11;AQR;AGO4;U2AF2;AGO3;PTBP1;EIF4H;EXOSC10;ZFR;AGO1;SNRPC;CNBP;SRA1;FXR1;STRBP;HNRNPU;JMJD6;DDX3X
prerank,mRNA binding (GO:0003729),0.3344919385563654,0.9631045185549346,0.6122244488977956,0.980057172707895,1.0,84/249,26.18%,ADARB1;MRPS11;SRSF6;HDLBP;NYNRIN;RBMS3;ZFP36L1;DAZL;RBM4;CLUH;EIF4A1;SCAF8;SAMD4B;TARDBP;C1QBP;RC3H1;CARHSP1;DHX33;AUH;NSRP1;LARP4;MRPL13;NUP98;CPSF6;AGO2;TDRD7;CELF2;RBFOX2;NUDT16;SLPI;PUM1;IGF2BP1;UNK;EIF3A;LARP1;ZFP36;RPS5;AQR;ZC3H12A;THOC2;CRYZ;ZC3H11A;FYTTD1;RSL1D1;PKM;EIF3D;DDX5;FXR2;CPEB1;YTHDF1;SNIP1;YTHDF2;LUC7L3;EIF2S2;NCBP3;SLBP;SRRM3;LUC7L2;ELAVL2;NOVA1;PTBP1;SF3B1;RC3H2;EIF2A;PTBP2;YTHDF3;RBM5;TPR;EDC3;CSTF2T;EIF4G3;DAZAP1;G3BP1;KHNYN;CALR;LARP6;RBM24;CELF3;RNF20;UPF3B;DCP1A;DCP1B;RBMX;EIF4G1
prerank,mitogen-activated protein kinase binding (GO:0051019),0.3903369900409832,0.9576432239529303,0.5332541567695962,0.9916874267206259,1.0,6/29,11.99%,MAPK7;MAPK14;PTPRJ;NFATC1;ATF7;TNIP1
prerank,protein phosphatase binding (GO:0019903),0.346316969883552,0.957612868216062,0.5842696629213483,0.9885778717317858,1.0,29/117,19.47%,EGFR;EIF2AK3;DLG4;PIK3R2;MAPK14;GRIN3A;ATP2B4;FOXO1;FBXL2;IQGAP1;SIRPA;MAPT;ANAPC5;SLC9A1;JUP;SHOC2;STX17;ADCY8;KIF3A;PPP1R3C;CDC27;SMG7;GTF2F1;ANK1;TRAF3;PPP1R9B;ANAPC4;PPP3CB;PPP1R3D
prerank,SUMO binding (GO:0032183),0.4461137040855095,0.9567370832411461,0.5469613259668509,0.9878235973059047,1.0,7/13,29.74%,CBX4;RNF111;UBA2;PML;SIMC1;HABP4;SERBP1
prerank,G protein-coupled receptor activity (GO:0004930),0.33557335794057325,0.9563218864100073,0.6256256256256256,0.9857686386968751,1.0,21/239,11.84%,ADGRD1;AVPR1A;VIPR2;LPAR3;PROKR2;MTNR1B;GPR12;F2R;LPAR1;GLP2R;S1PR2;ADGRG2;CRHR1;GPR20;LTB4R2;TM2D1;GPR141;GPR161;GPR45;GPR37L1;TSHR
prerank,phosphatase inhibitor activity (GO:0019212),-0.3175040059980172,-0.9560897046753116,0.5420560747663551,0.7657665662022961,1.0,3/20,4.13%,PTN;LMTK2;BOD1L1
prerank,neurexin family protein binding (GO:0042043),0.46221718554350716,0.9518587800521211,0.5339805825242718,0.9942159327242396,1.0,2/10,9.17%,CEL;SYTL5
prerank,ephrin receptor activity (GO:0005003),0.42532294648195756,0.9499501963133391,0.5383631713554987,0.9928590555681598,1.0,4/17,11.72%,EPHB2;EPHA3;EPHB3;EPHA10
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.42532294648195756,0.9499501963133391,0.5383631713554987,0.9928590555681598,1.0,4/17,11.72%,EPHB2;EPHA3;EPHB3;EPHA10
prerank,voltage-gated anion channel activity (GO:0008308),-0.32715557580305654,-0.9498071019486154,0.5209302325581395,0.7719114821032511,1.0,6/15,17.08%,VDAC3;ANO1;CLCN2;GPR89B;GPR89A;CLCN1
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.4358581304781428,0.9481105023764034,0.5603112840466926,0.9945072926130006,1.0,2/15,5.90%,SESTD1;PLEKHF1
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.45215065131728893,0.9472942050395361,0.5612813370473537,0.9933894294977673,1.0,2/12,10.58%,B3GALNT1;B3GNT8
prerank,cation:chloride symporter activity (GO:0015377),-0.3650743326870911,-0.9468759613746818,0.5,0.7706115519414753,1.0,3/10,3.01%,SLC12A7;SLC12A2;SLC6A1
prerank,sodium:proton antiporter activity (GO:0015385),0.45098229135195295,0.9468328913077529,0.5465587044534413,0.9914760527281135,1.0,4/11,15.88%,SLC9A9;SLC9A1;SLC9A7;SLC9A6
prerank,DNA-binding transcription factor binding (GO:0140297),0.3330098469320821,0.9467272781440057,0.6211055276381909,0.9887038497471242,1.0,31/189,15.36%,PRRX1;AR;TLE6;DGKQ;BHLHE40;CRTC2;NFE2L2;HDAC9;HDAC7;MEF2D;SKI;DACT1;TCF7L2;NFATC1;PIAS3;ZFPM2;TBX6;NOC2L;BEX1;TLE2;NPM1;TCERG1;NCOR1;TWIST1;HDAC4;BBS4;DMAP1;NBN;KLF4;TTC8;DDX20
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.40279408046728016,0.9461199256476277,0.5428571428571428,0.9872034826106625,1.0,6/22,16.96%,RBMS3;ZFP36L1;ZFP36L2;ZFP36;ZC3H12A;CPEB1
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.37816829740727675,-0.9448238215025948,0.5104895104895105,0.7670628463375669,1.0,2/10,7.68%,MECOM;PRDM16
prerank,aspartic-type peptidase activity (GO:0070001),0.466240486161568,0.9441459324037133,0.5555555555555556,0.9890455089916482,1.0,4/10,20.22%,PSEN1;NAPSA;CTSD;BACE1
prerank,protein serine/threonine kinase activity (GO:0004674),0.325871843688425,0.9437238143395986,0.676,0.9871265983689838,1.0,56/335,14.38%,SYK;PRKCA;EGFR;MAPK12;EIF2AK3;RPS6KA2;CAMKK1;CDKL2;DYRK4;MAPK7;IRAK3;SGK3;SGK2;CDK14;TGFBR2;TAOK3;MAPK14;TRIO;ACVR1;CDK4;RIOK1;MTOR;CLK1;CAMK2D;PRKAB2;MAST4;PRKD2;SLK;CHUK;TESK2;CDK9;CDK20;AKT3;BMP2K;NRBP2;MAPK11;ERN1;DYRK2;SQSTM1;CSNK1G1;IRAK4;AMHR2;CSNK1G3;STK16;AKT1;MAP3K6;IRAK1;PASK;STK39;ULK2;PRKD3;TAOK2;ULK1;HIPK4;STK24;STK3
prerank,protein kinase binding (GO:0019901),0.32353160376170503,0.9417012085683605,0.709,0.9893373653593419,1.0,95/480,19.06%,NOX4;GHR;AVPR1A;ESR1;LAX1;NELL2;IRS1;DNM1;DCTN1;PRAM1;MAPK7;DACT3;ANK2;CKS1B;IRAK3;CAMK2N1;TNNI3;ADAM9;LLGL1;HDAC9;HDAC7;SKI;PKD1;AXIN1;ACVR1;DACT1;DACT2;MAP2K3;TCF7L2;FAM83G;PTPRJ;PRKAB2;CSK;RBBP6;AP2A2;MAPRE3;TRIP4;BICD1;BANK1;YWHAG;STX1B;CLTC;SLC12A4;PRKD2;PARD6A;SRCIN1;TIRAP;IQGAP1;GSKIP;KAT2B;ITGAV;SIRPA;SQSTM1;NPM1;MAPRE1;IRAK4;ATF7;MAPT;IRAK1;PPEF2;FBXO5;TNIP1;CALM2;ZFP36;SMCR8;TAOK2;CDKN1A;PIN1;CCND1;RHOA;PDE3B;HSP90AA1;TUBA4A;VDAC1;RND3;TRIM68;CDK5RAP2;NSF;RAC3;CAVIN3;KIZ;NBR1;PPP1CC;RNF138;UFL1;RCC2;SNAP91;QARS1;ILK;DOK7;STK38;ATG13;TOP2B;PRKAR2A;IBTK
prerank,endopeptidase regulator activity (GO:0061135),-0.26185652491876465,-0.9406399711833032,0.5431034482758621,0.7682311816646401,1.0,11/40,14.06%,TFPI;ITIH2;SERPIND1;USP14;RENBP;PSMF1;PSME2;PROS1;PSME1;A2M;CST3
prerank,actin binding (GO:0003779),0.33155246446053893,0.9392613958093408,0.6383838383838384,0.9922919376356486,1.0,49/170,22.60%,DBN1;GSN;KCNMA1;CORO2B;SCIN;MAP1B;ANG;TNNI3;COBL;ABLIM1;MSRB1;FHDC1;PDLIM7;SYNE1;FSCN1;PFN2;ABL2;MYO9B;FXYD5;NCALD;TWF1;SSH1;AVIL;MICAL2;MAPT;PDLIM1;FLNB;ADCY8;MOBP;GIPC1;CAP1;ARPC1A;EPS8L2;CORO7;CXCR4;COTL1;MICAL1;ALDOA;TNNC2;PDLIM2;GC;MAP1A;FMN2;ABITRAM;SSH3;SPTBN4;MAP1S;CCDC88A;MYO1F
prerank,MAP kinase kinase activity (GO:0004708),0.4258599434311678,0.9373377855529449,0.5601552393272963,0.9938933904827022,1.0,4/15,18.54%,MAPK14;MAP2K3;MAP2K2;MAP2K4
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.35976487049354444,-0.9372945444259362,0.5485074626865671,0.7675626135894453,1.0,4/12,8.26%,DCPS;CYFIP2;EIF4E;GEMIN5
prerank,N-methyltransferase activity (GO:0008170),0.4137647846487208,0.934897849325595,0.5784810126582278,0.9969183369259336,1.0,7/20,22.63%,DIMT1;FDXACB1;ZCCHC4;TRMT1;TRMT11;N6AMT1;RNMT
prerank,tau protein binding (GO:0048156),0.3717591514436728,0.9344762273444415,0.5977401129943503,0.9949956696756963,1.0,9/40,14.60%,DCTN1;FYN;BIN1;HDAC6;STUB1;PPP5C;TAOK2;PIN1;HSP90AA1
prerank,sodium channel activity (GO:0005272),0.363492903243439,0.931517088905796,0.5753739930955121,0.9990703013610598,1.0,12/37,26.21%,SCNN1B;PKD2;HCN4;ASIC2;SCN4B;HCN1;ASIC1;SCN9A;GRIK5;GRIK2;GRIK4;SCN2A
prerank,tau-protein kinase activity (GO:0050321),-0.3050049144831871,-0.9310002544849568,0.5469613259668509,0.7737140915245491,1.0,7/20,18.67%,MARK1;DYRK1A;MARK3;TTBK1;CDK5;TAOK1;ROCK1
prerank,histone methyltransferase activity (GO:0042054),0.37904225847996686,0.9302934005126027,0.5886524822695035,0.99897582846762,1.0,15/32,28.91%,PRMT2;NTMT1;SETD7;SETD2;EHMT2;PRDM9;KMT2C;N6AMT1;CARM1;EZH2;SETDB1;KMT5A;MEN1;SUV39H1;PRMT8
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.34127056222314467,-0.9295595698645664,0.5805243445692884,0.7688796316247297,1.0,5/14,13.75%,MAL;CASP8AP2;BCL2L13;ATP2A3;NOD1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.36805443647724756,-0.9294716029933607,0.5147058823529411,0.7612194246848109,1.0,3/10,12.86%,LACC1;ADARB2;APOBEC1
prerank,pyrophosphatase activity (GO:0016462),0.35328015343389274,0.9292232376619366,0.5843307943416758,0.9986915441944125,1.0,20/50,29.07%,ENTPD2;NUDT1;NUDT7;PLPP5;PLPP1;NUDT16L1;NUDT16;ATCAY;NUDT6;NUDT5;PRUNE2;ENTPD6;CILP;LHPP;DHX29;PPA1;ITPA;ADPRM;PPA2;BNIP2
prerank,hexosaminidase activity (GO:0015929),-0.3518680327305823,-0.9290834276722362,0.5461847389558233,0.7543728763772336,1.0,2/12,3.16%,CEMIP;CEMIP2
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.26470994794145947,-0.9286855641454712,0.6137931034482759,0.7476097903548884,1.0,6/32,10.38%,KCNB1;KCNB2;KCNS3;KCNQ5;KCNA1;KCNQ1
prerank,GTPase inhibitor activity (GO:0005095),-0.3426403933978028,-0.9281296206327192,0.5735849056603773,0.7415311954236435,1.0,6/13,10.43%,TNK2;IQGAP2;CPEB2;CDC42SE1;ARL2;RHOH
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.4094185566869284,0.9259412535913147,0.5712484237074401,1.0,1.0,4/20,14.79%,DESI2;COPS5;USP50;USP7
prerank,kinase binding (GO:0019900),0.31754028339207846,0.9251142801034428,0.751,1.0,1.0,102/435,22.28%,GHR;GSN;ESR1;LAX1;EGFR;DNM1;DCTN1;PRAM1;ANK2;DGKQ;CKS1B;PDE8A;IRAK3;TNS2;CAMK2N1;TNNI3;STX1A;LLGL1;DLG4;HDAC7;ATF5;CD160;ATP1A4;SKI;PKD1;AXIN1;MIDN;MAP2K3;TCF7L2;FAM83G;PTPRJ;TTC28;PRKAB2;RBBP6;DLG2;AP2A2;MAPRE3;CARD16;TRIP4;SRC;BICD1;STX1B;STUB1;CLTC;STRADA;SLC12A4;SRCIN1;IQGAP1;GSKIP;KAT2B;SQSTM1;NPM1;MAPRE1;IRAK4;MAPT;IRAK1;FBXO5;PIK3IP1;CALM2;ZFP36;SMCR8;CDKN1A;CCND1;RHOA;TUBA4A;VDAC1;CHP1;RND3;TRIM68;CDK5RAP2;NSF;PER1;RAC3;KIZ;PPP1CC;RNF138;UFL1;TAX1BP1;RCC2;SNAP91;QARS1;ILK;DOK7;ATG13;IBTK;CIT;TOLLIP;IL31RA;OXSR1;FLNA;TIAM1;LYST;MOB1B;CAB39;CDKN2C;NISCH;BTG1;SIKE1;DCTN2;ATF4;DCX;STK11IP
prerank,rRNA binding (GO:0019843),0.36120877565290616,0.9245474449137813,0.6186726659167604,1.0,1.0,10/42,19.50%,MRPS11;ANG;MRPS27;DDX21;SBDS;RPS5;NOP53;RCC1L;RPF2;RPL23
prerank,ubiquitin binding (GO:0043130),0.33902279242506167,0.9239924212829815,0.6160427807486631,0.99947010444012,1.0,21/73,21.82%,UCHL1;CKS1B;RAD23B;MVB12A;UBE2N;ADRM1;SIRT2;USP33;SQSTM1;DNAJB2;USP5;ILRUN;RBCK1;NBR1;CXCR4;AUP1;UBAP1;TOLLIP;VPS36;USP13;UBXN11
prerank,GTP binding (GO:0005525),0.32138274216633883,0.9234408639859161,0.6680080482897385,0.997902109616414,1.0,55/172,27.93%,RAB32;RAB6A;GTPBP4;RAP1B;ARF4;SCG5;RIT2;DYNC1LI1;RHOJ;ARF1;RHOQ;TUBB6;RAB2A;NRAS;KRAS;GTPBP10;NUDT16;RRAD;TUBD1;RHOA;RRAGD;ARF6;TUBB4A;TUBA4A;GEM;RAB27B;GLUD1;RND3;RAC3;RAB35;NME1;RAB1B;RRAS2;PIP4K2B;RALA;RAB10;ADSS2;TUBG2;RABL3;ARL8A;NOA1;ANXA6;RAC1;RAB29;ATL1;RHOT2;RHOBTB2;EIF2B2;RND2;RAP1A;DIRAS2;TUBB2A;RHEBL1;TSR1;RAP2B
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.32232313514173894,0.9227386145966844,0.6696787148594378,0.9966765010019669,1.0,31/181,15.05%,PRRX1;AR;BHLHE40;NFE2L2;MAPK14;DACT1;TCF7L2;NFATC1;TACC2;PIAS3;NCOA3;TRIP4;ZFPM2;TBX6;MDFIC;BEX1;HDAC3;NPM1;TCERG1;JUP;NCOR2;NCOR1;COMMD6;HDAC4;BBS4;DMAP1;KLF4;CTDP1;BCAS3;TTC8;SMARCA4
prerank,syntaxin binding (GO:0019905),0.34283167431250994,0.9226886375053005,0.5905172413793104,0.9938442785738731,1.0,25/61,27.18%,SYT2;SYT12;SCFD2;VPS52;VAMP1;ABCA1;SCFD1;SNAP23;NAPA;SNAP25;SNAP47;NSF;NAPG;SNPH;SYT1;VPS11;VAMP2;NAPB;STX16;STXBP5L;BAIAP3;STX7;SYT6;STXBP4;VAMP3
prerank,nucleoside-diphosphatase activity (GO:0017110),0.44125259656247473,0.9197114350741847,0.5912208504801097,0.9978602015111577,1.0,4/12,18.58%,ENTPD2;NUDT5;CANT1;ENTPD6
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.4251098775709852,0.9196979409914942,0.5780189959294437,0.9949571743393136,1.0,6/15,20.13%,CXXC1;WDR5;PRDM9;KMT2C;SETD1B;KMT2A
prerank,nuclear receptor coactivator activity (GO:0030374),0.3490558678944037,0.9173466406559914,0.6173913043478261,0.997459224137059,1.0,17/52,23.79%,ZMIZ1;FGF2;SFR1;NCOA3;WDR77;ATXN7L3;MED24;HELZ2;SLC30A9;DCAF6;MED13;USP22;THRAP3;CARM1;TMF1;NCOA2;NCOA6
prerank,nuclease activity (GO:0004518),0.347850907144282,0.9162106839879426,0.6114790286975718,0.9971971551572985,1.0,16/52,25.16%,DIS3L2;ANG;RNASE4;N4BP2;SAMHD1;RNASE6;DNA2;ZC3H12A;DNASE1L2;NME1;ERCC5;OGG1;MAP1S;DFFB;DNASE1L1;RNASE1
prerank,solute:anion antiporter activity (GO:0140323),0.42072681528712086,0.915965653693141,0.5828877005347594,0.994815203802324,1.0,4/14,11.33%,SLC26A5;SLC26A11;SLC4A3;SLC26A6
prerank,single-stranded DNA binding (GO:0003697),0.33065342528467934,0.9155633857596169,0.6363636363636364,0.9928420991269034,1.0,19/93,18.32%,POLR2H;HNRNPA1;CTC1;RAD51B;RAD23B;IGHMBP2;HMCES;SAMHD1;MCM3;MAPT;ERCC4;POLR2D;POLR2G;SMC6;DDX11;FAM111A;RNF138;ERCC5;BLM
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.3580998220605654,-0.9145602650935396,0.5270758122743683,0.7616561176730342,1.0,3/12,7.03%,KDM7A;KDM4A;PHF2
prerank,calcium channel regulator activity (GO:0005246),0.3612130611767234,0.9143522992295686,0.5848837209302326,0.9928125966414364,1.0,9/37,14.84%,SGK3;TNNI3;SRI;STIMATE;YWHAE;MCUB;RRAD;CALM2;GEM
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.34613110423329496,0.9136884054577956,0.6123348017621145,0.9914400659055569,1.0,6/53,5.23%,SLC1A5;SLC1A7;SLC7A6;SLC1A6;SLC47A1;SLC43A2
prerank,voltage-gated potassium channel activity (GO:0005249),0.3323154636795802,0.9129770116489337,0.6317991631799164,0.9902144864055472,1.0,11/80,14.62%,KCNT2;KCNMA1;KCNV1;KCNJ2;KCND1;PKD2;HCN4;KCNA2;KCNA6;KCNJ3;KCNC2
prerank,outward rectifier potassium channel activity (GO:0015271),0.44310579169423797,0.9128787236773719,0.6051136363636364,0.9875755890582868,1.0,3/11,7.85%,KCNT2;KCND1;PKD2
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.41966721573071186,0.9115004552103035,0.5976253298153035,0.9877251502818586,1.0,2/15,5.45%,PIK3R2;SOCS2
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.40476290713344165,0.9099671626375486,0.6039473684210527,0.9854072489954497,1.0,3/16,17.36%,ANO3;TTYH3;ANO5
prerank,intracellular chloride channel activity (GO:0061778),0.40476290713344165,0.9099671626375486,0.6039473684210527,0.9854072489954497,1.0,3/16,17.36%,ANO3;TTYH3;ANO5
prerank,ATP hydrolysis activity (GO:0140603),0.35817053176898744,0.9098263319981609,0.6061293984108967,0.9829071026398353,1.0,12/41,20.66%,VPS4B;ABCG4;CLPX;TOR1A;KIF20B;DNA2;DDX4;HSP90AA1;CHD3;ATP2B1;ATAD1;ABCB10
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.3872964750619895,0.9075571417572491,0.5849056603773585,0.9852103986832487,1.0,5/20,19.98%,SLC39A13;SLC39A14;SLC39A7;SLC30A5;SLC39A3
prerank,GTPase binding (GO:0051020),0.3163519397093424,0.9061075496164648,0.7259036144578314,0.9854924754509145,1.0,66/195,25.80%,SGSM2;AKAP13;RABGGTA;PLCE1;RABGAP1L;CDC42EP2;RADIL;DOCK7;WASF1;BICD1;ABCA1;FMNL1;MYO5A;MYO9B;MYCBP2;PARD6A;OCRL;HPS4;IQGAP1;GGA1;USP33;DMXL2;ATP6AP1;KIF3A;HPS6;KIF3B;TMEM127;RRAGD;GNB1;ULK1;TRIOBP;HSP90AA1;CCDC186;GGA2;GOLGA4;EVI5;SGSM1;SPTBN1;PEX5L;HACE1;ANKRD27;EVI5L;RCC2;SRGAP2;PEX5;EPRS1;STK19;AIMP1;EXOC4;DOCK4;RASA1;FLNA;RNF41;ATG16L1;SIKE1;LZTR1;ANKFY1;ATG14;RAB11FIP3;PDE6D;ALS2;TSC2;RABGGTB;RAB29;CYFIP1;MAPKAP1
prerank,small GTPase binding (GO:0031267),0.3177573260916572,0.9051024624858708,0.7150050352467271,0.9850296344732646,1.0,45/170,20.46%,SGSM2;AKAP13;RABGGTA;PLCE1;RABGAP1L;CDC42EP2;DOCK7;WASF1;BICD1;ABCA1;FMNL1;MYO5A;MYO9B;MYCBP2;PARD6A;OCRL;HPS4;IQGAP1;GGA1;USP33;DMXL2;ATP6AP1;KIF3A;HPS6;KIF3B;TMEM127;ULK1;TRIOBP;CCDC186;GGA2;GOLGA4;EVI5;SGSM1;PEX5L;HACE1;ANKRD27;EVI5L;RCC2;SRGAP2;PEX5;STK19;EXOC4;DOCK4;FLNA;RNF41
prerank,UDP-galactosyltransferase activity (GO:0035250),0.4477176776254981,0.9048089630924395,0.586013986013986,0.982860115077704,1.0,1/10,2.22%,B4GALT1
prerank,microtubule motor activity (GO:0003777),0.34269092755272884,0.9046800181274347,0.6277292576419214,0.980418668060302,1.0,14/51,21.55%,KIFC2;KIF21B;STARD9;DNAH8;DYNC1I1;KIF2A;KIF20B;KIF3A;KIF21A;KIF3B;CENPE;KIFC3;KIF26B;DYNLRB1
prerank,protein kinase regulator activity (GO:0019887),0.32686854668821363,0.9037956637942438,0.6855087358684481,0.9796740877879287,1.0,23/95,19.27%,CCNL2;FGF13;TAOK3;PPP1R1B;CXCL10;GPRC5D;STRADA;GSKIP;ELP4;NPM1;KIDINS220;CCNC;SMCR8;CDKN1A;CCND1;CCNH;CCNQ;MADD;NCK1;QARS1;GMFB;PRKAR2A;DUS2
prerank,ubiquitin protein ligase binding (GO:0031625),0.3115159192758656,0.90358783239385,0.759,0.9774032232321924,1.0,75/254,28.17%,MID1;EGFR;UCHL1;GLMN;UBE2B;UBE2J2;SKI;SYT11;AXIN1;FOXO1;SCAMP3;SMAD5;HDAC6;STUB1;UBE2N;UBE2W;YWHAE;FANCL;CUL3;SMAD6;SQSTM1;UBE2A;UBA52;XRCC5;CDKN1A;FHIT;SMC6;GPR37;TNFRSF1B;TRIOBP;HSP90AA1;USP7;FZD4;BAG4;DIO2;ACTG1;TRAF3;PER1;BLZF1;PML;CXCR4;UBE2G1;AUP1;KCNH2;NEDD8;PRKAR2A;RPL23;ARIH1;CUL5;RALA;JKAMP;ARRB1;USP13;JUN;TRAF4;DERL1;TRAF5;BAG5;RELA;RTN4;ACVR1B;MDM2;CALR;RNF20;FBXW7;UBE2K;RNF31;MUL1;EIF4E2;SMG5;BCL10;DNAJA1;CASP8;LAPTM5;NPLOC4
prerank,fatty acid synthase activity (GO:0004312),-0.35852753398151627,-0.9014826452031939,0.5830388692579506,0.7816290569003305,1.0,5/10,18.84%,ELOVL7;CBR4;ELOVL1;ELOVL4;OXSM
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.30979387598899916,0.8996573595813707,0.771,0.9831724686947397,1.0,79/269,28.17%,MID1;EGFR;UCHL1;GLMN;UBE2B;UBE2J2;SKI;SYT11;AXIN1;ITCH;FOXO1;SCAMP3;TRIP4;SMAD5;HDAC6;STUB1;UBE2N;UBE2W;YWHAE;FANCL;CUL3;SMAD6;SQSTM1;UBE2A;UBA52;XRCC5;CDKN1A;FHIT;SMC6;GPR37;TNFRSF1B;TRIOBP;HSP90AA1;USP7;FZD4;BAG4;DIO2;ACTG1;TRAF3;PER1;BLZF1;PML;CXCR4;UBE2G1;AUP1;KCNH2;NEDD8;PRKAR2A;RPL23;ARIH1;CUL5;RALA;JKAMP;ARRB1;USP13;JUN;TRAF4;DERL1;STAT2;TRAF5;BAG5;RELA;STAM;RTN4;ACVR1B;MDM2;CALR;RNF20;FBXW7;UBE2K;RNF31;MUL1;EIF4E2;SMG5;BCL10;DNAJA1;CASP8;LAPTM5;NPLOC4
prerank,cytochrome-c oxidase activity (GO:0004129),-0.3139395554942598,-0.8994144783598456,0.5907172995780591,0.7786479483312062,1.0,11/15,43.92%,COX4I1;NDUFA4;COX5A;NDUFA4L2;COX4I2;COX6B1;COX6A1;COX7A1;COX5B;COX6A2;COX8A
prerank,CARD domain binding (GO:0050700),-0.32129310144912815,-0.8959698292172916,0.5390946502057613,0.7785651012541769,1.0,9/14,27.66%,CASP4;MAVS;NOD1;CARD19;IRGM;NOD2;RIPK2;CASP1;CARD14
prerank,Hsp90 protein binding (GO:0051879),0.3564025189795111,0.8955704333465078,0.6244186046511628,0.9892561460161434,1.0,16/33,30.69%,HDAC6;STUB1;PPP5C;ERN1;MAPT;PPEF2;CHORDC1;AHSA1;USP19;NR3C1;TSC2;UNC45A;TSC1;HDAC8;HSF1;TELO2
prerank,NADPH binding (GO:0070402),-0.3417864650196857,-0.8952419305672817,0.5877551020408164,0.7727939426052634,1.0,9/13,28.61%,HMGCR;QDPR;CBR4;NDOR1;LBR;DECR1;CBR3;GRHPR;KCNAB1
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.41987625897395126,0.8935200974931821,0.6152815013404825,0.9908291236545507,1.0,4/12,15.88%,SLC9A9;SLC9A1;SLC9A7;SLC9A6
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.3086736357995005,0.8923023063752034,0.7592778335005015,0.9906031929173938,1.0,79/232,26.47%,SH3RF3;SMURF2;NEURL4;SYVN1;TRIM71;ITCH;RFWD3;CBX4;RNF121;PIAS3;RBBP6;MSL2;COP1;RNF111;RC3H1;PELI3;STUB1;RNF2;MYCBP2;FBXO2;FANCL;SIAH1;FBXO17;MYLIP;CUL3;ASB12;HECW2;RNF10;TRIM11;IRF2BPL;RNF7;LTN1;BSPRY;TRAF3IP2;CBL;UBR4;AMFR;RNF128;UHRF2;RNF216;RNF14;TRIM68;RNF187;HACE1;RNF138;UFL1;VPS11;ARIH2;RNF19A;RING1;UBE3C;MEX3C;LRSAM1;BRAP;UBE2D3;TRIM35;ARIH1;RNF41;RC3H2;SMURF1;UBE3A;RNF6;UBR2;DTX2;RNF114;RNF13;CBLB;TRIM24;NSMCE2;RNF157;MKRN2;TRIM44;MDM2;RNF166;ZNRF2;RNF126;RNF167;PRPF19;MUL1
prerank,tRNA binding (GO:0000049),0.34653512572144457,0.8920945281166164,0.63954802259887,0.9883280864705419,1.0,14/43,21.87%,IGHMBP2;DALRD3;MRPS27;YRDC;SARS2;PSTK;ELP1;TRMT10B;TYW5;AIMP1;PTCD1;XPOT;NEMF;EIF2A
prerank,aspartic-type endopeptidase activity (GO:0004190),0.42201268524333946,0.8883942303099632,0.6057298772169167,0.9933220567455765,1.0,4/12,20.22%,PSEN1;SPPL2B;NAPSA;BACE1
prerank,alpha-tubulin binding (GO:0043014),0.3622927122983959,0.8874790809153155,0.6400911161731208,0.9924643373973172,1.0,7/31,14.55%,FYN;DLEC1;HDAC6;TBCEL;SETD2;BBS4;INO80
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.36684916339004137,0.886264015457714,0.6176808266360505,0.9922337305735068,1.0,6/28,18.54%,RPS6KA2;MAPK14;MAP2K3;AKT1;MAP2K2;MAP2K4
prerank,phosphoric diester hydrolase activity (GO:0008081),0.3519790347517194,0.8859420249794414,0.6566473988439306,0.9901795952236805,1.0,9/35,20.38%,SMPD3;PLCE1;PLCB4;PDE11A;MPPE1;PDIA3;SMPD1;GPLD1;GDPD3
prerank,transmitter-gated ion channel activity (GO:0022824),0.3545812317855805,0.8857723806682851,0.6465721040189125,0.9877870353391571,1.0,13/29,30.12%,GRIN2D;GRIA2;GABRG3;GRID1;GABRG2;GRIK5;GRIK2;GRIK4;GLRA3;GABRA3;GRID2;GABRA1;GLRA2
prerank,ephrin receptor binding (GO:0046875),0.3797678341951962,0.8846953894147153,0.6273525721455459,0.9874618316753891,1.0,4/21,6.81%,EFNA5;FYN;ANKS1B;SRC
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.34909732483047373,0.8842076297121666,0.6393629124004551,0.98571318456746,1.0,16/35,29.85%,FOXP1;AGO2;NPM1;UBTF;DR1;SMARCA4;RRN3;BAZ2A;TBP;NR3C1;RELA;KLF10;SNAPC3;AGO1;TP53;FOS
prerank,phosphatase activity (GO:0016791),0.3236045842632017,0.883612619010874,0.6786850477200425,0.9843021497906204,1.0,23/73,23.47%,PLPP3;ACP2;PTPRJ;PLPP5;PLPP1;NT5M;BPNT2;OCRL;PPP5C;DUSP11;NUDT16L1;INPP5K;NUDT16;PGAM5;PLPPR3;PHOSPHO2;PPP1CC;PLPP2;ACP3;LPIN3;CILP;ACP6;LHPP
prerank,N-acyltransferase activity (GO:0016410),0.36194092157304336,0.8831326697917429,0.6510228640192539,0.982639983739795,1.0,7/32,18.79%,CERS6;PLAAT1;GNPNAT1;NAT8;PLA2G4E;SAT1;NAA50
prerank,ion channel activity (GO:0005216),0.3180888851528207,0.8826787653072236,0.696149843912591,0.9809314193973677,1.0,23/80,25.89%,PIEZO2;TRPV3;GRIN3A;TMEM63A;GRIN2D;PKD2;GRIA2;CNGB1;MCUB;TMEM120A;CALHM2;GRID1;GRIN2A;CHRNA7;TMC3;CHRNA5;GRIA3;GRIK5;GRIK2;TRPC1;GRIK4;ANXA6;TRPV2
prerank,thioesterase binding (GO:0031996),0.43385658720215176,0.8816361480934216,0.628005657708628,0.9804922976478996,1.0,6/11,30.46%,ARF6;TRAF3;TRAF4;TRAF5;RAC1;TRAF6
prerank,nuclear receptor binding (GO:0016922),0.3159938207619112,0.8786840808251412,0.7248459958932238,0.983499108474407,1.0,41/111,27.20%,ESR1;FOXP1;TCF7L2;TACC2;PRMT2;NCOA3;TRIP4;GAS2L1;MED24;JUP;NCOR2;MED13;NCOR1;DCAF13;BCAS3;SMARCA4;RNF14;TRIM68;STAT5B;DDX5;PADI2;NRIP1;JMJD1C;NSD1;THRAP3;TMF1;RNF6;BAZ2A;NCOA2;KDM4C;NCOA6;LATS1;LCOR;CALR;ASXL1;KDM3A;BRD8;PRPF6;GRIP1;ARID1A;MMS19
prerank,PDZ domain binding (GO:0030165),0.3237949649282416,0.878443348550057,0.6691810344827587,0.9813395800097982,1.0,22/61,21.82%,CCDC88C;DLG4;ATP2B4;GNG12;FZD7;PSEN1;SLC26A6;TBC1D10A;KIDINS220;PLEKHA1;CRIPT;FZD4;MAP2K2;ACOX1;NSF;SDC2;ATP2B1;SNTG2;CIT;DOCK4;PTEN;SRR
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.3148761022085417,0.8773317480127228,0.7176591375770021,0.9810331060249302,1.0,24/100,19.62%,NCF4;SESTD1;GAP43;MYO10;PLEKHF1;ATG2B;CLVS2;ARHGAP9;IQGAP1;WIPI2;PLEKHA4;WDR45B;PLEKHB2;SNX21;AKT1;MAPT;ATG2A;DENND1A;PLA2G4E;OGT;ARAP1;ANXA8;BBS5;CLVS1
prerank,potassium ion antiporter activity (GO:0022821),-0.30681860464910504,-0.875594726608258,0.6473029045643154,0.8054981824452229,1.0,2/15,2.49%,SLC24A3;SLC9A2
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.39355741918962855,0.8737289901871688,0.6486129458388376,0.9854175964906928,1.0,8/17,31.01%,NME2;CMPK2;NME1;AK8;AK9;NME6;AK3;AK5
prerank,hyaluronic acid binding (GO:0005540),0.4354010391852949,0.8730100817954667,0.625,0.9841251443153052,1.0,2/10,6.64%,CD44;C1QBP
prerank,MAP kinase kinase kinase activity (GO:0004709),0.4196216753145139,0.8725802037429914,0.6472184531886025,0.9823742957172735,1.0,3/11,12.80%,EGFR;MAP3K6;TAOK2
prerank,transcription cis-regulatory region binding (GO:0000976),0.30006308028576595,0.8717194058944153,0.857,0.9814136185813254,1.0,61/406,16.80%,LMX1A;AR;LHX8;TRPS1;BNC2;WT1;SCRT2;HSF2;PBX1;FOXP1;GLIS2;RUNX1;SMAD4;NFE2L2;ZNF25;ATF5;LMX1B;MEF2D;SOX10;FOXK2;JUND;TCF7L2;RBAK;CREB3L1;NR1D1;CREBZF;MTF1;FOXC2;AGO2;SOX5;SMAD6;RNF10;SATB2;BRD7;ZNF3;NPM1;MZF1;CEBPB;GLI3;XRCC5;DR1;ATF1;PEG3;NCOR1;IKZF5;TWIST1;SIX1;HDAC4;RFX5;PLAGL1;KLF4;MLXIP;NR2C2;E2F3;CDK5RAP2;ZBTB5;PER1;SNAI2;CHD3;E4F1;TFAP4
prerank,Tat protein binding (GO:0030957),0.42300155885915935,0.8709352077361538,0.6176890156918687,0.9803705493618563,1.0,4/10,15.05%,MDFIC;NPM1;CTDP1;SMARCA4
prerank,phosphatidic acid binding (GO:0070300),0.38466460738895647,0.8694422428633015,0.6675159235668789,0.9806688341408973,1.0,2/19,1.06%,SESTD1;SMPD3
prerank,protein phosphatase 2A binding (GO:0051721),-0.27854067480995415,-0.866235325002615,0.6952380952380952,0.816268725491674,1.0,5/23,4.13%,CTTNBP2NL;STRN3;DAB2IP;STRN;BOD1L1
prerank,NADP binding (GO:0050661),-0.24780712629335686,-0.8659242799144179,0.7028985507246377,0.8094765860551073,1.0,16/32,22.17%,GMDS;DPYD;NOS3;HMGCR;QDPR;CBR4;NOS1;SPR;NDOR1;CRYZL1;DHCR7;LBR;DECR1;CBR3;TM7SF2;HSD11B1
prerank,gamma-tubulin binding (GO:0043015),0.36525598405113063,0.864569949898476,0.6727716727716728,0.9871828235226757,1.0,8/22,29.56%,RAB11FIP5;BLOC1S2;CDK5RAP2;TUBGCP5;RAD51D;ARHGEF7;TUBGCP3;CENPJ
prerank,acyl-CoA hydrolase activity (GO:0047617),0.38771820376293475,0.8639364459577936,0.6571798188874515,0.985895684699593,1.0,3/17,14.25%,ACOT6;ACOT9;ACOT1
prerank,ubiquitin protein ligase activity (GO:0061630),0.2978662032167815,0.860775930804443,0.8164493480441324,0.9893297325453292,1.0,76/228,26.47%,SH3RF3;SMURF2;NEURL4;SYVN1;TRIM71;ITCH;RFWD3;RNF121;RBBP6;MSL2;COP1;RNF111;RC3H1;PELI3;STUB1;RNF2;MYCBP2;FBXO2;FANCL;SIAH1;FBXO17;MYLIP;CUL3;ASB12;HECW2;RNF10;TRIM11;IRF2BPL;RNF7;LTN1;BSPRY;TRAF3IP2;CBL;UBR4;AMFR;RNF128;UHRF2;RNF216;RNF14;TRIM68;RNF187;HACE1;RNF138;VPS11;ARIH2;RNF19A;RING1;UBE3C;MEX3C;LRSAM1;BRAP;UBE2D3;TRIM35;ARIH1;RNF41;RC3H2;SMURF1;UBE3A;RNF6;UBR2;DTX2;RNF114;RNF13;CBLB;TRIM24;RNF157;MKRN2;TRIM44;MDM2;RNF166;ZNRF2;RNF126;UBE2K;RNF167;PRPF19;MUL1
prerank,poly(U) RNA binding (GO:0008266),0.36566527562938345,0.8594496381176989,0.6532663316582915,0.9893303161539608,1.0,3/20,10.62%,DIS3L2;RBMS3;HNRNPH1
prerank,protein kinase activator activity (GO:0030295),0.32272939721251465,0.8578331834165247,0.6963519313304721,0.989864977905004,1.0,13/60,15.90%,FGF13;ETAA1;GPRC5D;GAS6;STRADA;ABI1;IQGAP1;CALM2;CDKN1A;DBF4;STK3;MAP2K2;MADD
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.2998210428792192,0.8576288868073806,0.8187311178247734,0.9877484874803207,1.0,36/188,18.74%,AR;BNC2;WT1;PBX1;GLIS2;RUNX1;SMAD4;NFE2L2;ATF5;SOX10;FOXK2;JUND;TCF7L2;CREB3L1;NR1D1;CREBZF;FOXC2;SOX5;SMAD6;RNF10;BRD7;MZF1;CEBPB;XRCC5;NCOR1;SIX1;HDAC4;KLF4;CDK5RAP2;PER1;CHD3;TFAP4;ZBED4;CTCF;KCNH2;PRDM9
prerank,metal ion:proton antiporter activity (GO:0051139),0.3974740029020896,0.8568808321324705,0.6520584329349269,0.9865896824564766,1.0,4/13,15.88%,SLC9A9;SLC9A1;SLC9A7;SLC9A6
prerank,steroid hydroxylase activity (GO:0008395),0.3832734253733039,0.8544812719497019,0.6675191815856778,0.9887247606394425,1.0,1/16,1.39%,CYP2S1
prerank,hydro-lyase activity (GO:0016836),0.3343788244835028,0.8516456608187676,0.6911595866819747,0.9914327378921741,1.0,6/41,15.31%,EHHADH;CYP2S1;AUH;ACO2;CDYL;HACD3
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.3590177598130856,0.8508037329487964,0.6767554479418886,0.9904308466859493,1.0,11/24,29.99%,ZDHHC7;ZDHHC2;ZDHHC4;ZDHHC24;ZDHHC21;ZDHHC20;ZDHHC18;ZDHHC8;YKT6;ZDHHC15;GOLGA7B
prerank,peptide N-acetyltransferase activity (GO:0034212),0.4136882213106725,0.8493279602458388,0.6887052341597796,0.9905408057020327,1.0,4/10,23.22%,NAA15;NAA50;NAA20;NAA30
prerank,carboxylic acid binding (GO:0031406),0.33223808695841817,0.8491270640929319,0.6952595936794582,0.9884695953601704,1.0,10/38,22.64%,GCLC;GRIN3A;SESN3;GLUD1;EPDR1;GLDC;CASTOR2;SRR;SESN2;UBR2
prerank,ATPase regulator activity (GO:0060590),0.33349183900870016,0.8468711296091722,0.7028248587570621,0.9902233421630403,1.0,14/38,29.78%,TOR1AIP2;DNAJA2;GRPEL2;DNAJB2;BAG4;AHSA1;DNAJB1;BAG3;BAG5;HSPH1;TSC1;DNAJA1;FNIP1;DNAJC1
prerank,actin monomer binding (GO:0003785),0.36088757008486616,0.8459026925689247,0.6817625458996328,0.9895066936487658,1.0,4/22,10.26%,COBL;PFN2;ABL2;TWF1
prerank,chloride channel inhibitor activity (GO:0019869),0.41780475840974557,0.8452785963424506,0.6612665684830633,0.9881174733373252,1.0,7/10,34.05%,STX1A;WNK2;STX7;CFTR;STX8;VAMP8;WNK3
prerank,lipoprotein particle receptor binding (GO:0070325),0.35104989049722163,0.8427014610614487,0.6810551558752997,0.9901297214213364,1.0,7/27,27.79%,LRP1;CLTC;HSPG2;SYT1;AP2M1;HSP90B1;DNAJA1
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.3409031762904111,0.8422881103600065,0.6984687868080094,0.9883677378422431,1.0,11/28,30.04%,GABRG3;GRID1;CHRNA7;CHRNA5;GABRG2;GRIK5;GRIK2;GRIK4;GABRA3;GRID2;GABRA1
prerank,mRNA methyltransferase activity (GO:0008174),0.4035298656775567,0.8418862967431135,0.6899862825788752,0.9866047230072483,1.0,4/12,22.63%,TRMT61A;CMTR2;PCIF1;RNMT
prerank,muscle alpha-actinin binding (GO:0051371),0.3786201416093239,0.8413522561434469,0.6802096985583224,0.9850092694009575,1.0,5/15,19.64%,PDLIM7;PKD2;PDLIM1;PALLD;PDLIM2
prerank,cysteine-type peptidase activity (GO:0008234),0.30690284650064714,0.8393065340727643,0.7287066246056783,0.9861684502175401,1.0,13/73,15.82%,UCHL1;CAPN2;USP36;USP10;USP29;USP26;USP33;OTUD7B;USP48;USP50;USP5;USP7;PDIA3
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.41972656570391886,0.8382775027550832,0.688858695652174,0.985493649840566,1.0,4/10,21.58%,SETD2;SETD5;PRDM9;NSD1
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.3333279671914965,0.836640946606052,0.7002314814814815,0.9859935473538672,1.0,2/32,5.23%,SLC1A5;SLC43A2
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.3992549292282357,0.8363744473891928,0.7,0.9840233577348938,1.0,4/11,23.22%,NAA15;NAA50;NAA20;NAA30
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.25821721469188286,-0.8347672211797837,0.7415730337078652,0.8600291502252286,1.0,8/27,14.61%,SIAH2;PPARA;UBE3D;RNF144B;DCUN1D4;RNF180;DCUN1D3;SIAH3
prerank,metal ion transmembrane transporter activity (GO:0046873),0.34161599350512084,0.8332697082344375,0.6948356807511737,0.9869184180929843,1.0,9/27,18.07%,SLC4A8;ATP2B4;SLC11A2;SLC23A1;SLC8A2;CNNM4;TUSC3;TMEM165;ATP2B1
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.39755703217638394,0.8300469468229151,0.6858345021037868,0.9899124702130395,1.0,2/11,17.91%,CHRNA7;CHRNA5
prerank,organic anion transmembrane transporter activity (GO:0008514),0.29331111701184803,0.8286155430136145,0.8351983723296033,0.989923608914307,1.0,20/134,14.88%,SLCO2A1;SLC1A5;SLC25A21;SLC1A7;SLC26A5;SLC4A8;SLC25A25;SLC4A3;SLC6A8;SLC35B1;SLC26A6;SLC35D1;SLC2A10;SFXN1;SLC7A3;ABCC1;SLC23A1;SLC23A2;SLC15A4;SLC25A17
prerank,anion channel activity (GO:0005253),0.31064480943287964,0.8280663844832248,0.750816104461371,0.9883870707290817,1.0,11/61,19.26%,ANO3;LRRC8D;CLCN5;GABRR3;VDAC2;CLCC1;GABRG3;TTYH3;VDAC1;ANO5;GABRG2
prerank,glutamate receptor activity (GO:0008066),0.3572321719398289,0.8274275304515833,0.6948717948717948,0.9870539621142409,1.0,9/19,27.38%,GRIN2D;GRIA2;GRID1;GRM1;GRIK5;GRIK2;GRIK4;GRM5;GRID2
prerank,magnesium ion binding (GO:0000287),0.29256917201907573,0.8265056664474708,0.8221544715447154,0.9862136654867887,1.0,44/135,28.99%,GCLC;MAPK12;DIS3L2;IRAK3;FOXK2;MVK;IDH1;EYA2;ABL2;UBA2;ERN1;DYRK2;MAP3K6;NUDT16;CERK;FAN1;STK3;GEM;NUDT5;NME1;ADPRH;STK38;RP2;IDH3G;OXSR1;STK26;XYLT2;SRPK1;SRR;PI4K2A;MTHFD2;ADCY2;LATS1;MARK2;XXYLT1;MAST2;PLSCR3;PPA1;MSH6;PSPH;DUT;PGP;HMGCL;PPA2
prerank,peptide hormone receptor binding (GO:0051428),0.4011147879253686,0.8264580940907728,0.6792717086834734,0.9839266404984297,1.0,1/11,7.34%,ADCYAP1
prerank,3'-5' exonuclease activity (GO:0008408),0.3217730935430505,0.8251106149955081,0.753072625698324,0.9837883586182032,1.0,6/45,12.48%,REV3L;DIS3L2;ERI3;EXOSC7;RAD1;REXO2
prerank,protein kinase C activity (GO:0004697),-0.3024166611966902,-0.8241376411873563,0.6980392156862745,0.8722138787498266,1.0,4/14,8.78%,PRKCH;PRKD1;PRKCE;PRKCQ
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.31316527795536714,0.8238612496946309,0.7494505494505495,0.9835087271786043,1.0,14/54,20.07%,HDAC9;HDAC6;SIRT2;HDAC3;GLS2;GLS;NIT2;HDAC4;NGLY1;NTAN1;ASRGL1;SUDS3;NIT1;MIER1
prerank,thyroid hormone receptor binding (GO:0046966),0.3440440504429076,0.8232506498277788,0.7398568019093079,0.9820616279310662,1.0,10/28,23.79%,PRMT2;NCOA3;GAS2L1;MED24;MED13;NCOR1;JMJD1C;NSD1;THRAP3;NCOA6
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.3048794207853045,0.8183689544091988,0.7675392670157068,0.9874243715653603,1.0,19/74,19.35%,PAPSS2;DGKQ;PIK3C2B;MVK;CHKB;GK5;PIK3CA;GALK1;AGK;PGM2L1;PI4KB;PANK1;PI4KA;PKM;IPPK;TRPT1;GNE;PANK3;DCAKD
prerank,signaling receptor complex adaptor activity (GO:0030159),0.31733468534671094,0.8181045599752578,0.7110609480812641,0.9855353920831604,1.0,4/38,6.28%,IRS1;AXIN1;SPATA2;SH2B1
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.37093219060356863,0.8175452250029224,0.6908850726552179,0.9841289693307483,1.0,3/13,15.00%,FAN1;DNA2;DNASE1L2
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.36459539576938277,0.8173525490110412,0.7017082785808147,0.9798148390285847,1.0,6/16,25.52%,ATP6V0A2;ATP6V0A1;ATP6V1D;ATP6V1B2;ATP6V0B;ATP5F1B
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.36459539576938277,0.8173525490110412,0.7017082785808147,0.9798148390285847,1.0,6/16,25.52%,ATP6V0A2;ATP6V0A1;ATP6V1D;ATP6V1B2;ATP6V0B;ATP5F1B
prerank,calcium channel inhibitor activity (GO:0019855),-0.3225368050876616,-0.8169096411694118,0.7,0.8766667635715256,1.0,1/11,0.06%,ITPR1
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.344112534169245,0.815959664341883,0.7094763092269327,0.9797284645186698,1.0,6/22,16.13%,ATP6V0A2;ATP6V1E1;ATP2A2;ATP6V0A1;ATP6V1D;ATP6V1B2
prerank,DNA binding (GO:0003677),0.27786457277226767,0.8158008178349553,0.98,0.9776755536680357,1.0,126/694,18.74%,MPG;FOXP2;IRF4;EGFR;POLR2H;C1D;WT1;MEOX2;HNRNPA1;ANG;HIVEP2;TSHZ2;CTC1;PBX1;KLF12;TRNP1;TIPIN;SMAD4;NFE2L2;ATF5;SOX10;FOXK2;KLF2;RAD51B;MAFF;TCF7L2;COLEC11;HOXA5;RAD23B;MEIS2;FOXO1;JRKL;NFIB;MND1;CREBZF;TARDBP;IGHMBP2;CGAS;MLXIPL;MTF1;AIFM2;GLI2;TBX6;FOXL1;PHF1;MSL3;HMCES;SOX8;SPTY2D1;VDR;NR6A1;FOXC2;SYCP2;DNASE2;CDK9;RYBP;SAMHD1;POLG2;MCM3;ZNF3;CHD2;SMC1A;CSRNP3;BCL6;CEBPB;MAPT;SLPI;ERCC3;RAD1;ERCC4;CCDC25;FAN1;XRCC5;GTF3C2;LIN9;KDM5B;QRICH1;POLR2D;POLR2G;DDB1;TERF1;DNA2;CR2;BRIP1;SMC6;SIX1;DDX11;HDAC4;RFX5;PLAGL1;EZH1;NME2;ZC3H12A;FANCG;PLAGL2;NBN;HOXA7;INO80;POU3F2;FAM111A;DNASE1L2;SMARCA4;CHD8;NUPR1;NR2C2;RPL6;E2F3;HMGB3;CENPC;PSIP1;SNAI2;CHD3;BCLAF3;RNF138;TFAP4;NUFIP1;ILF2;RAD50;ERCC5;RBM6;BLM;POLD1;SUPV3L1;TINF2;CTCF;PRDM9
prerank,phosphatase activator activity (GO:0019211),0.3780839084801517,0.8146943119181799,0.6859838274932615,0.9770223737028013,1.0,4/14,17.06%,B3GAT3;CALM2;GTF2F1;PPP2R5B
prerank,histone acetyltransferase activity (GO:0004402),0.33190835083273557,0.8134295099858898,0.7517647058823529,0.9766565557560464,1.0,12/30,25.21%,NCOA3;MCM3AP;KAT2B;KAT14;SRCAP;USP22;NAA50;ARRB1;KAT6B;BAZ1A;KAT5;KAT7
prerank,kinase activator activity (GO:0019209),-0.23021474386706628,-0.8111693144069146,0.7880794701986755,0.8791102856693694,1.0,4/30,6.55%,PRKAG2;GPRC5C;RPTOR;RGCC
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.3253686017979589,0.8093013368373885,0.7337962962962963,0.9807129230822897,1.0,6/30,12.21%,CARD16;GAS6;CAST;DPEP1;CSTB;CD27
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.3441090466355121,0.8070495194823655,0.7278325123152709,0.9819666766844293,1.0,2/23,4.67%,PLCE1;PLCB4
prerank,ion channel inhibitor activity (GO:0008200),0.3174438037928966,0.8069931726557071,0.7373271889400922,0.9797764028910605,1.0,6/35,12.62%,KCNV1;TNNI3;STX1A;CAMK2D;MCUB;CALM2
prerank,amino acid binding (GO:0016597),0.3263440840816504,0.8069914721918386,0.7352941176470589,0.9775001429610991,1.0,2/31,5.10%,GCLC;GRIN3A
prerank,MAP-kinase scaffold activity (GO:0005078),0.3951668919269772,0.8034496955330319,0.7246175243393602,0.9808018485984645,1.0,3/11,15.60%,AKAP13;IQGAP1;MAP2K2
prerank,cation channel activity (GO:0005261),0.28963292859685996,0.8031799256016346,0.8209109730848861,0.9789029905698753,1.0,11/94,10.51%,KCNK5;PIEZO2;ANXA2;PKD1;TRPV3;TMEM63A;PKD2;MCU;PSEN1;KCNK9;KCNA2
prerank,exoribonuclease activity (GO:0004532),0.3792302023052838,0.8011304867413882,0.7166900420757363,0.9797371303686051,1.0,3/12,14.15%,EXOSC7;ZC3H12A;EXOSC1
prerank,ATPase activator activity (GO:0001671),0.34761522448485616,0.7981572568667917,0.7330827067669173,0.9819082513376746,1.0,5/20,21.23%,TOR1AIP2;DNAJA2;DNAJB2;AHSA1;DNAJB1
prerank,cadherin binding (GO:0045296),0.27564139117417946,0.795740652139002,0.946,0.9833133730734214,1.0,82/315,22.80%,DBN1;CDH26;AHNAK;EGFR;ANXA1;PFKP;PKP3;ANXA2;DIAPH3;HDLBP;STX5;MPP7;SPTAN1;ACVR1;PTPRJ;PPL;IDH1;SRC;FSCN1;SNX1;CAST;SLK;ABI1;FXYD5;USO1;YWHAE;SH3GL1;PSEN1;IQGAP1;PDXDC1;CDH22;TWF1;MAPRE1;PAICS;ZC3HAV1;TBC1D10A;PDLIM1;VASN;JUP;FLNB;SFN;LARP1;SCYL1;ATXN2L;CBL;STK24;CTNND2;ARGLU1;EIF3E;TNKS1BP1;GIPC1;EVPL;PI4KA;RSL1D1;RPL6;PKM;SPTBN1;EPS8L2;NCK1;EEF1G;AHSA1;CKAP5;SHTN1;PUF60;STK38;LASP1;ALDOA;UBFD1;LDHA;FLNA;RAB10;ATIC;CCS;DNAJB1;CTNNA3;EIF2A;CTTN;YWHAB;PLEC;SEPTIN9;BAG3;PACSIN2
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.306049474400378,-0.795062772529549,0.7463768115942029,0.898789765318833,1.0,5/12,19.45%,CASP8AP2;BCL2L13;ATP2A3;NOD1;CTSH
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.3384678573958074,0.7928395061815515,0.748451053283767,0.9853443824208018,1.0,4/22,10.44%,ZRANB1;ZBTB1;OTUD7B;SQSTM1
prerank,secondary active transmembrane transporter activity (GO:0015291),0.3030063231688518,0.7907581874958172,0.7828947368421053,0.986093058431751,1.0,10/51,16.78%,SLCO2A1;SLC35E3;MCU;SLC25A16;SLC16A10;SLC4A4;SLC35D1;SLC25A3;SLC35E1;SLC20A1
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.3000441061416229,0.7899304319314734,0.7922651933701658,0.985039899378438,1.0,20/55,26.25%,ANXA2;PKD1;TRPV3;ATP2B4;PKD2;MCU;PSEN1;ATP2A2;SLC8A2;SEC61A1;TMEM165;CHRNA7;ATP2B1;CUL5;TRPC1;ANXA6;TRPV2;TMCO1;SLC24A4;SLC24A2
prerank,ADP binding (GO:0043531),0.33160687053195664,0.7878131405562716,0.7600950118764845,0.9858419306427173,1.0,4/25,10.24%,GCLC;MYO9B;PPP5C;ERN1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.38039004819835043,0.7872685924117577,0.742296918767507,0.9843197153354782,1.0,2/11,20.40%,PADI2;DDAH2
prerank,voltage-gated calcium channel activity (GO:0005245),0.3086915650221368,0.7855813306687044,0.7592165898617511,0.984697756765443,1.0,8/37,18.37%,CACNA2D2;PKD2;ITGAV;CACNG2;CACHD1;CATSPER3;CACNB1;NCS1
prerank,protein phosphatase regulator activity (GO:0019888),0.2977807551900386,0.7853507674494258,0.8013029315960912,0.9827417103178608,1.0,14/53,19.23%,PPP1R1B;PPP6R2;RCAN3;B3GAT3;RCAN1;SAG;SHOC2;CALM2;MGAT5;PPP2R1B;PPP2R5B;PPP1R9B;SET;PPP2R2A
prerank,C2H2 zinc finger domain binding (GO:0070742),0.3826648763443249,0.7837992468020326,0.7520891364902507,0.9825703904301257,1.0,1/11,1.41%,WT1
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.34894162182890515,0.7832083302306186,0.7468193384223919,0.981222274399846,1.0,4/17,16.56%,BLVRB;TECR;PTGR1;BDH2
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.34368601644073066,0.7823859784854749,0.7619047619047619,0.9802010527924216,1.0,9/19,30.04%,GABRG3;GRID1;GABRG2;GRIK5;GRIK2;GRIK4;GABRA3;GRID2;GABRA1
prerank,retinoic acid receptor binding (GO:0042974),0.3445544581195711,0.7821992936208538,0.7606727037516171,0.9782351008036582,1.0,7/17,25.84%,PRMT2;VDR;NRIP1;NSD1;NCOA6;ASXL1;RARG
prerank,transaminase activity (GO:0008483),0.37485259136523036,0.7813763103848519,0.7646239554317549,0.9772053063097508,1.0,3/11,20.58%,BCAT1;PSAT1;GOT1
prerank,H4 histone acetyltransferase activity (GO:0010485),0.38064025565159354,0.7802069357765944,0.7416666666666667,0.9767339651794978,1.0,3/10,18.79%,MSL3;USP22;NAA50
prerank,lysine N-methyltransferase activity (GO:0016278),0.3402307835958459,0.7773912295411333,0.7571606475716065,0.978437933610153,1.0,7/20,26.78%,SETD7;SETD2;ANTKMT;EHMT2;EEF2KMT;EEF1AKMT3;KMT5A
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.31184820423913184,0.7770505179137515,0.771889400921659,0.9767428151547454,1.0,4/33,12.48%,DIS3L2;ERI3;EXOSC7;REXO2
prerank,neuropeptide binding (GO:0042923),-0.2587190668376702,-0.7761561854053426,0.8512820512820513,0.9211956304880431,1.0,10/18,40.47%,SORL1;OPRK1;OPRM1;NMUR2;OPRL1;SSTR2;MC4R;SSTR1;OPRD1;NMUR1
prerank,nucleotidase activity (GO:0008252),0.3511311260560337,0.7755991791540838,0.7635135135135135,0.9765201556462291,1.0,4/15,21.18%,NT5M;BPNT2;ACP3;NT5DC2
prerank,acetylcholine receptor activity (GO:0015464),0.3272335800740753,0.7664494602173884,0.7670384138785625,0.9865303867482831,1.0,3/22,17.91%,CHRNA7;CHRFAM7A;CHRNA5
prerank,estrogen receptor binding (GO:0030331),0.3075738574615324,0.7654494578660268,0.7929465301478953,0.9856350293261392,1.0,10/32,24.40%,ESR1;PRMT2;TRIP4;DCAF13;PADI2;NRIP1;NSD1;NCOA6;LATS1;LCOR
prerank,carboxylic ester hydrolase activity (GO:0052689),0.27616559669080526,0.7647304259007889,0.8681204569055037,0.9845202303072016,1.0,11/85,20.38%,MGLL;CEL;PLAAT1;LCAT;PON3;APMAP;DAGLB;PLA2G4E;PTRH2;LIPC;GDPD3
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.334196324192622,0.7643986690139443,0.7571059431524548,0.982782763213138,1.0,7/18,24.70%,TGFBR2;ACVR1;AMHR2;TGFBR1;ACVR2A;BMPR1A;ACVR1B
prerank,calcium channel activity (GO:0005262),0.27650290413341605,0.7628659996674324,0.8417721518987342,0.9825600960610307,1.0,23/84,26.25%,CACNA2D2;ANXA2;PKD1;TRPV3;PKD2;MCU;PSEN1;ITGAV;CACNG2;CACHD1;CATSPER3;CACNB1;SEC61A1;CHRNA7;NCS1;CUL5;TRPC1;CACNA2D1;ANXA6;TRPV2;TMCO1;SLC24A4;SLC24A2
prerank,glutathione transferase activity (GO:0004364),-0.23879943032389722,-0.7623515832691323,0.8128342245989305,0.9339964495474976,1.0,8/23,26.35%,LANCL1;GSTA4;MGST1;GSTA3;MGST3;GSTO1;GSTT2;GSTK1
prerank,four-way junction DNA binding (GO:0000400),0.344546202136499,0.7588797562826401,0.7817715019255456,0.9856499590338066,1.0,7/17,27.43%,XRCC3;RAD51B;HMGB3;BLM;RAD51D;MSH6;MEN1
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.28838808747693273,0.7542208401648429,0.8325991189427313,0.9895174753272635,1.0,15/49,25.51%,ZRANB1;RAD23B;HDAC6;ZBTB1;OTUD7B;SQSTM1;TNIP1;ABRAXAS1;FAAP20;TAB2;TNIP2;UBQLN4;PSMD4;AGAP3;UFD1
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.3720784715172635,0.7525379386967376,0.7823613086770982,0.9895647533741819,1.0,2/11,14.88%,SLC25A25;SLC25A17
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.2708366682321118,-0.751379319757784,0.7985074626865671,0.9422826768226467,1.0,4/13,13.36%,PRKAR1B;KCNQ1;RYR2;PRKAR2B
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.3730380524955712,0.7512288406960177,0.7878787878787878,0.9890510131513184,1.0,2/10,8.49%,PIK3C2B;PIK3CA
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.3112950255503013,0.7505717546797278,0.7920673076923077,0.9877385529774235,1.0,7/25,21.13%,SESTD1;PLEKHA4;AKT1;PLEKHA1;PLA2G4E;ANXA8;GAB2
prerank,hexose transmembrane transporter activity (GO:0015149),0.35577261970287405,0.7503008322484248,0.7861111111111111,0.9859266705038174,1.0,1/12,2.06%,MFSD4A
prerank,microtubule minus-end binding (GO:0051011),-0.2730171804728181,-0.7490428572927548,0.8,0.9371881641738737,1.0,3/13,9.66%,TUBGCP4;CEP290;MACF1
prerank,NF-kappaB binding (GO:0051059),0.313954978203081,0.7467071310239192,0.8012422360248447,0.9880994262359653,1.0,9/24,31.82%,HDAC3;NPM1;COMMD6;ANXA4;CPNE1;RELA;BCL10;BRMS1;CDK5RAP3
prerank,voltage-gated sodium channel activity (GO:0005248),0.31542429272973144,0.7466697598494059,0.7871287128712872,0.9860080985805814,1.0,11/22,35.52%,PKD2;HCN4;SCN4B;HCN1;SCN9A;SCN2A;CACNA1H;CACNA1I;CACNA1G;SCN8A;SCN1A
prerank,nucleosomal DNA binding (GO:0031492),-0.24499400449884406,-0.7463653089927607,0.8507462686567164,0.9329520982182047,1.0,5/21,14.05%,H3-3A;CHD4;ACTB;MTA2;SMARCB1
prerank,poly-pyrimidine tract binding (GO:0008187),0.3154048261993124,0.7463417664629154,0.8071693448702101,0.9842603293564243,1.0,3/23,10.62%,DIS3L2;RBMS3;HNRNPH1
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.2945772366777946,-0.7457627046838875,0.7896551724137931,0.9260419077412541,1.0,2/11,10.38%,KCND3;KCNQ1
prerank,phospholipid transfer activity (GO:0120014),0.322516217022814,0.7454961524545497,0.8095838587641866,0.9831940911792425,1.0,6/21,20.35%,TRIAP1;OSBPL2;PRELID3A;GLTP;PITPNM1;PRELID1
prerank,RNA cap binding (GO:0000339),0.33842376846242267,0.7450227183530246,0.8071808510638298,0.9817360360232922,1.0,8/16,28.38%,EIF4A1;AGO2;LARP1;EIF3D;NCBP3;CYFIP1;EIF4E2;LSM1
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.2555773188932058,0.7441569529223785,0.989,0.9806755403753245,1.0,128/431,28.87%,TNK1;PFKP;RAB32;RAB6A;IRAK3;ATP1A3;ATP1A1;P2RX3;ACVR1;GTPBP4;ACLY;RAP1B;MVK;ABCE1;IGHMBP2;ARF4;SCG5;TBCK;RIT2;ABCA1;ABCB8;MYO9B;UBA2;N4BP2;HSPA13;DYNC1LI1;PPP5C;CLPX;GALK1;AKT3;RHOJ;ARF1;RHOQ;ERN1;TWF1;DYRK2;TUBB6;RAB2A;TARS1;NRAS;KRAS;AKT1;MAP3K6;SARS2;PNPLA8;GTPBP10;NUDT16;RRAD;TUBD1;PXK;RHOA;RRAGD;STK3;HSP90AA1;PEX1;ARF6;TUBB4A;TUBA4A;GEM;RAB27B;CHD8;HSPA14;GLUD1;RND3;PMVK;HARS1;RAC3;PRPS1;PRPS1L1;RAB35;IDE;NME1;ABCF1;ABCB9;RAB1B;BLM;TGFBR1;STK38;PANK3;RRAS2;ABCD3;OXSR1;STK26;PIP4K2B;RALA;RAB10;BMPR1A;SRPK1;SRR;PI4K2A;ADSS2;MYO1F;TUBG2;KCNJ11;RABL3;LATS1;WNK2;ARL8A;NOA1;ACVR1B;MARK2;ANXA6;RAC1;RAB29;ATL1;RHOT2;RHOBTB2;EIF2B2;EIF4G1;MAST2;RND2;MSH6;RAP1A;NDUFA13;DIRAS2;P2RX4;TUBB2A;RHEBL1;PRPS2;TSR1;RAP2B;PRKCI;RPS6KA5;MYH10;PEAK1;BMPR1B;ATP5F1A;PTPA
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.2990015542491301,0.7436746500678311,0.8080459770114943,0.9791954820914281,1.0,14/34,28.06%,SETD7;SETD2;ANTKMT;EHMT2;EEF2KMT;PRDM9;N6AMT1;EZH2;SETDB1;CAMKMT;EEF1AKMT3;KMT5A;MEN1;SUV39H1
prerank,cyclic nucleotide binding (GO:0030551),0.320380157315174,0.743590557857608,0.795,0.9772105507494461,1.0,5/21,11.90%,PDE11A;PDE10A;CNGB1;PDE4D;PDE5A
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.25958119415621417,0.7372839399435924,0.9304435483870968,0.9827034614436405,1.0,36/147,20.73%,ARHGEF28;AKAP13;PLCE1;CCDC88C;RASGRF1;PREB;FARP2;RASGEF1A;FARP1;FRMD7;MYCBP2;RGL1;HPS4;ARHGEF10;RGL2;NGEF;EGF;SMCR8;DENND1A;RAPGEF1;EEF1B2;MADD;EPS8L2;SOS1;ANKRD27;RCC1L;MON1A;DENND6A;DNMBP;EIF2B1;ARFGEF1;DOCK4;SERGEF;TIAM1;DENND4B;DENND2A
prerank,histone acetyltransferase binding (GO:0035035),0.3160757424847719,0.7332849661471673,0.8015267175572519,0.9854319789313764,1.0,5/21,15.77%,TRIP4;SIRT2;GLI3;BCAS3;TRIM68
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.3373382021014996,0.7313375977148028,0.8200270635994588,0.9856863359898678,1.0,3/14,18.73%,KCNJ2;KCNJ3;KCNH2
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.35383908661822816,0.7311467771451998,0.7983425414364641,0.9838498712765891,1.0,3/13,14.59%,SLC7A6;SLC7A3;SLC15A4
prerank,phosphatidylcholine transporter activity (GO:0008525),0.3265368927921795,0.7296467917933144,0.8051282051282052,0.9834701042512644,1.0,2/17,7.00%,ATP8B1;ABCA1
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.3095052397071847,0.7245413384315728,0.8390243902439024,0.9873014458491136,1.0,2/24,5.90%,SESTD1;PLEKHF1
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.34486998254328066,0.7226290600269846,0.8014184397163121,0.9874878241122563,1.0,2/12,4.40%,TGFBR2;ACVR1
prerank,organic cation transmembrane transporter activity (GO:0015101),0.32928942263067174,0.7171813695657206,0.820855614973262,0.9915728164485509,1.0,4/16,17.46%,SLC18A3;SLC44A1;SLC25A17;SLC44A2
prerank,potassium channel regulator activity (GO:0015459),0.277850059621765,0.7171747249998843,0.8549280177187154,0.9895068382639304,1.0,10/49,20.33%,KCNV1;SGK3;SGK2;YWHAE;AKT1;KCNAB3;CHP1;AKAP9;RASA1;FLNA
prerank,purinergic nucleotide receptor activity (GO:0001614),0.32653916917823916,0.7171593141266347,0.8173455978975033,0.9874638275531075,1.0,1/15,4.28%,P2RX3
prerank,pseudouridine synthase activity (GO:0009982),0.3374039424956847,0.7121190639149971,0.8276333789329685,0.9911242161119745,1.0,1/13,4.19%,RPUSD1
prerank,mRNA 5'-UTR binding (GO:0048027),0.2964264942794843,0.7111896140107925,0.8441558441558441,0.9901281586739279,1.0,4/24,15.49%,MRPS11;IGF2BP1;LARP1;RSL1D1
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.3435750530709635,0.7082067245943195,0.8260869565217391,0.9913562367642738,1.0,2/12,14.88%,SLC25A25;SLC25A17
prerank,adenylate cyclase binding (GO:0008179),-0.2900782302709575,-0.7077232533262305,0.8155339805825242,0.9661127807295365,1.0,3/10,12.80%,ADCY5;CAP2;AKAP6
prerank,GTPase regulator activity (GO:0030695),0.24719482555697345,0.7070395709417597,0.978894472361809,0.9904858778276386,1.0,30/212,10.24%,GPSM2;ARHGAP10;SGSM2;ARHGAP44;RABGAP1L;SLIT2;CDC42EP2;ELMOD1;LLGL1;RAP1GAP2;PREB;ARHGAP42;ADAP1;ASAP3;TBCK;MYO9B;FLCN;SEC23A;OCRL;ARHGAP9;GPSM1;TBC1D2B;ARFGAP3;ARFGAP1;ARHGEF10L;IQGAP1;TBC1D17;TAGAP;SIRPA;GDI1
prerank,single-stranded DNA helicase activity (GO:0017116),0.306815495037951,0.7037795671385785,0.85995085995086,0.9919761367049458,1.0,3/19,15.70%,HELQ;DNA2;RFC4
prerank,GTPase activator activity (GO:0005096),0.24363901916881633,0.7036731356010226,0.984,0.9900606451612622,1.0,92/313,24.88%,ARHGEF28;ARHGAP10;SGSM2;ARHGAP44;AKAP13;PLCE1;CCDC88C;RABGAP1L;CDC42EP2;ELMOD1;LLGL1;RAP1GAP2;RASGRF1;PREB;ARHGAP42;ADAP1;FARP2;ASAP3;TBCK;RASGEF1A;FARP1;MYO9B;FRMD7;FLCN;MYCBP2;SEC23A;OCRL;ARHGAP9;RGL1;HPS4;TBC1D2B;ARFGAP3;ARFGAP1;ARHGEF10L;IQGAP1;TBC1D17;ARHGEF10;TAGAP;RGL2;TBC1D10A;PGAM5;NGEF;EGF;SMCR8;DENND1A;RAPGEF1;HACD3;EEF1B2;MADD;EVI5;SGSM1;EPS8L2;SOS1;ANKRD27;EVI5L;TBC1D13;SRGAP2;ARAP1;RCC1L;ADPRH;TBC1D22B;RP2;TBC1D15;MON1A;DENND6A;DNMBP;EIF2B1;ARFGEF1;DOCK4;SERGEF;RASA1;TIAM1;DENND4B;DENND2A;ARHGAP17;ARRB1;RUNDC1;JUN;NF1;GNB5;CCDC88A;TBC1D8B;TBC1D12;VAV2;DOCK11;BCR;ARHGAP20;STXBP5L;ALS2;TSC2;ITSN1;RGS2
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),-0.24559982414937914,-0.7016500967177256,0.8479087452471483,0.965284997750443,1.0,1/15,2.42%,CCR9
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.33333825576909937,0.6997928576304947,0.8226666666666667,0.9920369626335841,1.0,2/12,8.96%,CDK4;CDK9
prerank,exonuclease activity (GO:0004527),0.26445955494307605,0.6948690346703428,0.8972375690607735,0.9952077240354519,1.0,8/46,17.41%,REV3L;EXOSC7;RAD1;FAN1;REXO2;ZC3H12A;EXOSC1;RAD50
prerank,metalloexopeptidase activity (GO:0008235),0.2633577298076528,0.694609729455171,0.8947939262472885,0.9934383249208817,1.0,15/51,25.31%,ANPEP;LNPEP;DPEP1;XPNPEP3;NUDT16;NPEPPS;LAP3;MMP16;METAP2;METAP1;CPZ;METAP1D;MMP15;ZMPSTE24;AGBL1
prerank,phospholipase C activity (GO:0004629),0.2905396857147553,0.6914704635686989,0.8604651162790697,0.9945999050397171,1.0,2/25,4.67%,PLCE1;PLCB4
prerank,nuclear export signal receptor activity (GO:0005049),-0.28620446121314636,-0.6909657269203299,0.8549618320610687,0.9685047344859238,1.0,4/11,26.88%,XPO5;NUP214;XPO1;CSE1L
prerank,voltage-gated chloride channel activity (GO:0005247),0.35025850370485506,0.6887369009091783,0.8475033738191633,0.9953917776888354,1.0,1/10,5.11%,CLCN5
prerank,G protein-coupled photoreceptor activity (GO:0008020),-0.25666804491824624,-0.6883234815690085,0.8644688644688645,0.9634107663835684,1.0,11/12,50.41%,ELOVL4;GPR88;GPR52;RRH;OPN1MW3;OPN1MW;RHO;OPN5;OPN1SW;GNAT2;OPN4
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.17077290228988745,-0.6875405463023795,0.9868421052631579,0.9564990942245845,1.0,23/57,26.29%,COX4I1;NDUFA9;NDUFA5;NDUFB4;CYB561A3;UQCR11;NDUFA4;NDUFB10;NDUFB8;NDUFS4;NDUFC1;UQCRFS1;NDUFA10;CYBRD1;NDUFA6;NDUFS2;COX5A;NDUFS8;NDUFA12;NDUFA8;NDUFS6;NDUFS7;NDUFA4L2
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.33205683926203283,0.6875375118257004,0.847682119205298,0.9945613904832952,1.0,2/12,8.49%,PIK3C2B;PIK3CA
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.32105536939544455,0.6875152413840263,0.8419654714475432,0.9925619996244425,1.0,6/14,20.31%,EXO5;NDUFS1;ACO2;ETFDH;RSAD1;CIAO3
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.27052029576652065,0.6874444636085634,0.8893905191873589,0.9906285058079779,1.0,18/40,35.14%,MEPCE;COMTD1;GAMT;COMT;N6AMT1;ICMT;ASMT;NNMT;SUV39H1;PRMT8;METTL9;THUMPD3;LRTOMT;AS3MT;PRMT7;DNMT3B;FBL;THUMPD2
prerank,acetyltransferase activity (GO:0016407),0.27742503943063856,0.6868893298443849,0.8875739644970414,0.9891563520185405,1.0,9/31,22.21%,GNPNAT1;LCAT;KAT2B;NAT8;SAT1;NAA15;NAA50;ACAT1;KAT6B
prerank,DNA replication origin binding (GO:0003688),-0.21514943039712328,-0.6827739391573434,0.9034090909090909,0.9536436290248926,1.0,2/23,3.07%,ORC5;MCM9
prerank,adenylyltransferase activity (GO:0070566),0.29058976170008505,0.6825470428353804,0.8541409147095179,0.9913844932589961,1.0,5/21,18.36%,TENT4A;SELENOO;PAPOLB;TENT2;TENT4B
prerank,phospholipase A2 activity (GO:0004623),0.28363890724052276,0.6825338966588379,0.8552631578947368,0.9894016427656097,1.0,3/26,15.33%,PLAAT1;PNPLA8;PLA2G4E
prerank,proton transmembrane transporter activity (GO:0015078),0.26540195564373087,0.6781124358980688,0.9051918735891648,0.9916598865902523,1.0,7/39,21.20%,CLCN5;SLC11A2;SLC9A1;UQCRQ;ATP6V1B2;UQCRH;UQCR10
prerank,retinoid X receptor binding (GO:0046965),0.3214516148715356,0.6755405230028753,0.8473389355742297,0.9920680721307418,1.0,5/11,25.84%,VDR;NRIP1;NSD1;NCOA6;RARG
prerank,adenyl ribonucleotide binding (GO:0032559),0.23407357774860546,0.6754892570873807,0.991,0.9901469524989703,1.0,59/291,21.08%,GCLC;TNK1;PFKP;IRAK3;ATP1A3;ATP1A1;P2RX3;ACVR1;ACLY;MVK;ABCE1;IGHMBP2;TBCK;PDE10A;ABCA1;ABCB8;MYO9B;UBA2;N4BP2;HSPA13;PPP5C;CLPX;GALK1;AKT3;ERN1;TWF1;DYRK2;TARS1;AKT1;MAP3K6;SARS2;PNPLA8;PDE4D;PXK;STK3;HSP90AA1;PEX1;CHD8;HSPA14;GLUD1;PMVK;HARS1;PRPS1;PRPS1L1;IDE;NME1;ABCF1;ABCB9;BLM;TGFBR1;STK38;HCN1;PANK3;ABCD3;OXSR1;STK26;PIP4K2B;BMPR1A;SRPK1
prerank,Wnt-activated receptor activity (GO:0042813),0.30681616851743987,0.6753495442705627,0.8715953307392996,0.9883042540798519,1.0,3/15,15.34%,PKD1;FZD7;FZD4
prerank,inward rectifier potassium channel activity (GO:0005242),0.285403928488645,0.6752364829871352,0.8724179829890644,0.9864532057260262,1.0,5/24,23.16%,KCNJ2;KCNJ3;KCNH2;ABCC8;KCNJ11
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.31329375036341983,0.6736800117488925,0.8567639257294429,0.9859093112763582,1.0,5/13,21.27%,PIK3C2B;PIK3CA;PIP4K2C;PIP4K2B;PIK3CG
prerank,ATP binding (GO:0005524),0.23336189160048673,0.6734538237392423,0.987,0.9841192011461485,1.0,54/266,21.08%,TNK1;PFKP;IRAK3;ATP1A3;ATP1A1;P2RX3;ACVR1;ACLY;MVK;ABCE1;IGHMBP2;TBCK;ABCA1;ABCB8;MYO9B;UBA2;N4BP2;HSPA13;PPP5C;CLPX;GALK1;AKT3;ERN1;TWF1;DYRK2;TARS1;AKT1;MAP3K6;SARS2;PNPLA8;PXK;STK3;HSP90AA1;PEX1;CHD8;HSPA14;PMVK;HARS1;PRPS1;PRPS1L1;IDE;NME1;ABCF1;ABCB9;BLM;TGFBR1;STK38;PANK3;ABCD3;OXSR1;STK26;PIP4K2B;BMPR1A;SRPK1
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.32882819297271937,0.6687589028485555,0.8544668587896254,0.986422894984865,1.0,5/10,33.39%,POLD1;DCLRE1A;MGME1;EXO1;TATDN1
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.2585121471699716,0.6679028912353465,0.9091928251121076,0.9852712677875413,1.0,19/44,29.32%,CXXC1;SETD7;WDR5;SETD2;EHMT2;SETD5;PRDM9;KMT2C;SETD1B;KMT2A;N6AMT1;NSD1;EZH2;SETDB1;SETDB2;KMT5A;MEN1;SUV39H1;SETD1A
prerank,channel activity (GO:0015267),0.26270554962842463,0.6666322983539443,0.9098265895953758,0.9844290895775876,1.0,5/41,17.16%,TRPV3;TMEM266;MCUB;TMEM120A;CHRNA7
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.2683018275221891,0.6654943439992426,0.903755868544601,0.9834855613164654,1.0,9/33,20.30%,UBA2;SIAH1;TCERG1;RNF14;AUP1;ARIH2;RNF19A;TOLLIP;ARIH1
prerank,5'-3' RNA polymerase activity (GO:0034062),0.26986827667237034,0.6635719586616744,0.8956310679611651,0.9832634198969202,1.0,10/27,27.36%,POLR2D;POLR2G;POLR3H;TENT2;POLR1D;POLR1C;POLR3A;POLR1B;POLR2C;MED21
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.2645026896340878,0.6631217504887499,0.9083619702176403,0.9818046010752802,1.0,8/35,20.76%,TYW3;FTSJ1;DTWD1;PTRH2;TRPT1;QTRT1;DUS2;QRSL1
prerank,DNA secondary structure binding (GO:0000217),0.26732102485906184,0.6625040788497838,0.9028901734104047,0.9804092981594579,1.0,12/31,28.97%,XRCC3;RAD51B;MAPT;HMGB3;ERCC5;BLM;KMT2A;CLSPN;RAD51D;MSH6;MEN1;LIN54
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.2694444466623616,0.6574626414931268,0.8967587034813925,0.9828848994452379,1.0,15/27,35.69%,POLR2D;POLR2G;POLR3H;POLR1D;POLR1C;POLR3A;POLR1B;POLR2C;MED21;PRIM1;POLR2I;CRCP;POLR2E;POLR2B;POLR2J
prerank,kinase activity (GO:0016301),0.23784902402850133,0.6569236481553834,0.9452479338842975,0.9814315108592728,1.0,26/109,21.27%,PAPSS2;DGKQ;PIK3C2B;MTOR;MVK;CHKB;GK5;PIK3CA;AGK;AKT1;PGM2L1;IRAK1;STK39;PSTK;CERK;PRKD3;PI4KB;PANK1;PI4KA;PMVK;IPPK;PANK3;DCAKD;IP6K1;TRRAP;PIK3CG
prerank,FMN binding (GO:0010181),-0.2621415919854122,-0.655507727318856,0.901060070671378,0.9703513053829559,1.0,4/11,18.51%,NOS3;NOS1;NDOR1;PPCDC
prerank,chloride channel activity (GO:0005254),0.248363360557652,0.6543227650212136,0.9293478260869565,0.9817614806551691,1.0,8/59,19.26%,ANO3;CLCN5;GABRR3;CLCC1;GABRG3;TTYH3;ANO5;GABRG2
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.27723212923981067,0.6522695689021788,0.8932515337423312,0.9814917415753603,1.0,7/24,20.19%,NME2;PMVK;CMPK2;NME1;AK8;AK9;IP6K1
prerank,death receptor binding (GO:0005123),0.2988973409943865,0.6486846165540235,0.8788694481830417,0.982535892006069,1.0,3/15,15.90%,TMBIM1;EDA;MADD
prerank,NAD binding (GO:0051287),0.2714351311957236,0.6467928579567522,0.902200488997555,0.9820904833519939,1.0,9/26,21.42%,SIRT2;ZC3HAV1;CRYZ;HSD17B8;GLUD1;NUDT6;BDH2;CTBP1;UXS1
prerank,diacylglycerol kinase activity (GO:0004143),0.3165080289441089,0.6456447261719478,0.8595505617977528,0.9811449737390132,1.0,2/11,9.22%,DGKQ;AGK
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.3045561173046315,0.6445760434310446,0.8943758573388203,0.9801044546902482,1.0,8/13,34.85%,GABRG3;GABRG2;GLRA3;GABRA3;GABRA1;GLRA2;GABRA5;GLRA1
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.257224530895004,0.6369088991725655,0.9256678281068524,0.9841728810775184,1.0,4/34,12.48%,DIS3L2;ERI3;EXOSC7;REXO2
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.3051769113593212,0.6340783719193293,0.8934081346423562,0.9845196142195138,1.0,5/10,31.20%,GLCE;GNE;GALM;DSEL;GALE
prerank,phosphoric ester hydrolase activity (GO:0042578),0.24077296788089003,0.6330084046150505,0.9441964285714286,0.9834635201757382,1.0,13/49,23.47%,ACP2;PTPRJ;PPP5C;DUSP11;SAMHD1;PGAM5;PHOSPHO2;PPP1CC;SMPD1;ACP3;GDPD3;ACP6;LHPP
prerank,alpha-actinin binding (GO:0051393),0.2619078695741385,0.6287061760932727,0.9215686274509803,0.9847026662053949,1.0,4/24,13.54%,PDLIM7;PKD2;PDLIM1;PALLD
prerank,sequence-specific mRNA binding (GO:1990825),-0.24838365451007466,-0.6280749896057091,0.9220338983050848,0.9838153744403745,1.0,10/10,75.18%,SSB;SHFL;TYMS;LIN28A;FMR1;DHX9;ETF1;DHFR;RBM24;LARP6
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.28815169233094956,0.6256902706352547,0.8912751677852349,0.9850520404055376,1.0,6/14,29.84%,BLVRB;CRYM;PYCR1;DHFR;NOXRED1;PYCR3
prerank,5'-nucleotidase activity (GO:0008253),0.28516539714993466,0.6174164342836529,0.9097222222222222,0.9892392146404835,1.0,3/13,21.18%,NT5M;ACP3;NT5DC2
prerank,histone demethylase activity (GO:0032452),0.2565895758801927,0.6161100538473686,0.9253554502369669,0.988257056140549,1.0,11/27,28.64%,KDM3B;KDM5C;KDM5B;JMJD1C;FBXL19;KDM2B;KDM4C;KDM3A;JARID2;KDM4B;KDM2A
prerank,carbohydrate kinase activity (GO:0019200),0.3031454834720725,0.6143045105673542,0.8941504178272981,0.9875644861931215,1.0,3/11,18.68%,NAGK;GALK1;GNE
prerank,voltage-gated ion channel activity (GO:0005244),0.2840546163665127,0.611282550386874,0.9104477611940298,0.9879151176816164,1.0,4/14,19.05%,PKD2;VDAC2;VDAC1;HCN1
prerank,endodeoxyribonuclease activity (GO:0004520),0.2635876200834766,0.6094490647243879,0.9312581063553826,0.9872295351526561,1.0,5/20,22.85%,ERCC4;DNA2;RAD50;ERCC5;ERCC1
prerank,tRNA methyltransferase activity (GO:0008175),0.27709079905269374,0.6084460769164088,0.9191374663072777,0.9859892002892829,1.0,2/16,8.42%,TYW3;FTSJ1
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.27635204213717185,0.6070527456983745,0.9067909454061251,0.9850465164333229,1.0,4/15,17.63%,HS2ST1;HS3ST6;HS3ST5;NDST2
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.23176639105940178,-0.599890130982274,0.9518518518518518,0.9939040259757694,1.0,6/12,26.74%,GABRG1;GABRB3;GABRA4;GABRE;GABRB2;GABRA2
prerank,NAD+ binding (GO:0070403),0.28698078951866196,0.5942350769628316,0.9402560455192034,0.990990553485605,1.0,4/12,21.42%,SIRT2;ZC3HAV1;GLUD1;UXS1
prerank,pyridoxal phosphate binding (GO:0030170),0.25923534140430693,0.5930254825044289,0.9346733668341709,0.989770464305799,1.0,8/20,30.21%,ACCS;PSAT1;PYGB;GLDC;SRR;CTH;PNPO;PLPBP
prerank,ankyrin binding (GO:0030506),0.2569870249815633,0.5910301298385073,0.9451530612244898,0.9890159152575916,1.0,6/19,25.91%,SPTBN1;KCTD6;PLEC;SPTBN4;KCNJ11;NRCAM
prerank,cation transmembrane transporter activity (GO:0008324),0.22669377749375527,0.5866327154326013,0.96353591160221,0.9897733440867195,1.0,11/48,25.71%,SLC1A5;SFXN1;SLC7A3;SLC15A4;SLC38A1;SLC25A15;SLC8B1;SLC38A9;SLC25A2;SLC36A4;SFXN2
prerank,symporter activity (GO:0015293),0.2785280834026433,0.573746328305233,0.9322990126939351,0.9947493770090106,1.0,1/10,11.12%,SLC4A4
prerank,neuropeptide receptor binding (GO:0071855),0.2661518176681108,0.5733849707680946,0.948,0.9930748146714569,1.0,14/14,73.41%,NMU;SHANK1;AGRP;NTS;PPY;APELA;UCN3;QRFP;GHRH;NPPA;UCN2;GAL;APLN;NPY
prerank,GABA receptor binding (GO:0050811),0.2743670051515804,0.5718569773951432,0.9306930693069307,0.9920122646948868,1.0,1/11,6.69%,TRAK2
prerank,5'-3' exonuclease activity (GO:0008409),0.26331844936623694,0.5688245955988327,0.9497282608695652,0.991656966681027,1.0,6/14,32.81%,FAN1;DCLRE1A;TRIR;CPSF3;EXO1;XRN2
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.2707433355499906,0.5665598132797547,0.9416666666666667,0.9909437758773882,1.0,1/11,8.04%,HMCES
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.27286526597275684,0.5659242960319584,0.9466484268125855,0.9894324110594032,1.0,4/11,26.34%,STUB1;AMFR;UBE2K;PRPF19
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.24055447090135446,0.5565772388779535,0.955,0.9920668051972931,1.0,6/22,27.79%,CLTC;HSPG2;SYT1;AP2M1;HSP90B1;DNAJA1
prerank,GABA-A receptor activity (GO:0004890),0.23821688256544452,0.5453965511040239,0.960559796437659,0.994927227885311,1.0,3/18,19.26%,GABRR3;GABRG3;GABRG2
prerank,kinesin binding (GO:0019894),0.22410089426258636,0.5375666001218787,0.9782082324455206,0.996222355354666,1.0,11/27,31.69%,TOR1A;ARHGEF10;ATCAY;CROCC;RAB29;KIFAP3;SPAG9;MAPK8IP3;PLEKHM2;KLC2;KIF1B
prerank,protein phosphatase activator activity (GO:0072542),0.2548480843138413,0.5355704336741297,0.9681881051175657,0.9951730975031892,1.0,3/13,17.06%,B3GAT3;CALM2;PPP2R5B
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.16553083920226197,-0.5203985166749583,1.0,1.0,1.0,12/22,38.94%,HTR4;HTR7;HRH1;HTR1B;HRH2;CHRM1;HTR6;HTR5A;HTR1A;HRH3;CHRM5;HTR1D
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.16553083920226197,-0.5203985166749583,1.0,1.0,1.0,12/22,38.94%,HTR4;HTR7;HRH1;HTR1B;HRH2;CHRM1;HTR6;HTR5A;HTR1A;HRH3;CHRM5;HTR1D
prerank,serotonin receptor activity (GO:0099589),-0.16553083920226197,-0.5203985166749583,1.0,1.0,1.0,12/22,38.94%,HTR4;HTR7;HRH1;HTR1B;HRH2;CHRM1;HTR6;HTR5A;HTR1A;HRH3;CHRM5;HTR1D
prerank,tumor necrosis factor receptor binding (GO:0005164),0.2474511339405953,0.5188247804848312,0.9718706047819972,0.9987839512661281,1.0,4/12,23.69%,TRAF3;TRAF4;TRAF5;TRAP1
prerank,ligand-gated anion channel activity (GO:0099095),0.23068914900717113,0.5167595294716315,0.9747340425531915,0.9975934421261581,1.0,9/17,34.85%,GABRG3;GABRG2;GLRA3;GABRA3;CFTR;GABRA1;GLRA2;GABRA5;GLRA1
prerank,vitamin D receptor binding (GO:0042809),0.24069136297779903,0.5135984855583013,0.9744279946164199,0.9967109329799361,1.0,3/14,21.59%,MED24;MED13;THRAP3
prerank,Notch binding (GO:0005112),0.2202132273952659,0.5134613672464999,0.9814126394052045,0.9949420614411731,1.0,5/22,23.82%,CUL3;JAG1;NCOR2;KCTD10;CCN3
prerank,histone methyltransferase binding (GO:1990226),0.24756093829798104,0.5093542573541113,0.9715832205683356,0.9943253769350964,1.0,5/11,34.41%,PHF1;LCOR;NOP56;WIZ;HSP90AB1
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.2539895306534567,0.5079720192099237,0.9586305278174037,0.9928889141812707,1.0,5/10,33.00%,GABRG3;GABRG2;GABRA3;GABRA1;GABRA5
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.19869765591169677,0.49564699010107,0.9909808342728298,0.992510071717345,1.0,9/34,27.23%,NDUFS5;NDUFS1;NDUFB7;NDUFV2;NDUFA2;NDUFB2;NDUFB3;NDUFB9;NDUFA13
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.19869765591169677,0.49564699010107,0.9909808342728298,0.992510071717345,1.0,9/34,27.23%,NDUFS5;NDUFS1;NDUFB7;NDUFV2;NDUFA2;NDUFB2;NDUFB3;NDUFB9;NDUFA13
prerank,endopeptidase activator activity (GO:0061133),0.24028868270392922,0.4861258826725057,0.9712643678160919,0.9927677825225978,1.0,1/10,8.48%,ADRM1
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.17067503924646782,-0.48351402700078594,0.9845559845559846,1.0,1.0,16/16,82.96%,CD38;TDG;NEIL1;NEIL3;NTHL1;NEIL2;BST1;DNPH1;RPS3;OARD1;MACROD1;ADPRS;SMUG1;MACROD2;ADPRH;SARM1
prerank,neuropeptide receptor activity (GO:0008188),-0.1372549019607843,-0.46512536442236707,1.0,0.9966961143431732,1.0,29/29,86.31%,TACR1;TACR3;OPRM1;GALR1;NPY5R;NMUR2;GRPR;KISS1R;SSTR2;NPY1R;GPR143;NPY2R;SSTR1;NMUR1;NTSR1;NPFFR1;GAL;HCRTR2;TACR2;MCHR1;SSTR4;SSTR5;GALR3;GALR2;SORCS2;NPSR1;SORCS3;SORCS1;GPR37
prerank,GABA receptor activity (GO:0016917),0.1962210027705967,0.45893085198039907,0.9899497487437185,0.995905725008613,1.0,3/21,19.26%,GABRR3;GABRG3;GABRG2
prerank,MHC class I protein binding (GO:0042288),0.2124936912776828,0.4555331700406222,0.9877049180327869,0.9946156987786814,1.0,4/13,28.84%,ABCB9;DERL1;ATP5F1B;ATP5F1A
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.1868014567374104,0.4072044702098668,0.9973718791064389,0.9976824885582816,1.0,15/15,81.34%,PLA2G4E;PLA2G12A;PLA2G4D;PLA2G1B;PLA2G2F;PLA2G2E;PLA2G10;PLA2G2D;PLA2G2C;PLA2G3;PLA2G5;PLA2G4B;PLA2G4A;PLA2G4F;PLA2G4C
